BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016;24:490-502. [PMID: 27012512 DOI: 10.1016/j.tim.2016.03.003] [Cited by in Crossref: 1273] [Cited by in F6Publishing: 1359] [Article Influence: 212.2] [Reference Citation Analysis]
Number Citing Articles
1 Wang XC, Wu GL, Cai YF, Zhang SJ. The safety and efficacy of melatonin in the treatment of COVID-19: A systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e30874. [PMID: 36181086 DOI: 10.1097/MD.0000000000030874] [Reference Citation Analysis]
2 Alizadehmohajer N, Zahedifar S, Sohrabi E, Shaddel Basir S, Nourigheimasi S, Falak R, Nedaeinia R, A Ferns G, Emami Nejad A, Manian M. Using In Silico Bioinformatics Algorithms for the Accurate Prediction of the Impact of Spike Protein Mutations on the Pathogenicity, Stability, and Functionality of the SARS-CoV-2 Virus and Analysis of Potential Therapeutic Targets. Biochem Genet 2022. [PMID: 36173498 DOI: 10.1007/s10528-022-10282-9] [Reference Citation Analysis]
3 Singh A, Deolia P. COVID-19 outbreak: a predictive mathematical study incorporating shedding effect. J Appl Math Comput . [DOI: 10.1007/s12190-022-01792-1] [Reference Citation Analysis]
4 Mir AA, Sevukan R. Sentiment analysis of Indian Tweets about Covid-19 vaccines. Journal of Information Science. [DOI: 10.1177/01655515221118049] [Reference Citation Analysis]
5 Rajan M, Prabhakaran S, Prusty JS, Chauhan N, Gupta P, Kumar A. Phytochemicals of Cocculus hirsutus deciphered SARS-CoV-2 inhibition by targeting main proteases in molecular docking, simulation, and pharmacological analyses. J Biomol Struct Dyn 2022;:1-15. [PMID: 36099182 DOI: 10.1080/07391102.2022.2121758] [Reference Citation Analysis]
6 Babaei R, Bokharaei-Salim F, Khanaliha K, Kiani SJ, Marjani A, Garshasbi S, Dehghani-Dehej F, Chavoshpour S. Prevalence of SARS-CoV-2 infection in neonates born to mothers or relatives with COVID-19. BMC Infect Dis 2022;22:730. [PMID: 36076173 DOI: 10.1186/s12879-022-07688-6] [Reference Citation Analysis]
7 Pandey A, Madan R, Singh S. Immunology to Immunotherapeutics of SARS-CoV-2: Identification of Immunogenic Epitopes for Vaccine Development. Curr Microbiol 2022;79:306. [PMID: 36064873 DOI: 10.1007/s00284-022-03003-3] [Reference Citation Analysis]
8 Hu C, Wang Z, Ren L, Hao Y, Zhu M, Jiang H, Wang S, Li D, Shao Y. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination. Front Cell Infect Microbiol 2022;12:978440. [DOI: 10.3389/fcimb.2022.978440] [Reference Citation Analysis]
9 Rumaling MI, Chee FP, Bade A, Hasbi NH, Daim S, Juhim F, Duinong M, Rasmidi R. Methods of optical spectroscopy in detection of virus in infected samples: A review. Heliyon 2022;8:e10472. [DOI: 10.1016/j.heliyon.2022.e10472] [Reference Citation Analysis]
10 Tarek Ibrahim M, Tao P. Computational investigation of peptidomimetics as potential inhibitors of SARS-CoV-2 spike protein. J Biomol Struct Dyn 2022;:1-14. [PMID: 36038961 DOI: 10.1080/07391102.2022.2116601] [Reference Citation Analysis]
11 Leowattana W, Leowattana T, Leowattana P. SARS-CoV-2 viral load in the upper respiratory tract and disease severity in COVID-19 patients. World J Meta-Anal 2022; 10(4): 195-205 [DOI: 10.13105/wjma.v10.i4.195] [Reference Citation Analysis]
12 Merigo F, Lotti V, Bernardi P, Conti A, Clemente AD, Ligozzi M, Lagni A, Sorio C, Sbarbati A, Gibellini D. Ultrastructural Characterization of Human Bronchial Epithelial Cells during SARS-CoV-2 Infection: Morphological Comparison of Wild-Type and CFTR-Modified Cells. IJMS 2022;23:9724. [DOI: 10.3390/ijms23179724] [Reference Citation Analysis]
13 Armero A, Li R, Bienes KM, Chen X, Li J, Xu S, Chen Y, Hughes AC, Berthet N, Wong G. Myotis fimbriatus Virome, a Window to Virus Diversity and Evolution in the Genus Myotis. Viruses 2022;14:1899. [DOI: 10.3390/v14091899] [Reference Citation Analysis]
14 Tallei TE, Alhumaid S, AlMusa Z, Fatimawali, Kusumawaty D, Alynbiawi A, Alshukairi AN, Rabaan AA. Update on the omicron sub-variants BA.4 and BA.5. Rev Med Virol 2022;:e2391. [PMID: 36017597 DOI: 10.1002/rmv.2391] [Reference Citation Analysis]
15 Jiao Z, Yan Y, Chen Y, Wang G, Wang X, Li L, Yang M, Hu X, Guo Y, Shi Y, Peng G. Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors. J Virol 2022;:e0090722. [PMID: 36000844 DOI: 10.1128/jvi.00907-22] [Reference Citation Analysis]
16 Choudhary OP, Priyanka, Saied AA. COVID-19 vaccination in animals: A strategy for combating the global outbreak. Int J Surg 2022;105:106848. [PMID: 36028140 DOI: 10.1016/j.ijsu.2022.106848] [Reference Citation Analysis]
17 Saifulazmi NF, Rohani ER, Harun S, Bunawan H, Hamezah HS, Nor Muhammad NA, Azizan KA, Ahmed QU, Fakurazi S, Mediani A, Sarian MN. A Review with Updated Perspectives on the Antiviral Potentials of Traditional Medicinal Plants and Their Prospects in Antiviral Therapy. Life (Basel) 2022;12:1287. [PMID: 36013466 DOI: 10.3390/life12081287] [Reference Citation Analysis]
18 Zhang L, Jiang Z, Zhou Z, Sun J, Yan S, Gao W, Shao Y, Bai Y, Wu Y, Yan Z, Sheng S, Lai A, Su S. A TaqMan Probe-Based Multiplex Real-Time PCR for Simultaneous Detection of Porcine Epidemic Diarrhea Virus Subtypes G1 and G2, and Porcine Rotavirus Groups A and C. Viruses 2022;14:1819. [PMID: 36016441 DOI: 10.3390/v14081819] [Reference Citation Analysis]
19 Li J, Gao Z, Chen J, Cheng R, Niu J, Zhang J, Yang Y, Yuan X, Xia J, Mao G, Liu H, Dong Y, Wu C. Development of a panel of three multiplex allele-specific qRT-PCR assays for quick differentiation of recombinant variants and Omicron subvariants of SARS-CoV-2. Front Cell Infect Microbiol 2022;12:953027. [DOI: 10.3389/fcimb.2022.953027] [Reference Citation Analysis]
20 García-López R, Laresgoiti-Servitje E, Lemus-Martin R, Sanchez-Flores A, Sanders-Velez C. The New SARS-CoV-2 Variants and Their Epidemiological Impact in Mexico. mBio 2022;:e0106021. [PMID: 35972143 DOI: 10.1128/mbio.01060-21] [Reference Citation Analysis]
21 Alamri MM, Devol EB, Al-otaibi AB, Albaiz FA, Alabdely MH, Althawadi SI, Mutabagani MS, Alhamlan FS, Alrabiah FA, Almaghrabi RS. Descriptive analysis of clinical and laboratory findings in relation to changes in SARS-CoV-2 viral dynamics and cyclic threshold: a retrospective, single center observational study in patients treated with Hydroxychloroquine/Azithromycin combination therapy. F1000Res 2022;11:925. [DOI: 10.12688/f1000research.28290.1] [Reference Citation Analysis]
22 Karimabad MN, Hassanshahi G, Kounis NG, Mplani V, Roditis P, Gogos C, Lagadinou M, Assimakopoulos SF, Dousdampanis P, Koniari I. The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses. Vaccines 2022;10:1299. [DOI: 10.3390/vaccines10081299] [Reference Citation Analysis]
23 Tahyra ASC, Calado RT, Almeida F. The Role of Extracellular Vesicles in COVID-19 Pathology. Cells 2022;11:2496. [DOI: 10.3390/cells11162496] [Reference Citation Analysis]
24 Asghar A, Imran HM, Bano N, Maalik S, Mushtaq S, Hussain A, Varjani S, Aleya L, Iqbal HMN, Bilal M. SARS-COV-2/COVID-19: scenario, epidemiology, adaptive mutations, and environmental factors. Environ Sci Pollut Res Int 2022. [PMID: 35947257 DOI: 10.1007/s11356-022-22333-0] [Reference Citation Analysis]
25 da Silva SJR, do Nascimento JCF, Germano Mendes RP, Guarines KM, Targino Alves da Silva C, da Silva PG, de Magalhães JJF, Vigar JRJ, Silva-Júnior A, Kohl A, Pardee K, Pena L. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infect Dis 2022. [PMID: 35940589 DOI: 10.1021/acsinfecdis.2c00204] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Islam MM, Noor FM. Correlation between COVID-19 and weather variables: A meta-analysis. Heliyon 2022;8:e10333. [PMID: 35996423 DOI: 10.1016/j.heliyon.2022.e10333] [Reference Citation Analysis]
27 Cajigas S, Alzate D, Fernández M, Muskus C, Orozco J. Electrochemical genosensor for the specific detection of SARS-CoV-2. Talanta 2022;245:123482. [DOI: 10.1016/j.talanta.2022.123482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Solomon M, Liang C. Human coronaviruses: the emergence of SARS-CoV-2 and management of COVID-19. Virus Research 2022. [DOI: 10.1016/j.virusres.2022.198882] [Reference Citation Analysis]
29 Li Y, Zheng P, Liu T, Shi C, Wang B, Xu Y, Jin T. Structural Requirements and Plasticity of Receptor-Binding Domain in Human Coronavirus Spike. Front Mol Biosci 2022;9:930931. [PMID: 35903152 DOI: 10.3389/fmolb.2022.930931] [Reference Citation Analysis]
30 Pedersen J, Koumakpayi IH, Babuadze G, Baz M, Ndiaye O, Faye O, Diagne CT, Dia N, Naghibosadat M, McGeer A, Muberaka S, Moukandja IP, Ndidi S, Tauil CB, Lekana-Douki JB, Loucoubar C, Faye O, Sall A, Magalhães KG, Weis N, Kozak R, Kobinger GP, Fausther-Bovendo H. Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic. Sci Rep 2022;12:12962. [PMID: 35902675 DOI: 10.1038/s41598-022-17241-9] [Reference Citation Analysis]
31 Tang L, Zhang D, Han P, Kang X, Zheng A, Xu Z, Zhao X, Wang VY, Qi J, Wang Q, Liu K, Gao GF. Structural basis of SARS-CoV-2 and its variants binding to intermediate horseshoe bat ACE2. Int J Biol Sci 2022;18:4658-68. [PMID: 35874946 DOI: 10.7150/ijbs.73640] [Reference Citation Analysis]
32 Robert S J, Kadhiravan S. Prevalence of Digital Amnesia, Somatic Symptoms and Sleep Disorders among Youth during COVID-19 Pandemic. Heliyon 2022;:e10026. [PMID: 35880083 DOI: 10.1016/j.heliyon.2022.e10026] [Reference Citation Analysis]
33 Müller NF, Kistler KE, Bedford T. A Bayesian approach to infer recombination patterns in coronaviruses. Nat Commun 2022;13:4186. [PMID: 35859071 DOI: 10.1038/s41467-022-31749-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Soares R, Vieira CP, Vieira J. Predictive Models of within- and between-Species SARS-CoV-2 Transmissibility. Viruses 2022;14:1565. [DOI: 10.3390/v14071565] [Reference Citation Analysis]
35 Wright LR, Wright DL, Weller SK. Viral Nucleases from Herpesviruses and Coronavirus in Recombination and Proofreading: Potential Targets for Antiviral Drug Discovery. Viruses 2022;14:1557. [PMID: 35891537 DOI: 10.3390/v14071557] [Reference Citation Analysis]
36 Mitra J, Kodavati M, Provasek VE, Rao KS, Mitra S, Hamilton DJ, Horner PJ, Vahidy FS, Britz GW, Kent TA, Hegde ML. SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations. Ageing Res Rev 2022;80:101687. [PMID: 35843590 DOI: 10.1016/j.arr.2022.101687] [Reference Citation Analysis]
37 Otieno JR, Cherry JL, Spiro DJ, Nelson MI, Trovão NS. Origins and Evolution of Seasonal Human Coronaviruses. Viruses 2022;14:1551. [PMID: 35891531 DOI: 10.3390/v14071551] [Reference Citation Analysis]
38 Bhargava A, Dahiya P. COVID-19 Pandemic: Assessment of Current Strategies and Socio-economic Impact. Journal of Health Management. [DOI: 10.1177/09720634221109295] [Reference Citation Analysis]
39 Zhu J, Rawal G, Aljets E, Yim-im W, Yang Y, Huang Y, Krueger K, Gauger P, Main R, Zhang J. Development and Clinical Applications of a 5-Plex Real-Time RT-PCR for Swine Enteric Coronaviruses. Viruses 2022;14:1536. [DOI: 10.3390/v14071536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Qin L, Meng J, Ding X, Jiang T. Mapping Genetic Events of SARS-CoV-2 Variants. Front Microbiol 2022;13:890590. [DOI: 10.3389/fmicb.2022.890590] [Reference Citation Analysis]
41 Mas M, García-vicente JA, Estrada-gelonch A, Pérez-mañá C, Papaseit E, Torrens M, Farré M. Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence. JCM 2022;11:4038. [DOI: 10.3390/jcm11144038] [Reference Citation Analysis]
42 Wang X, Chen Y, Shi H, Zou P. Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly Inactivating the Virus Particle. Front Cell Infect Microbiol 2022;12:905248. [DOI: 10.3389/fcimb.2022.905248] [Reference Citation Analysis]
43 Li J, Lin C, Zhou X, Zhong F, Zeng P, McCormick PJ, Jiang H, Zhang J. Structural Basis of Main Proteases of Coronavirus Bound to Drug Candidate PF-07304814. J Mol Biol 2022;434:167706. [PMID: 35809383 DOI: 10.1016/j.jmb.2022.167706] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Raheja H, Das S, Banerjee A, P. D, C. D, Mukhopadhyay D, Ramachandra SG, Das S, Neogi U. RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System. Microbiol Spectr. [DOI: 10.1128/spectrum.00781-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Fazia T, Bubbico F, Nova A, Riggi E, Caimi G, Calgan B, Salvato G, Bruno S, Bottini G, Bernardinelli L. Online Short-Term Mindfulness-Based Intervention During COVID-19 Quarantine in Italy: Effects on Wellbeing, Stress, and Anxiety. Front Psychol 2022;13:914183. [DOI: 10.3389/fpsyg.2022.914183] [Reference Citation Analysis]
46 Zhou H, Cheng Y, Xu L, Li J, Tao C, Ji C, Han N, Yang R, Wu H, Li Y, Wu A. Genomic evidence for divergent co-infections of co-circulating SARS-CoV-2 lineages. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.07.042] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Asif M, Amir M, Hussain A, Achakzai NM, Natesan Pushparaj P, Rasool M. Role of tyrosine kinase inhibitor in chronic myeloid leukemia patients with SARS-CoV-2 infection: A narrative Review. Medicine (Baltimore) 2022;101:e29660. [PMID: 35777011 DOI: 10.1097/MD.0000000000029660] [Reference Citation Analysis]
48 Tang G, Liu Z, Chen D. Human coronaviruses: Origin, host and receptor. Journal of Clinical Virology 2022;155:105246. [DOI: 10.1016/j.jcv.2022.105246] [Reference Citation Analysis]
49 Georgakopoulou VE, Gkoufa A, Garmpis N, Makrodimitri S, Papageorgiou CV, Barlampa D, Garmpi A, Chiapoutakis S, Sklapani P, Trakas N, Damaskos C. COVID-19 and Acute Pancreatitis: A Systematic Review of Case Reports and Case Series. Ann Saudi Med 2022;42:276-87. [PMID: 35933608 DOI: 10.5144/0256-4947.2022.276] [Reference Citation Analysis]
50 Combes P, Bisseux M, Bal A, Marin P, Latour J, Archimbaud C, Brebion A, Chabrolles H, Regagnon C, Lafolie J, Destras G, Simon B, Izopet J, Josset L, Henquell C, Mirand A. Evidence of co-infections during Delta and Omicron SARS-CoV-2 variants co-circulation through prospective screening and sequencing. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.06.030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Leventopoulos M, Michou V, Papadimitropoulos M, Vourva E, Manias NG, Kavvadas HP, Nikolopoulos D, Tsilivakos V, Georgoulias G. Evaluation of the Boson Rapid Ag Test vs RT–PCR for use as a self–testing platform. Diagnostic Microbiology and Infectious Disease 2022. [DOI: 10.1016/j.diagmicrobio.2022.115786] [Reference Citation Analysis]
52 Sherwani S, Khan MWA, Mallik A, Khan M, Saleem M, Raafat M, Shati AA, Alam N. Seroprevalence of Anti-S1-RBD Antibodies in Pre-pandemic and Pandemic Subjects From Hail Region, KSA. Front Public Health 2022;10:874741. [PMID: 35757607 DOI: 10.3389/fpubh.2022.874741] [Reference Citation Analysis]
53 Tiwari G, Chauhan MS, Sharma D. Systematic In Silico Studies of Corticosteroids and Its Binding Affinities with Glucocorticoid Receptor for Covid-19 Treatment: Ab-Initio, Molecular Docking and MD Simulation Studies. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2022.2092878] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Qian B, Liao K, Zeng D, Peng W, Wu X, Li J, Bo Z, Hu Y, Nan W, Wen Y, Cao Y, Xue F, Zhang X, Dai J. Clustered Regularly Interspaced Short Palindromic Repeat/Cas12a Mediated Multiplexable and Portable Detection Platform for GII Genotype Porcine Epidemic Diarrhoea Virus Rapid Diagnosis. Front Microbiol 2022;13:920801. [PMID: 35756009 DOI: 10.3389/fmicb.2022.920801] [Reference Citation Analysis]
55 He S, Li L, Chen H, Hu X, Wang W, Zhang H, Wei R, Zhang X, Chen Y, Liu X. PRRSV Infection Induces Gasdermin D-Driven Pyroptosis of Porcine Alveolar Macrophages through NLRP3 Inflammasome Activation. J Virol 2022;:e0212721. [PMID: 35758658 DOI: 10.1128/jvi.02127-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Kalamatianos KG. In silico drug repurposing for coronavirus (COVID-19): screening known HCV drugs against the SARS-CoV-2 spike protein bound to angiotensin-converting enzyme 2 (ACE2) (6M0J). Mol Divers 2022. [PMID: 35739375 DOI: 10.1007/s11030-022-10469-7] [Reference Citation Analysis]
57 Zhang Y, Huang Z, Zhu J, Li C, Fang Z, Chen K, Zhang Y. An updated review of SARS‐CoV ‐2 detection methods in the context of a novel coronavirus pandemic. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10356] [Reference Citation Analysis]
58 Yang KS, Leeuwon SZ, Xu S, Liu WR. Evolutionary and Structural Insights about Potential SARS-CoV-2 Evasion of Nirmatrelvir. J Med Chem 2022. [PMID: 35731933 DOI: 10.1021/acs.jmedchem.2c00404] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
59 Xu Z, Kang X, Han P, Du P, Li L, Zheng A, Deng C, Qi J, Zhao X, Wang Q, Liu K, Gao GF. Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses. Nat Commun 2022;13:3547. [PMID: 35729237 DOI: 10.1038/s41467-022-31276-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Li R, Tian X, Pang J, Li L, Yuan J, Tian Z, Wang Z. Point-of-Care Tests for Rapid Detection of Porcine Epidemic Diarrhea Virus: A Systematic Review and Meta-Analysis. Viruses 2022;14:1355. [DOI: 10.3390/v14071355] [Reference Citation Analysis]
61 Sodhi KK, Singh CK. A systematic review on the occurrence, fate, and remediation of SARS-CoV-2 in wastewater. Int J Environ Sci Technol (Tehran) 2022;:1-14. [PMID: 35755183 DOI: 10.1007/s13762-022-04326-1] [Reference Citation Analysis]
62 Pantaleo G, Correia B, Fenwick C, Joo VS, Perez L. Antibodies to combat viral infections: development strategies and progress. Nat Rev Drug Discov 2022. [PMID: 35725925 DOI: 10.1038/s41573-022-00495-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 McHenry A, Iyer K, Wang J, Liu C, Harigopal M. Detection of SARS-CoV-2 in tissue: the comparative roles of RT-qPCR, in situ RNA hybridization, and immunohistochemistry. Expert Rev Mol Diagn 2022. [PMID: 35658709 DOI: 10.1080/14737159.2022.2085508] [Reference Citation Analysis]
64 Chunli W, Liya H, Weiwei L, Guoxi C, Yuyang C, Xiaopan L, Xing L, Yaling W, Xiaoqin D, Guangwang Z, Lin W, Chen J, Hai H, Ling Y. Clinical characteristics of pneumonia patients of long course of illness infected with SARS-CoV-2. Open Med (Wars) 2022;17:947-54. [PMID: 35647305 DOI: 10.1515/med-2022-0465] [Reference Citation Analysis]
65 Torres F, Kiwi M, Schuller IK. The impact of the suppression of highly connected protein interactions on the corona virus infection. Sci Rep 2022;12:9188. [PMID: 35654986 DOI: 10.1038/s41598-022-13373-0] [Reference Citation Analysis]
66 Faustino R, Faria M, Teixeira M, Palavra F, Sargento P, do Céu Costa M. Systematic review and meta-analysis of the prevalence of coronavirus: One health approach for a global strategy. One Health 2022;14:100383. [DOI: 10.1016/j.onehlt.2022.100383] [Reference Citation Analysis]
67 Krishnaveni M, Venkatesh S. RNA enigma: "From origin of life to novel Coronavirus- COVID-19". Saudi J Biol Sci 2022;:103331. [PMID: 35668729 DOI: 10.1016/j.sjbs.2022.103331] [Reference Citation Analysis]
68 Mohapatra S, Menon NG. Factors responsible for the emergence of novel viruses: An emphasis on SARS-CoV-2. Curr Opin Environ Sci Health 2022;27:100358. [PMID: 35369608 DOI: 10.1016/j.coesh.2022.100358] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Hamdy ME, El-deeb AH, Hagag NM, Shahein MA, Alaidi O, Hussein HA. Mutations of the SARS-CoV-2 Spike Glycoprotein Detected in Cats and Their Effect on Its Structure and Function. Front Cell Infect Microbiol 2022;12:875123. [DOI: 10.3389/fcimb.2022.875123] [Reference Citation Analysis]
70 Alghamdy Z, Alshahrani A, Memon I, Khan A, Khan MA, Alrayan Y, Alfawzan F, Zaidi SF. Awareness regarding COVID-19 and its effects on mental health among pre-professional health sciences students at King Saud bin Abdulaziz University for health sciences in Riyadh and Jeddah, Saudi Arabia. Environ Sci Pollut Res Int 2022. [PMID: 35624363 DOI: 10.1007/s11356-022-20934-3] [Reference Citation Analysis]
71 Shin GE, Park JY, Lee KK, Ku BK, Park CK, Jeoung HY. Recombination between the Fostera MLV-like Strain and the Strain Belonging to Lineage 1 of Porcine Reproductive and Respiratory Syndrome Virus in Korea. Viruses 2022;14:1153. [PMID: 35746625 DOI: 10.3390/v14061153] [Reference Citation Analysis]
72 Torrente‐rodríguez RM, Montero‐calle A, San Bartolomé C, Cano O, Vázquez M, Iglesias‐caballero M, Corral‐lugo A, Mcconnell MJ, Pascal M, Mas V, Pingarrón JM, Barderas R, Campuzano S. Towards Control and Oversight of SARS‐CoV‐2 Diagnosis and Monitoring through Multiplexed Quantitative Electroanalytical Immune Response Biosensors. Angewandte Chemie. [DOI: 10.1002/ange.202203662] [Reference Citation Analysis]
73 Dijkman R, Verma AK, Selvaraj M, Ghimire R, Gad HH, Hartmann R, More S, Perlman S, Thiel V, Channappanavar R. Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice. J Virol 2022;:e0036422. [PMID: 35588276 DOI: 10.1128/jvi.00364-22] [Reference Citation Analysis]
74 Thakor JC, Dinesh M, Manikandan R, Bindu S, Sahoo M, Sahoo D, Dhawan M, Pandey MK, Tiwari R, Emran TB, Dhama K, Chaicumpa W. Swine coronaviruses (SCoVs) and their emerging threats to swine population, inter-species transmission, exploring the susceptibility of pigs for SARS-CoV-2 and zoonotic concerns. Vet Q 2022;:1-39. [PMID: 35584308 DOI: 10.1080/01652176.2022.2079756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Ning T, Liu S, Xu J, Yang Y, Zhang N, Xie S, Min L, Zhang S, Zhu S, Wang Y. Potential intestinal infection and faecal-oral transmission of human coronaviruses. Rev Med Virol 2022;:e2363. [PMID: 35584273 DOI: 10.1002/rmv.2363] [Reference Citation Analysis]
76 Zhang Z, Jiang S, Wang X, Dong T, Wang Y, Li D, Gao X, Qu Z, Li Y. A novel enhanced substrate for label-free detection of SARS-CoV-2 based on surface-enhanced Raman scattering. Sens Actuators B Chem 2022;359:131568. [PMID: 35185297 DOI: 10.1016/j.snb.2022.131568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Kumar A, Sharma M, Richardson CD, Kelvin DJ. Potential of Natural Alkaloids From Jadwar (Delphinium denudatum) as Inhibitors Against Main Protease of COVID-19: A Molecular Modeling Approach. Front Mol Biosci 2022;9:898874. [DOI: 10.3389/fmolb.2022.898874] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Moisan A, Mastrovito B, De Oliveira F, Martel M, Hedin H, Leoz M, Nesi N, Schaeffer J, Ar Gouilh M, Plantier JC. Evidence of transmission and circulation of Deltacron XD recombinant SARS-CoV-2 in Northwest France. Clin Infect Dis 2022:ciac360. [PMID: 35535770 DOI: 10.1093/cid/ciac360] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Pérez-gómez HR, Morfín-otero R, González-díaz E, Esparza-ahumada S, León-garnica G, Rodríguez-noriega E. The Multifaceted Manifestations of Multisystem Inflammatory Syndrome during the SARS-CoV-2 Pandemic. Pathogens 2022;11:556. [DOI: 10.3390/pathogens11050556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Bangaru S, Antanasijevic A, Kose N, Sewall LM, Jackson AM, Suryadevara N, Zhan X, Torres JL, Copps J, de la Peña AT, Crowe JE Jr, Ward AB. Structural mapping of antibody landscapes to human betacoronavirus spike proteins. Sci Adv 2022;8:eabn2911. [PMID: 35507649 DOI: 10.1126/sciadv.abn2911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
81 Channappanavar R, Selvaraj M, More S, Perlman S. Alveolar macrophages protect mice from MERS-CoV-induced pneumonia and severe disease. Vet Pathol. [DOI: 10.1177/03009858221095270] [Reference Citation Analysis]
82 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Feng Z, Cui S, Lyu B, Liang Z, Li F, Shen L, Xu H, Yang P, Wang Q, Zhang D, Pan Y. Genomic characteristics of SARS-CoV-2 in Beijing, 2021. Biosafety and Health 2022. [DOI: 10.1016/j.bsheal.2022.04.006] [Reference Citation Analysis]
84 Namazi N. The effectiveness of dexamethasone as a combination therapy for COVID-19. Acta Pharmaceutica 2022;72:345-58. [DOI: 10.2478/acph-2022-0030] [Reference Citation Analysis]
85 Choi S, Kim KW, Ku KB, Kim SJ, Park C, Park D, Kim S, Yi H. Human Alphacoronavirus Universal Primers for Genome Amplification and Sequencing. Front Microbiol 2022;13:789665. [PMID: 35401489 DOI: 10.3389/fmicb.2022.789665] [Reference Citation Analysis]
86 Jo KJ, Choi S, Oh CE, Kim H, Choi BS, Jo DS, Park SE. Epidemiology and Clinical Characteristics of Human Coronaviruses-Associated Infections in Children: A Multi-Center Study. Front Pediatr 2022;10:877759. [DOI: 10.3389/fped.2022.877759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Chourasia R, Padhi S, Phukon LC, Abedin MM, Sirohi R, Singh SP, Rai AK. Peptide candidates for the development of therapeutics and vaccines against β-coronavirus infection. Bioengineered 2022;13:9435-54. [PMID: 35387556 DOI: 10.1080/21655979.2022.2060453] [Reference Citation Analysis]
88 Alharbi MH, Kribs CM. How the nature of behavior change affects the impact of asymptomatic coronavirus transmission. Ricerche mat. [DOI: 10.1007/s11587-022-00691-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Wang L, Gao GF. The "Wolf" Is Indeed Coming: Recombinant "Deltacron" SARS-CoV-2 Detected. China CDC Wkly 2022;4:285-7. [PMID: 35433090 DOI: 10.46234/ccdcw2022.054] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
90 Gu H, Ng DYM, Liu GYZ, Cheng SSM, Krishnan P, Chang LDJ, Cheuk SSY, Hui MMY, Lam TTY, Peiris M, Poon LLM. Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022. Emerg Infect Dis 2022;28. [PMID: 35394420 DOI: 10.3201/eid2806.220523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
91 Aloufi BH, Snoussi M, Sulieman AME. Antiviral Efficacy of Selected Natural Phytochemicals against SARS-CoV-2 Spike Glycoprotein Using Structure-Based Drug Designing. Molecules 2022;27:2401. [DOI: 10.3390/molecules27082401] [Reference Citation Analysis]
92 Xie X, Hu L, Xue H, Xiong Y, Panayi AC, Lin Z, Chen L, Yan C, Zhou W, Mi B, Liu G. Prognosis and treatment of complications associated with COVID-19: a systematic review and meta-analysis. Acta Materia Medica 2022;1. [DOI: 10.15212/amm-2022-0002] [Reference Citation Analysis]
93 Khan T, Khan A, Ansari JK, Najmi MH, Wei DQ, Muhammad K, Waheed Y. Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach. Molecules 2022;27:2375. [PMID: 35408772 DOI: 10.3390/molecules27072375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
94 Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q. A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases. Acta Pharm Sin B 2022;12:1652-61. [PMID: 34367893 DOI: 10.1016/j.apsb.2021.07.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
95 Pandit K, Kc K, Khanal S, Thapa SR, Shah CP, Pokharel R, Adhikari P. Coronavirus disease 2019 (COVID 19) induced acute necrotizing pancreatitis in a female child: A case report. Annals of Medicine and Surgery 2022;76:103551. [DOI: 10.1016/j.amsu.2022.103551] [Reference Citation Analysis]
96 Sha X, Li Y, Huang J, Zhou Q, Song X, Zhang B. Detection and molecular characteristics of canine coronavirus in Chengdu city, Southwest China from 2020 to 2021. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105548] [Reference Citation Analysis]
97 McLean G, Kamil J, Lee B, Moore P, Schulz TF, Muik A, Sahin U, Türeci Ö, Pather S. The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines. mBio 2022;:e0297921. [PMID: 35352979 DOI: 10.1128/mbio.02979-21] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 20.0] [Reference Citation Analysis]
98 Paria D, Kwok KS, Raj P, Zheng P, Gracias DH, Barman I. Label-Free Spectroscopic SARS-CoV-2 Detection on Versatile Nanoimprinted Substrates. Nano Lett 2022. [PMID: 35348344 DOI: 10.1021/acs.nanolett.1c04722] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
99 Toapanta-pinta PC, Vasco-toapanta CS, Herrera-tasiguano AE, Verdesoto-jácome CA, Páez-pástor MJ, Vasco-morales S. COVID 19 in pregnant women and neonates: Clinical characteristics and laboratory and imaging findings. An overview of systematic reviews. Rev Fac Med 2021;71:e97588. [DOI: 10.15446/revfacmed.v71n1.97588] [Reference Citation Analysis]
100 Wardzala CL, Wood AM, Belnap DM, Kramer JR. Mucins Inhibit Coronavirus Infection in a Glycan-Dependent Manner. ACS Cent Sci 2022;8:351-60. [PMID: 35345395 DOI: 10.1021/acscentsci.1c01369] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
101 El-Ashrey MK, Bakr RO, Fayed MAA, Refaey RH, Nissan YM. Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease. Virology 2022;570:18-28. [PMID: 35339903 DOI: 10.1016/j.virol.2022.03.003] [Reference Citation Analysis]
102 He Q, Lu J, Liu N, Lu W, Li Y, Shang C, Li X, Hu L, Jiang G. Antiviral Properties of Silver Nanoparticles against SARS-CoV-2: Effects of Surface Coating and Particle Size. Nanomaterials 2022;12:990. [DOI: 10.3390/nano12060990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
103 Kozlakidis Z. Evidence for Recombination as an Evolutionary Mechanism in Coronaviruses: Is SARS-CoV-2 an Exception? Front Public Health 2022;10:859900. [DOI: 10.3389/fpubh.2022.859900] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
104 Odetokun IA, Alhaji NB, Akpabio U, Abdulkareem MA, Bilat GT, Subedi D, Ghali-Mohammed I, Elelu N. Knowledge, risk perception, and prevention preparedness towards COVID-19 among a cross-section of animal health professionals in Nigeria. Pan Afr Med J 2022;41:20. [PMID: 35291358 DOI: 10.11604/pamj.2022.41.20.28315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Kirichenko AD, Poroshina AA, Sherbakov DY, Sadovsky MG, Krutovsky KV. Comparative analysis of alignment-free genome clustering and whole genome alignment-based phylogenomic relationship of coronaviruses. PLoS One 2022;17:e0264640. [PMID: 35259178 DOI: 10.1371/journal.pone.0264640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Eslami N, Aghbash PS, Shamekh A, Entezari-Maleki T, Nahand JS, Sales AJ, Baghi HB. SARS-CoV-2: Receptor and Co-receptor Tropism Probability. Curr Microbiol 2022;79:133. [PMID: 35292865 DOI: 10.1007/s00284-022-02807-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
107 Zhang D, Tian J, Wang Y, Lu J. Evitar: designing anti-viral RNA therapies against future RNA viruses. Bioinformatics 2022:btac144. [PMID: 35294970 DOI: 10.1093/bioinformatics/btac144] [Reference Citation Analysis]
108 Wang L, Yang J, Sun K, Bi Y, Gao GF. More efforts are needed for background surveys of zoonotic coronaviruses in animals. Cell Rep Med 2022;3:100524. [PMID: 35474743 DOI: 10.1016/j.xcrm.2022.100524] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Song Y, Zhang H, Wang Y, Guo J, Tang S, Wang L, Peng K, Dong CS. Importin KPNA2 confers HIV-1 pre-integration complex nuclear import by interacting with the capsid protein. Antiviral Res 2022;200:105289. [PMID: 35301060 DOI: 10.1016/j.antiviral.2022.105289] [Reference Citation Analysis]
110 Altmann DM, Boyton RJ. COVID-19 vaccination: The road ahead. Science 2022;375:1127-32. [PMID: 35271316 DOI: 10.1126/science.abn1755] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 21.0] [Reference Citation Analysis]
111 Pattinson D, Jester P, Guan L, Yamayoshi S, Chiba S, Presler R, Rao H, Iwatsuki-horimoto K, Ikeda N, Hagihara M, Uchida T, Mitamura K, Halfmann P, Neumann G, Kawaoka Y. A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs. Viruses 2022;14:562. [DOI: 10.3390/v14030562] [Reference Citation Analysis]
112 Gonzalez Lomeli F, Elmaraghy N, Castro A, Osuna Guerrero CV, Newcomb LL. Conserved Targets to Prevent Emerging Coronaviruses. Viruses 2022;14:563. [DOI: 10.3390/v14030563] [Reference Citation Analysis]
113 Lima M, Aloizou AM, Siokas V, Bakirtzis C, Liampas I, Tsouris Z, Bogdanos DP, Baloyannis SJ, Dardiotis E. Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia? Rev Neurosci 2022. [PMID: 35258237 DOI: 10.1515/revneuro-2021-0148] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Kyprianou I, Carlucci S, Serghides D. Energy affordability and trends of mortality in Cyprus. International Journal of Sustainable Energy. [DOI: 10.1080/14786451.2022.2046581] [Reference Citation Analysis]
115 Zhang Y, Zhang H, Zhang W. SARS-CoV-2 variants, immune escape, and countermeasures. Front Med . [DOI: 10.1007/s11684-021-0906-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
116 Muangman S, Pimainog Y, Kunaratnpruk S, Kanchanaphum P, Deiana G. The Prevalence of COVID-19 Infection in Students and Staff at a Private University in Thailand by Rapid SARS-CoV-2 Antigen Detection Assay. Journal of Environmental and Public Health 2022;2022:1-7. [DOI: 10.1155/2022/2350522] [Reference Citation Analysis]
117 Rayati Damavandi A, Dowran R, Al Sharif S, Kashanchi F, Jafari R. Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy. Med Microbiol Immunol 2022. [PMID: 35235048 DOI: 10.1007/s00430-022-00729-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
118 Gong Y, Sui L, Li Y. Recombination in Papillomavirus: Controversy and Possibility. Virus Research 2022. [DOI: 10.1016/j.virusres.2022.198756] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Uppalapati L, Roitburd-berman A, Weiss-ottolenghi Y, Graham BS, Dimitrov DS, Ying T, Failayev H, Tsfadia Y, Gershoni JM. Functional Reconstitution of the MERS CoV Receptor Binding Motif. Molecular Immunology 2022. [DOI: 10.1016/j.molimm.2022.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Jiang H, Yang P, Zhang J. Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone. Front Chem 2022;10:822785. [DOI: 10.3389/fchem.2022.822785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
121 Yue K, Yao B, Shi Y, Yang Y, Qian Z, Ci Y, Shi L. The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity. Biochem Biophys Res Commun 2022;601:129-36. [PMID: 35245742 DOI: 10.1016/j.bbrc.2022.02.068] [Reference Citation Analysis]
122 Han P, Li L, Liu S, Wang Q, Zhang D, Xu Z, Han P, Li X, Peng Q, Su C, Huang B, Li D, Zhang R, Tian M, Fu L, Gao Y, Zhao X, Liu K, Qi J, Gao GF, Wang P. Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2. Cell 2022;185:630-640.e10. [PMID: 35093192 DOI: 10.1016/j.cell.2022.01.001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 79] [Article Influence: 59.0] [Reference Citation Analysis]
123 Lawrence Panchali MJ, Oh HJ, Lee YM, Kim CM, Tariq M, Seo JW, Kim DY, Yun NR, Kim DM. Accuracy of Real-Time Polymerase Chain Reaction in COVID-19 Patients. Microbiol Spectr 2022;:e0059121. [PMID: 35170995 DOI: 10.1128/spectrum.00591-21] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
124 Hussein M, Andrade dos Ramos Z, Berkhout B, Herrera-carrillo E. In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack. Viruses 2022;14:385. [DOI: 10.3390/v14020385] [Reference Citation Analysis]
125 Kettenburg G, Kistler A, Ranaivoson HC, Ahyong V, Andrianiaina A, Andry S, Derisi JL, Gentles A, Raharinosy V, Randriambolamanantsoa TH, Ravelomanantsoa NAF, Tato CM, Dussart P, Heraud J, Brook CE. Full Genome Nobecovirus Sequences From Malagasy Fruit Bats Define a Unique Evolutionary History for This Coronavirus Clade. Front Public Health 2022;10:786060. [DOI: 10.3389/fpubh.2022.786060] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
126 Gradisteanu Pircalabioru G, Iliescu FS, Mihaescu G, Cucu AI, Ionescu ON, Popescu M, Simion M, Burlibasa L, Tica M, Chifiriuc MC, Iliescu C. Advances in the Rapid Diagnostic of Viral Respiratory Tract Infections. Front Cell Infect Microbiol 2022;12:807253. [DOI: 10.3389/fcimb.2022.807253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
127 Fay EJ, Balla KM, Roach SN, Shepherd FK, Putri DS, Wiggen TD, Goldstein SA, Pierson MJ, Ferris MT, Thefaine CE, Tucker A, Salnikov M, Cortez V, Compton SR, Kotenko SV, Hunter RC, Masopust D, Elde NC, Langlois RA. Natural rodent model of viral transmission reveals biological features of virus population dynamics. J Exp Med 2022;219:e20211220. [PMID: 34958350 DOI: 10.1084/jem.20211220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
128 Bitew M, Hailu G, Gebregziabher Tsegay Y, Tuki K, Asmamaw K, Tesfaye K, Dadi H, Orsini E, Dal Monego S, Licastro D, Marcello A. SARS-CoV-2 Genome Sequence Obtained from Ethiopia. Microbiol Resour Announc 2022;:e0118221. [PMID: 35112893 DOI: 10.1128/mra.01182-21] [Reference Citation Analysis]
129 Pecetta S, Kratochvil S, Kato Y, Vadivelu K, Rappuoli R. Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines. Pharmacol Rev 2022;74:313-39. [PMID: 35101964 DOI: 10.1124/pharmrev.120.000285] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Vargas-Rodriguez JR, Garza-Veloz I, Flores-Morales V, Badillo-Almaraz JI, Rocha-Pizaña MR, Valdés-Aguayo JJ, Martinez-Fierro ML. Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection. Front Med (Lausanne) 2021;8:758414. [PMID: 35096863 DOI: 10.3389/fmed.2021.758414] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Shahin K, Zhang L, Mehraban MH, Collard J, Hedayatkhah A, Mansoorianfar M, Soleimani-delfan A, Wang R. Clinical and experimental bacteriophage studies: Recommendations for possible approaches for standing against SARS-CoV-2. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105442] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
132 Ren PX, Shang WJ, Yin WC, Ge H, Wang L, Zhang XL, Li BQ, Li HL, Xu YC, Xu EH, Jiang HL, Zhu LL, Zhang LK, Bai F. A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors. Acta Pharmacol Sin 2022;43:483-93. [PMID: 33907306 DOI: 10.1038/s41401-021-00668-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
133 Ulugerger Avci G, Bektan Kanat B, Suzan V, Can G, Korkmazer B, Karaali R, Tabak F, Borekci S, Aygun G, Yavuzer H, Doventas A. Clinical outcomes of geriatric patients with COVID-19: review of one-year data. Aging Clin Exp Res 2022;34:465-74. [PMID: 35064542 DOI: 10.1007/s40520-021-02047-y] [Reference Citation Analysis]
134 Sanchez-burgos L, Gómez-lópez G, Al-shahrour F, Fernandez-capetillo O. An in silico analysis identifies drugs potentially modulating the cytokine storm triggered by SARS-CoV-2 infection. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-05597-x] [Reference Citation Analysis]
135 Gosavi D, Cheatham B, Sztuba-solinska J. Label-Free Detection of Human Coronaviruses in Infected Cells Using Enhanced Darkfield Hyperspectral Microscopy (EDHM). J Imaging 2022;8:24. [DOI: 10.3390/jimaging8020024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Bukhari SNH, Jain A, Haq E, Mehbodniya A, Webber J. Machine Learning Techniques for the Prediction of B-Cell and T-Cell Epitopes as Potential Vaccine Targets with a Specific Focus on SARS-CoV-2 Pathogen: A Review. Pathogens 2022;11:146. [DOI: 10.3390/pathogens11020146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
137 Bò L, Miotto M, Di Rienzo L, Milanetti E, Ruocco G. Exploring the Association Between Sialic Acid and SARS-CoV-2 Spike Protein Through a Molecular Dynamics-Based Approach. Front Med Technol 2020;2:614652. [PMID: 35047894 DOI: 10.3389/fmedt.2020.614652] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
138 Mistry P, Barmania F, Mellet J, Peta K, Strydom A, Viljoen IM, James W, Gordon S, Pepper MS. SARS-CoV-2 Variants, Vaccines, and Host Immunity. Front Immunol 2021;12:809244. [PMID: 35046961 DOI: 10.3389/fimmu.2021.809244] [Cited by in Crossref: 52] [Cited by in F6Publishing: 31] [Article Influence: 52.0] [Reference Citation Analysis]
139 Liang S, Liu X, Zhang S, Li M, Zhang Q, Chen J. Binding mechanism of inhibitors to SARS-CoV-2 main protease deciphered by multiple replica molecular dynamics simulations. Phys Chem Chem Phys 2022;24:1743-59. [PMID: 34985081 DOI: 10.1039/d1cp04361g] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
140 Malik H, Anees T, Mui-zzud-din. BDCNet: multi-classification convolutional neural network model for classification of COVID-19, pneumonia, and lung cancer from chest radiographs. Multimedia Systems. [DOI: 10.1007/s00530-021-00878-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Zamzami MA. Molecular docking, molecular dynamics simulation and MM-GBSA studies of the activity of glycyrrhizin relevant substructures on SARS-CoV-2 RNA-dependent-RNA polymerase. J Biomol Struct Dyn 2022;:1-13. [PMID: 35037842 DOI: 10.1080/07391102.2021.2025147] [Reference Citation Analysis]
142 Mehra R, Kepp KP. Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview. ACS Infect Dis 2022;8:29-58. [PMID: 34856799 DOI: 10.1021/acsinfecdis.1c00433] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
143 Tan S, Banwell MG, Ye WC, Lan P, White LV. The Inhibition of RNA Viruses by Amaryllidaceae Alkaloids: Opportunities for the Development of Broad-Spectrum Anti-Coronavirus Drugs. Chem Asian J 2022;:e202101215. [PMID: 35032358 DOI: 10.1002/asia.202101215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Zhou Y, Zheng R, Liu S, Disoma C, Du A, Li S, Chen Z, Dong Z, Zhang Y, Li S, Liu P, Razzaq A, Chen X, Liao Y, Tao S, Liu Y, Xu L, Zhang Q, Peng J, Deng X, Li S, Jiang T, Xia Z. Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation. J Biol Chem 2022;298:101584. [PMID: 35032548 DOI: 10.1016/j.jbc.2022.101584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
145 Oujja A, Abid MR, Boumhidi J, Bourhnane S, Mourhir A, Merchant F, Benhaddou D. High-performance computing for SARS-CoV-2 RNAs clustering: a data science‒based genomics approach. Genomics Inform 2021;19:e49. [PMID: 35012291 DOI: 10.5808/gi.21056] [Reference Citation Analysis]
146 Rashid TU, Sharmeen S, Biswas S. Effectiveness of N95 Masks against SARS-CoV-2: Performance Efficiency, Concerns, and Future Directions. ACS Chem Health Saf . [DOI: 10.1021/acs.chas.1c00016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
147 Li S, Zhu H, Zhao M, Liu W, Wang L, Zhu B, Xie W, Zhao C, Zhou Y, Ren C, Liu H, Jiang X. When stem cells meet COVID-19: recent advances, challenges and future perspectives. Stem Cell Res Ther 2022;13:9. [PMID: 35012650 DOI: 10.1186/s13287-021-02683-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Kong F, Wang Q, Kenney SP, Jung K, Vlasova AN, Saif LJ. Porcine Deltacoronaviruses: Origin, Evolution, Cross-Species Transmission and Zoonotic Potential. Pathogens 2022;11:79. [DOI: 10.3390/pathogens11010079] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
149 De Gani SM, Berger FMP, Guggiari E, Jaks R. Relation of corona-specific health literacy to use of and trust in information sources during the COVID-19 pandemic. BMC Public Health 2022;22:42. [PMID: 34991525 DOI: 10.1186/s12889-021-12271-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
150 Feng T, Nie C, Peng P, Lu H, Wang T, Li P, Huang W. Nanoagent-based theranostic strategies against human coronaviruses. Nano Res 2022;:1-15. [PMID: 35003529 DOI: 10.1007/s12274-021-3949-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Malik JA, Ahmed S, Mir A, Shinde M, Bender O, Alshammari F, Ansari M, Anwar S. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges. J Infect Public Health 2022;15:228-40. [PMID: 35042059 DOI: 10.1016/j.jiph.2021.12.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 31.0] [Reference Citation Analysis]
152 Marwah M, Agrawala PK. COVID-19 lockdown and environmental pollution: an Indian multi-state investigation. Environ Monit Assess 2022;194:49. [PMID: 34978634 DOI: 10.1007/s10661-021-09693-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Amoutzias GD, Nikolaidis M, Tryfonopoulou E, Chlichlia K, Markoulatos P, Oliver SG. The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2. Viruses 2022;14:78. [PMID: 35062282 DOI: 10.3390/v14010078] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 21.0] [Reference Citation Analysis]
154 Yousef A. . MATH 2022;7:10052-78. [DOI: 10.3934/math.2022560] [Reference Citation Analysis]
155 Nawaz Y, Shoaib Arif M, Shatanawi W, Ashraf MU. . MATH 2022;7:14299-322. [DOI: 10.3934/math.2022788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Rafi MO, Al-khafaji K, Sarker MT, Taskin-tok T, Rana AS, Rahman MS. Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods. RSC Adv 2022;12:4288-310. [DOI: 10.1039/d1ra06532g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
157 Qutub M, Aldabbagh Y, Mehdawi F, Alraddadi A, Alhomsy M, Alnahdi A, Fakeeh M, Maghrabi A, Alwagdani M, Bahabri N. Duration of viable SARS-CoV-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review. Clinical Infection in Practice 2022;13:100140. [DOI: 10.1016/j.clinpr.2022.100140] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Tarrahimofrad H, Rahimnahal S, Zamani J, Jahangirian E, Aminzadeh S. Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9. Sci Rep 2021;11:24485. [PMID: 34966175 DOI: 10.1038/s41598-021-03932-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
159 Nyaguthii DM, Otieno GP, Kombe IK, Koech D, Mutunga M, Medley GF, Nokes DJ, Munywoki PK. Infection patterns of endemic human coronaviruses in rural households in coastal Kenya. Wellcome Open Res 2021;6:27. [PMID: 34957334 DOI: 10.12688/wellcomeopenres.16508.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
160 Zhou H, Yang J, Zhou C, Chen B, Fang H, Chen S, Zhang X, Wang L, Zhang L. A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV. Front Med (Lausanne) 2021;8:628370. [PMID: 34950674 DOI: 10.3389/fmed.2021.628370] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
161 Liu W, Zeng Y, Li Y, Li N, Peng M, Cheng J, Tian B, Chen M. Exploring the Potential Targets and Mechanisms of Huang Lian Jie Du Decoction in the Treatment of Coronavirus Disease 2019 Based on Network Pharmacology. Int J Gen Med 2021;14:9873-85. [PMID: 34938107 DOI: 10.2147/IJGM.S337025] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
162 Hashemi SA, Bahrani S, Mousavi SM, Omidifar N, Behbahan NGG, Arjmand M, Ramakrishna S, Lankarani KB, Moghadami M, Firoozsani M. Graphene-Based Femtogram-Level Sensitive Molecularly Imprinted Polymer of SARS-CoV-2. Adv Mater Interfaces 2021;8:2101466. [PMID: 34900518 DOI: 10.1002/admi.202101466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
163 Singla RK, He X, Chopra H, Tsagkaris C, Shen L, Kamal MA, Shen B. Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources. Front Pharmacol 2021;12:758159. [PMID: 34925017 DOI: 10.3389/fphar.2021.758159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
164 Tian D, Sun Y, Zhou J, Ye Q. The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape. Front Immunol 2021;12:751778. [PMID: 34917076 DOI: 10.3389/fimmu.2021.751778] [Cited by in F6Publishing: 27] [Reference Citation Analysis]
165 Desantis J, Mercorelli B, Celegato M, Croci F, Bazzacco A, Baroni M, Siragusa L, Cruciani G, Loregian A, Goracci L. Indomethacin-based PROTACs as pan-coronavirus antiviral agents. Eur J Med Chem 2021;226:113814. [PMID: 34534839 DOI: 10.1016/j.ejmech.2021.113814] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
166 Perez-Gomez R. The Development of SARS-CoV-2 Variants: The Gene Makes the Disease. J Dev Biol 2021;9:58. [PMID: 34940505 DOI: 10.3390/jdb9040058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
167 Li CX, Noreen S, Zhang LX, Saeed M, Wu PF, Ijaz M, Dai DF, Maqbool I, Madni A, Akram F, Naveed M, Li JH. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies. Biomed Pharmacother 2021;146:112550. [PMID: 34959116 DOI: 10.1016/j.biopha.2021.112550] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
168 Chen J, Fan J, Chen Z, Zhang M, Peng H, Liu J, Ding L, Liu M, Zhao C, Zhao P, Zhang S, Zhang X, Xu J. Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells. Proc Natl Acad Sci U S A 2021;118:e2111011118. [PMID: 34873039 DOI: 10.1073/pnas.2111011118] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
169 Wang Y, Tang CY, Wan XF. Antigenic characterization of influenza and SARS-CoV-2 viruses. Anal Bioanal Chem 2021. [PMID: 34905077 DOI: 10.1007/s00216-021-03806-6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
170 Ma Q, Wang Z, Chen R, Lei B, Liu B, Jiang H, Chen Z, Cai X, Guo X, Zhou M, Huang J, Li X, Dai J, Yang Z. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action. Phytomedicine 2021;95:153874. [PMID: 34923232 DOI: 10.1016/j.phymed.2021.153874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Yapasert R, Khaw-On P, Banjerdpongchai R. Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets. Molecules 2021;26:7459. [PMID: 34946543 DOI: 10.3390/molecules26247459] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
172 Giugliano R, Buonocore C, Zannella C, Chianese A, Palma Esposito F, Tedesco P, De Filippis A, Galdiero M, Franci G, de Pascale D. Antiviral Activity of the Rhamnolipids Mixture from the Antarctic Bacterium Pseudomonas gessardii M15 against Herpes Simplex Viruses and Coronaviruses. Pharmaceutics 2021;13:2121. [PMID: 34959400 DOI: 10.3390/pharmaceutics13122121] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
173 Jacob Machado D, White RA, Kofsky J, Janies DA. Fundamentals of genomic epidemiology, lessons learned from the coronavirus disease 2019 (COVID-19) pandemic, and new directions. ASHE 2021;1. [DOI: 10.1017/ash.2021.222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
174 Rao GSNK, Gowthami B, Naveen NR, Samudrala PK. An updated review on potential therapeutic drug candidates, vaccines and an insight on patents filed for COVID-19. Curr Res Pharmacol Drug Discov 2021;2:100063. [PMID: 34870158 DOI: 10.1016/j.crphar.2021.100063] [Reference Citation Analysis]
175 Benslimane FM, Al Khatib HA, Al-Jamal O, Albatesh D, Boughattas S, Ahmed AA, Bensaad M, Younuskunju S, Mohamoud YA, Al Badr M, Mohamed AA, El-Kahlout RA, Al-Hamad T, Elgakhlab D, Al-Kuwari FH, Saad C, Jeremijenko A, Al-Khal A, Al-Maslamani MA, Bertollini R, Al-Kuwari EA, Al-Romaihi HE, Al-Marri S, Al-Thani M, Badji RM, Mbarek H, Al-Sarraj Y, Malek JA, Ismail SI, Abu-Raddad LJ, Coyle PV, Thani AAA, Yassine HM. One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar. Front Cell Infect Microbiol 2021;11:768883. [PMID: 34869069 DOI: 10.3389/fcimb.2021.768883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
176 Farag EA, Islam MM, Enan K, El-Hussein AM, Bansal D, Haroun M. SARS-CoV-2 at the human-animal interphase: A review. Heliyon 2021;7:e08496. [PMID: 34869934 DOI: 10.1016/j.heliyon.2021.e08496] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
177 Barthorpe A, Rogers JP. Coronavirus infections from 2002-2021: Neuropsychiatric Manifestations. Sleep Medicine 2021. [DOI: 10.1016/j.sleep.2021.11.013] [Reference Citation Analysis]
178 Payus AO, Jeffree MS, Ohn MH, Tan HJ, Ibrahim A, Chia YK, Raymond AA. Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19. Neurol Sci 2021. [PMID: 34853897 DOI: 10.1007/s10072-021-05785-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
179 Haque MH, Islam MA, Karim MR, Kayesh MEH, Sarker S, Nazir KHMNH, Anwer MS. Coronavirus disease 2019 and future pandemics: Impacts on livestock health and production and possible mitigation measures. Vet World 2021;14:2434-43. [PMID: 34840464 DOI: 10.14202/vetworld.2021.2434-2443] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
180 Wang LL, Yang JW, Xu JF. Coronavirus (SARS-CoV-2) causes lung inflammation and injury. Clin Microbiol Infect 2021:S1198-743X(21)00674-1. [PMID: 34861410 DOI: 10.1016/j.cmi.2021.11.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
181 Safari I, Elahi E. Evolution of the SARS-CoV-2 genome and emergence of variants of concern. Arch Virol 2021. [PMID: 34846601 DOI: 10.1007/s00705-021-05295-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Akram F, Haq IU, Aqeel A, Ahmed Z, Shah FI, Nawaz A, Zafar J, Sattar R. Insights into the evolutionary and prophylactic analysis of SARS-CoV-2: A review. J Virol Methods 2022;300:114375. [PMID: 34838536 DOI: 10.1016/j.jviromet.2021.114375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Li X, Hou P, Ma W, Wang X, Wang H, Yu Z, Chang H, Wang T, Jin S, Wang X, Wang W, Zhao Y, Zhao Y, Xu C, Ma X, Gao Y, He H. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy. Cell Mol Immunol 2021. [PMID: 34845370 DOI: 10.1038/s41423-021-00807-4] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
184 Soy M, Keser G, Atagündüz P. Pathogenesis and treatment of cytokine storm in COVID-19. Turk J Biol 2021;45:372-89. [PMID: 34803441 DOI: 10.3906/biy-2105-37] [Reference Citation Analysis]
185 Ruiz-Aravena M, McKee C, Gamble A, Lunn T, Morris A, Snedden CE, Yinda CK, Port JR, Buchholz DW, Yeo YY, Faust C, Jax E, Dee L, Jones DN, Kessler MK, Falvo C, Crowley D, Bharti N, Brook CE, Aguilar HC, Peel AJ, Restif O, Schountz T, Parrish CR, Gurley ES, Lloyd-Smith JO, Hudson PJ, Munster VJ, Plowright RK. Ecology, evolution and spillover of coronaviruses from bats. Nat Rev Microbiol 2021. [PMID: 34799704 DOI: 10.1038/s41579-021-00652-2] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
186 Lednicky JA, Tagliamonte MS, White SK, Elbadry MA, Alam MM, Stephenson CJ, Bonny TS, Loeb JC, Telisma T, Chavannes S, Ostrov DA, Mavian C, Beau De Rochars VM, Salemi M, Morris JG Jr. Independent infections of porcine deltacoronavirus among Haitian children. Nature 2021;600:133-7. [PMID: 34789872 DOI: 10.1038/s41586-021-04111-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 50] [Article Influence: 2.0] [Reference Citation Analysis]
187 Kayesh MEH, Kohara M, Tsukiyama-Kohara K. An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants. Viruses 2021;13:2302. [PMID: 34835108 DOI: 10.3390/v13112302] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
188 Adugna DG. Current Clinical Application of Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients: Review. Stem Cells Cloning 2021;14:71-80. [PMID: 34785907 DOI: 10.2147/SCCAA.S333800] [Reference Citation Analysis]
189 Marín-Palma D, Tabares-Guevara JH, Zapata-Cardona MI, Flórez-Álvarez L, Yepes LM, Rugeles MT, Zapata-Builes W, Hernandez JC, Taborda NA. Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms. Molecules 2021;26:6900. [PMID: 34833991 DOI: 10.3390/molecules26226900] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
190 Geng R, Zhou P. Severe acute respiratory syndrome (SARS) related coronavirus in bats. Anim Dis 2021;1:4. [PMID: 34778877 DOI: 10.1186/s44149-021-00004-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
191 Natarelli L, Virgili F, Weber C. SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad. Int J Mol Sci 2021;22:12243. [PMID: 34830125 DOI: 10.3390/ijms222212243] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
192 Jafarpour R, Pashangzadeh S, Dowran R. Host factors: Implications in immunopathogenesis of COVID-19. Pathol Res Pract 2021;228:153647. [PMID: 34749207 DOI: 10.1016/j.prp.2021.153647] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
193 Bimonte S, Forte CA, Cuomo M, Esposito G, Cascella M, Cuomo A. An Overview on the Potential Roles of EGCG in the Treatment of COVID-19 Infection. Drug Des Devel Ther 2021;15:4447-54. [PMID: 34737551 DOI: 10.2147/DDDT.S314666] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
194 Parkhe P, Verma S. Evolution, Interspecies Transmission, and Zoonotic Significance of Animal Coronaviruses. Front Vet Sci 2021;8:719834. [PMID: 34738021 DOI: 10.3389/fvets.2021.719834] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
195 Adil MS, Khulood D, Narayanan SP, Somanath PR. Bioinformatics analyses reveal cell-barrier junction modulations in lung epithelial cells on SARS-CoV-2 infection. Tissue Barriers 2021;:2000300. [PMID: 34740309 DOI: 10.1080/21688370.2021.2000300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
196 Alcendor DJ. Targeting COVID Vaccine Hesitancy in Rural Communities in Tennessee: Implications for Extending the COVID-19 Pandemic in the South. Vaccines (Basel) 2021;9:1279. [PMID: 34835210 DOI: 10.3390/vaccines9111279] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
197 Hui S. Recent scientific research progress and challenges of COVID-19 pandemic: a global public health event. Proc Indian Natl Sci Acad 2021;87:547-61. [DOI: 10.1007/s43538-021-00058-x] [Reference Citation Analysis]
198 Liu T, Feng M, Wen Z, He Y, Lin W, Zhang M. Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections. J Inflamm Res 2021;14:5475-87. [PMID: 34720596 DOI: 10.2147/JIR.S329697] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
199 Scott SJ, Pfotenhauer B, Weiner JJ, Hilleshiem J, Khubbar M, Bhattacharyya S. Respiratory Pathogen Coinfections in SARS-CoV-2-Positive Patients in Southeastern Wisconsin: A Retrospective Analysis. Microbiol Spectr 2021;9:e0083121. [PMID: 34668725 DOI: 10.1128/Spectrum.00831-21] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
200 Liu X, Wu Q, Zhang Z. Global Diversification and Distribution of Coronaviruses With Furin Cleavage Sites. Front Microbiol 2021;12:649314. [PMID: 34690939 DOI: 10.3389/fmicb.2021.649314] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
201 Kumar A, Mishra DC, Angadi UB, Yadav R, Rai A, Kumar D. Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study. Front Chem 2021;9:744376. [PMID: 34692642 DOI: 10.3389/fchem.2021.744376] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
202 Bukhari SNH, Jain A, Haq E, Mehbodniya A, Webber J. Ensemble Machine Learning Model to Predict SARS-CoV-2 T-Cell Epitopes as Potential Vaccine Targets. Diagnostics (Basel) 2021;11:1990. [PMID: 34829338 DOI: 10.3390/diagnostics11111990] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
203 Fan LQ, Hu XY, Chen YY, Peng XL, Fu YH, Zheng YP, Yu JM, He JS. Biological Significance of the Genomic Variation and Structural Dynamics of SARS-CoV-2 B.1.617. Front Microbiol 2021;12:750725. [PMID: 34691002 DOI: 10.3389/fmicb.2021.750725] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
204 Şimşek A, Taşbaş E, Koca N, Üstündağ Y, Yorulmaz Göktaş S, Dikiş Ö, Dülger S, Karaoğlu A, Soylu U. Clinical, radiological and laboratory features and treatment responses of COVID-19 diseases in pregnant women. Turkish Journal of Internal Medicine. [DOI: 10.46310/tjim.984108] [Reference Citation Analysis]
205 Jiao D, Dong X, Yu Y, Wei C. Gene Presence/Absence Variation analysis of coronavirus family displays its pan-genomic diversity. Int J Biol Sci 2021;17:3717-27. [PMID: 34671195 DOI: 10.7150/ijbs.58220] [Reference Citation Analysis]
206 Alzain AA, Elbadwi FA. Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies. Inform Med Unlocked 2021;26:100758. [PMID: 34667827 DOI: 10.1016/j.imu.2021.100758] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
207 Ahsan H, Arif A, Ansari S, Khan FH. The emergence of Covid-19: evolution from endemic to pandemic. J Immunoassay Immunochem 2021;:1-11. [PMID: 34672900 DOI: 10.1080/15321819.2021.1991947] [Reference Citation Analysis]
208 Milne G, Hames T, Scotton C, Gent N, Johnsen A, Anderson RM, Ward T. Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity? Lancet Respir Med 2021:S2213-2600(21)00407-0. [PMID: 34688434 DOI: 10.1016/S2213-2600(21)00407-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
209 Li X. Concerns on the multiple nomenclature systems for SARS-CoV-2. J Med Virol 2021. [PMID: 34672373 DOI: 10.1002/jmv.27406] [Reference Citation Analysis]
210 Butt RT, Janjua OS, Qureshi SM, Shaikh MS, Guerrero-Gironés J, Rodríguez-Lozano FJ, Zafar MS. Dental Healthcare Amid the COVID-19 Pandemic. Int J Environ Res Public Health 2021;18:11008. [PMID: 34769526 DOI: 10.3390/ijerph182111008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
211 Gransagne M, Aymé G, Brier S, Chauveau-Le Friec G, Meriaux V, Nowakowski M, Dejardin F, Levallois S, Dias de Melo G, Donati F, Prot M, Brûlé S, Raynal B, Bellalou J, Goncalves P, Montagutelli X, Di Santo JP, Lazarini F, England P, Petres S, Escriou N, Lafaye P. Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein. J Biol Chem 2021;:101290. [PMID: 34678315 DOI: 10.1016/j.jbc.2021.101290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
212 Nova N. Cross-Species Transmission of Coronaviruses in Humans and Domestic Mammals, What Are the Ecological Mechanisms Driving Transmission, Spillover, and Disease Emergence? Front Public Health 2021;9:717941. [PMID: 34660513 DOI: 10.3389/fpubh.2021.717941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
213 Nefedova E, Koptev V, Bobikova AS, Cherepushkina V, Mironova T, Afonyushkin V, Shkil N, Donchenko N, Kozlova Y, Sigareva N, Davidova N, Bogdanchikova N, Pestryakov A, Toledano-Magaña Y. The Infectious Bronchitis Coronavirus Pneumonia Model Presenting a Novel Insight for the SARS-CoV-2 Dissemination Route. Vet Sci 2021;8:239. [PMID: 34679068 DOI: 10.3390/vetsci8100239] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
214 Srivastava VK, Kaushik S, Bhargava G, Jain A, Saxena J, Jyoti A. A Bioinformatics Approach for the Prediction of Immunogenic Properties and Structure of the SARS-COV-2 B.1.617.1 Variant Spike Protein. Biomed Res Int 2021;2021:7251119. [PMID: 34651048 DOI: 10.1155/2021/7251119] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
215 Asghar M, Din M, Waris A, Yasin MT, Zohra T, Zia M. COVID-19 and the 1918 influenza pandemics: a concise overview and lessons from the past. Open Health 2021;2:40-9. [DOI: 10.1515/openhe-2021-0003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Zhugunissov K, Zakarya K, Khairullin B, Orynbayev M, Abduraimov Y, Kassenov M, Sultankulova K, Kerimbayev A, Nurabayev S, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Chervyakova O, Assanzhanova N, Burashev Y, Mambetaliyev M, Azanbekova M, Kopeyev S, Kozhabergenov N, Issabek A, Tuyskanova M, Kutumbetov L. Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters. Front Microbiol 2021;12:720437. [PMID: 34646246 DOI: 10.3389/fmicb.2021.720437] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
217 Khattab ESAEH, Ragab A, Abol-Ftouh MA, Elhenawy AA. Therapeutic strategies for Covid-19 based on molecular docking and dynamic studies to the ACE-2 receptors, Furin, and viral spike proteins. J Biomol Struct Dyn 2021;:1-19. [PMID: 34647855 DOI: 10.1080/07391102.2021.1989036] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
218 Khan J, Asoom LIA, Khan M, Chakrabartty I, Dandoti S, Rudrapal M, Zothantluanga JH. Evolution of RNA viruses from SARS to SARS-CoV-2 and diagnostic techniques for COVID-19: a review. Beni Suef Univ J Basic Appl Sci 2021;10:60. [PMID: 34642633 DOI: 10.1186/s43088-021-00150-7] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
219 Alonazi B, Farghaly AM, Mostafa MA, Al-Watban JA, Zindani SA, Altaimi F, Fagiry MA, Mahmoud MZ. Brain MRI in SARS-CoV-2 pneumonia patients with newly developed neurological manifestations suggestive of brain involvement. Sci Rep 2021;11:20476. [PMID: 34650073 DOI: 10.1038/s41598-021-00064-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
220 Nikolaidis M, Markoulatos P, Van de Peer Y, Oliver SG, Amoutzias GD. The neighborhood of the Spike gene is a hotspot for modular intertypic homologous and non-homologous recombination in Coronavirus genomes. Mol Biol Evol 2021:msab292. [PMID: 34638137 DOI: 10.1093/molbev/msab292] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
221 Do HQ, Nguyen VG, Chung CU, Jeon YS, Shin S, Jang KC, Pham LBH, Kong A, Kim CU, Park YH, Park BK, Chung HC. Genomic Characterization of a Novel Alphacoronavirus Isolated from Bats, Korea, 2020. Viruses 2021;13:2041. [PMID: 34696471 DOI: 10.3390/v13102041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
222 Dahal A, Sonju JJ, Kousoulas KG, Jois SD. Peptides and peptidomimetics as therapeutic agents for Covid-19. Pept Sci (Hoboken) 2021;:e24245. [PMID: 34901700 DOI: 10.1002/pep2.24245] [Reference Citation Analysis]
223 Straus MR, Bidon MK, Tang T, Jaimes JA, Whittaker GR, Daniel S. Inhibitors of L-Type Calcium Channels Show Therapeutic Potential for Treating SARS-CoV-2 Infections by Preventing Virus Entry and Spread. ACS Infect Dis 2021;7:2807-15. [PMID: 34498840 DOI: 10.1021/acsinfecdis.1c00023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
224 Christofferson RC, O'Neal HR, Jagneaux T, O'Neal C, Walsh CS, Mayton EH, Vu LD, Fish AI, Phan A, Stoufflet TE, Schroeder JR, Walker M, Turner EA, Pierce C, Wester KS, DeLeo C, Tenreiro E, Ogden B, Cormier SA. Reduced turnaround times through multi-sectoral community collaboration during the first surge of SARS-CoV-2 and associated effect on patient care and hospital operations. PLoS One 2021;16:e0257302. [PMID: 34618831 DOI: 10.1371/journal.pone.0257302] [Reference Citation Analysis]
225 Ng JH, Zaidan M, Jhaveri KD, Izzedine H. Acute tubulointerstitial nephritis and COVID-19. Clin Kidney J 2021;14:2151-7. [PMID: 34603692 DOI: 10.1093/ckj/sfab107] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
226 Tian D, Sun Y, Zhou J, Ye Q. The global epidemic of SARS-CoV-2 variants and their mutational immune escape. J Med Virol 2021. [PMID: 34609003 DOI: 10.1002/jmv.27376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
227 Yan X, Wang Z, Wang X, Zhang X, Wang L, Lu Z, Jia Z. Association between human coronaviruses' epidemic and environmental factors on a global scale. Environ Sci Pollut Res Int 2021. [PMID: 34609683 DOI: 10.1007/s11356-021-16500-y] [Reference Citation Analysis]
228 Khan AA, Alahmari AA, Almuzaini Y, Alamri F, Alsofayan YM, Aburas A, Al-Muhsen S, Van Kerkhove M, Yezli S, Ciottone GR, Assiri AM, Jokhdar HA. Potential Cross-Reactive Immunity to COVID-19 Infection in Individuals With Laboratory-Confirmed MERS-CoV Infection: A National Retrospective Cohort Study From Saudi Arabia. Front Immunol 2021;12:727989. [PMID: 34603300 DOI: 10.3389/fimmu.2021.727989] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
229 Meekins DA, Gaudreault NN, Richt JA. Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals. Viruses 2021;13:1993. [PMID: 34696423 DOI: 10.3390/v13101993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
230 Lee SH, Chu KB, Kang HJ, Kim MJ, Moon EK, Quan FS. Respiratory virus deterrence induced by modified mask filter. PLoS One 2021;16:e0257827. [PMID: 34591926 DOI: 10.1371/journal.pone.0257827] [Reference Citation Analysis]
231 Wang Q, Chen H, Shi Y, Hughes AC, Liu WJ, Jiang J, Gao GF, Xue Y, Tong Y. Tracing the origins of SARS-CoV-2: lessons learned from the past. Cell Res 2021;31:1139-41. [PMID: 34588626 DOI: 10.1038/s41422-021-00575-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
232 Hilpert K. Is the Gut Microbiome a Target for Adjuvant Treatment of COVID-19? Biologics 2021;1:285-99. [DOI: 10.3390/biologics1030017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
233 Ribeiro LK, Assis M, Lima LR, Coelho D, Gonçalves MO, Paiva RS, Moraes LN, Almeida LF, Lipsky F, San-Miguel MA, Mascaro LH, Grotto RMT, Sousa CP, Rosa ILV, Cruz SA, Andrés J, Longo E. Bioactive Ag3PO4/Polypropylene Composites for Inactivation of SARS-CoV-2 and Other Important Public Health Pathogens. J Phys Chem B 2021;125:10866-75. [PMID: 34546760 DOI: 10.1021/acs.jpcb.1c05225] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
234 Williams A, Branscome H, Khatkar P, Mensah GA, Al Sharif S, Pinto DO, DeMarino C, Kashanchi F. A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system. J Neurovirol 2021;27:667-90. [PMID: 34581996 DOI: 10.1007/s13365-021-00998-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
235 Hagag IT, Weber S, Sadeghi B, Groschup MH, Keller M. Impact of animal saliva on the performance of rapid antigen tests for detection of SARS-CoV-2 (wildtype and variants B.1.1.7 and B.1.351). Vet Microbiol 2021;262:109243. [PMID: 34563884 DOI: 10.1016/j.vetmic.2021.109243] [Reference Citation Analysis]
236 Steyer A, Marušić M, Kolenc M, Triglav T. A Throat Lozenge with Fixed Combination of Cetylpyridinium Chloride and Benzydamine Hydrochloride Has Direct Virucidal Effect on SARS-CoV-2. COVID 2021;1:435-46. [DOI: 10.3390/covid1020037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
237 Ahmadi AR, Ayazi-Nasrabadi R. Astaxanthin protective barrier and its ability to improve the health in patients with COVID-19. Iran J Microbiol 2021;13:434-41. [PMID: 34557270 DOI: 10.18502/ijm.v13i4.6965] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
238 Sacchetto L, Chaves BA, Costa ER, de Menezes Medeiros AS, Gordo M, Araújo DB, Oliveira DBL, da Silva APB, Negri AF, Durigon EL, Hanley KA, Vasilakis N, de Lacerda MVG, Nogueira ML. Lack of Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spillover in Free-Living Neotropical Non-Human Primates, Brazil. Viruses 2021;13:1933. [PMID: 34696363 DOI: 10.3390/v13101933] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
239 Kanduc D. From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry. Antibodies (Basel) 2021;10:36. [PMID: 34698069 DOI: 10.3390/antib10040036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
240 Buchy P, Buisson Y, Cintra O, Dwyer DE, Nissen M, Ortiz de Lejarazu R, Petersen E. COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control. Int J Infect Dis 2021;112:300-17. [PMID: 34563707 DOI: 10.1016/j.ijid.2021.09.045] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
241 Rafiee Z, Nejaddehbashi F, Nasrolahi A, Khademi Moghadam F. Stem cell-based and mesenchymal stem cell derivatives for coronavirus treatment. Biotechnol Appl Biochem 2021. [PMID: 34555225 DOI: 10.1002/bab.2259] [Reference Citation Analysis]
242 Jahangirian E, Jamal GA, Nouroozi M, Mohammadpour A. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2. Immunogenetics 2021;73:459-77. [PMID: 34542663 DOI: 10.1007/s00251-021-01228-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
243 Low ZY, Wen Yip AJ, Chow VTK, Lal SK. The Suppressor of Cytokine Signalling family of proteins and their potential impact on COVID-19 disease progression. Rev Med Virol 2021;:e2300. [PMID: 34546610 DOI: 10.1002/rmv.2300] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
244 Sharma HN, Latimore COD, Matthews QL. Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19. Pathogens 2021;10:1218. [PMID: 34578250 DOI: 10.3390/pathogens10091218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
245 He WT, Lu M, Xing G, Shao Y, Zhang M, Yang Y, Li X, Zhang L, Li G, Cao Z, Su S, Veit M, He H. Emergence and adaptive evolution of influenza D virus. Microb Pathog 2021;160:105193. [PMID: 34536503 DOI: 10.1016/j.micpath.2021.105193] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
246 Bozkurt F, Yousef A, Abdeljawad T, Kalinli A, Mdallal QA. A fractional-order model of COVID-19 considering the fear effect of the media and social networks on the community. Chaos Solitons Fractals 2021;152:111403. [PMID: 34522071 DOI: 10.1016/j.chaos.2021.111403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
247 Sanaie S, Golipour E, Shamekh A, Sadaie MR, Mahmoodpoor A, Yousefi M. Immune response variables and viral mutations impact on COVID-19 reinfection and relapse. Int Immunopharmacol 2021;100:108108. [PMID: 34521025 DOI: 10.1016/j.intimp.2021.108108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
248 Chaudhary JK, Yadav R, Chaudhary PK, Maurya A, Roshan R, Azam F, Mehta J, Handu S, Prasad R, Jain N, Pandey AK, Dhamija P. Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets. Cells 2021;10:2427. [PMID: 34572076 DOI: 10.3390/cells10092427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
249 Elbadwi FA, Khairy EA, Alsamani FO, Mahadi MA, Abdalrahman SE, Ahmed ZAM, Elsayed I, Ibraheem W, Alzain AA. Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies. Inform Med Unlocked 2021;26:100725. [PMID: 34514079 DOI: 10.1016/j.imu.2021.100725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
250 Tan CCS, Owen CJ, Tham CYL, Bertoletti A, van Dorp L, Balloux F. Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses. Infect Genet Evol 2021;95:105075. [PMID: 34509646 DOI: 10.1016/j.meegid.2021.105075] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
251 Kalita MJ, Dutta K, Hazarika G, Dutta R, Kalita S, Das PP, Sarma MP, Banu S, Idris MG, Talukdar AJ, Dutta S, Sharma A, Medhi S. In-house reverse transcriptase polymerase chain reaction for detection of SARS-CoV-2 with increased sensitivity. Sci Rep 2021;11:17878. [PMID: 34504255 DOI: 10.1038/s41598-021-97502-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
252 Hackstadt T, Chiramel AI, Hoyt FH, Williamson BN, Dooley CA, Beare PA, de Wit E, Best SM, Fischer ER. Disruption of the Golgi Apparatus and Contribution of the Endoplasmic Reticulum to the SARS-CoV-2 Replication Complex. Viruses 2021;13:1798. [PMID: 34578379 DOI: 10.3390/v13091798] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
253 Sun Y, Li C, Li Z, Shangguan A, Jiang J, Zeng W, Zhang S, He Q. Quercetin as an antiviral agent inhibits the Pseudorabies virus in vitro and in vivo. Virus Res 2021;305:198556. [PMID: 34492238 DOI: 10.1016/j.virusres.2021.198556] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
254 Dhanaraj P, Muthiah I, Rozbu MR, Nuzhat S, Paulraj MS. Computational Studies on T2Rs Agonist-Based Anti-COVID-19 Drug Design. Front Mol Biosci 2021;8:637124. [PMID: 34485378 DOI: 10.3389/fmolb.2021.637124] [Reference Citation Analysis]
255 Carvalho PPD, Alves NA. Featuring ACE2 binding SARS-CoV and SARS-CoV-2 through a conserved evolutionary pattern of amino acid residues. J Biomol Struct Dyn 2021;:1-10. [PMID: 34486937 DOI: 10.1080/07391102.2021.1965028] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
256 Adnet J, Dina J. [Influenza viruses and SARS-CoV-2, are we ready for the future?]. Actual Pharm 2021;60:28-35. [PMID: 34462618 DOI: 10.1016/j.actpha.2021.06.009] [Reference Citation Analysis]
257 Atique M, Ghafoor A, Javed R, Fatima N, Yousaf A, Zahra S. Correlation of Viral Load With the Clinical and Biochemical Profiles of COVID-19 Patients. Cureus 2021;13:e16655. [PMID: 34462686 DOI: 10.7759/cureus.16655] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
258 Vu MN, Menachery VD. Binding and entering: COVID finds a new home. PLoS Pathog 2021;17:e1009857. [PMID: 34460863 DOI: 10.1371/journal.ppat.1009857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
259 Salama ME, Suzan AR, Ayat F, Sarah SH, Muhammed RS, Noran MT, Heba M, Mohamed A. Medicinal plant-derived compounds as potential phytotherapy forCOVID-19: Future perspectives. J Pharmacognosy Phytother 2021;13:68-81. [DOI: 10.5897/jpp2021.0603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
260 Weidinger P, Kolodziejek J, Camp JV, Loney T, Kannan DO, Ramaswamy S, Tayoun AA, Corman VM, Nowotny N. MERS-CoV in sheep, goats, and cattle, United Arab Emirates, 2019: Virological and serological investigations reveal an accidental spillover from dromedaries. Transbound Emerg Dis 2021. [PMID: 34463031 DOI: 10.1111/tbed.14306] [Reference Citation Analysis]
261 Zhang Z, Liu Q, Sun Y, Li J, Liu J, Pan R, Cao L, Chen X, Li Y, Zhang Y, Xu K, Guo D, Zhou L, Lan K, Chen Y. Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice. Emerg Microbes Infect 2021;10:1626-37. [PMID: 34365904 DOI: 10.1080/22221751.2021.1964385] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
262 Toropov N, Osborne E, Joshi LT, Davidson J, Morgan C, Page J, Pepperell J, Vollmer F. SARS-CoV-2 Tests: Bridging the Gap between Laboratory Sensors and Clinical Applications. ACS Sens 2021;6:2815-37. [PMID: 34392681 DOI: 10.1021/acssensors.1c00612] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
263 Dhote AM, Patil VR, Lokwani DK, Amnerkar ND, Ugale VG, Charbe NB, Bhongade BA, Khadse SC. Strategic analyses to identify key structural features of antiviral/antimalarial compounds for their binding interactions with 3CLpro, PLpro and RdRp of SARS-CoV-2: in silico molecular docking and dynamic simulation studies. J Biomol Struct Dyn 2021;:1-18. [PMID: 34431452 DOI: 10.1080/07391102.2021.1965912] [Reference Citation Analysis]
264 Nuwagaba J, Rutayisire M, Balizzakiwa T, Kisengula I, Nagaddya EJ, Dave DA. The Era of Coronavirus: Knowledge, Attitude, Practices, and Barriers to Hand Hygiene Among Makerere University Students and Katanga Community Residents. Risk Manag Healthc Policy 2021;14:3349-56. [PMID: 34421315 DOI: 10.2147/RMHP.S318482] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
265 Srivastava M, Hall D, Omoru OB, Gill HM, Smith S, Janga SC. Mutational Landscape and Interaction of SARS-CoV-2 with Host Cellular Components. Microorganisms 2021;9:1794. [PMID: 34576690 DOI: 10.3390/microorganisms9091794] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
266 Liu J, Chen X, Liu Y, Lin J, Shen J, Zhang H, Yin J, Pu R, Ding Y, Cao G. Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein. Infect Dis Poverty 2021;10:112. [PMID: 34419160 DOI: 10.1186/s40249-021-00895-4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
267 Yi H, Wang J, Wang J, Lu Y, Zhang Y, Peng R, Lu J, Chen Z. The Emergence and Spread of Novel SARS-CoV-2 Variants. Front Public Health 2021;9:696664. [PMID: 34409009 DOI: 10.3389/fpubh.2021.696664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
268 Yang Q, Lin F, Wang Y, Zeng M, Luo M. Long Noncoding RNAs as Emerging Regulators of COVID-19. Front Immunol 2021;12:700184. [PMID: 34408749 DOI: 10.3389/fimmu.2021.700184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
269 Yashvardhini N, Jha DK, Bhattacharya S. Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target. Arch Microbiol 2021;203:5463-73. [DOI: 10.1007/s00203-021-02527-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
270 Lynch SA, Subbarao K, Mahanty S, Barber BE, Roulis EV, van der Hoek L, McCarthy JS, Spann KM. Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia. Viruses 2021;13:1618. [PMID: 34452482 DOI: 10.3390/v13081618] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
271 Lu RJ, Zhao L, Huang BY, Ye F, Wang WL, Tan WJ. Real-time reverse transcription-polymerase chain reaction assay panel for the detection of severe acute respiratory syndrome coronavirus 2 and its variants. Chin Med J (Engl) 2021;134:2048-53. [PMID: 34402479 DOI: 10.1097/CM9.0000000000001687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
272 Hildreth JEK, Moulton JD, Alcendor DJ. Vivo-Morpholino-Based Antiviral for SARS-CoV-2: Implications for Novel Therapies in the Treatment of Acute COVID-19 Disease. Biomedicines 2021;9:1018. [PMID: 34440222 DOI: 10.3390/biomedicines9081018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
273 Singh J, Pandit P, McArthur AG, Banerjee A, Mossman K. Evolutionary trajectory of SARS-CoV-2 and emerging variants. Virol J 2021;18:166. [PMID: 34389034 DOI: 10.1186/s12985-021-01633-w] [Cited by in F6Publishing: 38] [Reference Citation Analysis]
274 Scarpa F, Sanna D, Azzena I, Cossu P, Giovanetti M, Benvenuto D, Coradduzza E, Alexiev I, Casu M, Fiori PL, Ciccozzi M. Update on the Phylodynamics of SADS-CoV. Life (Basel) 2021;11:820. [PMID: 34440564 DOI: 10.3390/life11080820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
275 Jiang M, Kolehmainen P, Kakkola L, Maljanen S, Melén K, Smura T, Julkunen I, Österlund P. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells. Microbiol Spectr 2021;9:e0077421. [PMID: 34378952 DOI: 10.1128/Spectrum.00774-21] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
276 Ahirwar R, Gandhi S, Komal K, Dhaniya G, Tripathi PP, Shingatgeri VM, Kumar K, Sharma JG, Kumar S. Biochemical composition, transmission and diagnosis of SARS-CoV-2. Biosci Rep 2021;41:BSR20211238. [PMID: 34291285 DOI: 10.1042/BSR20211238] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
277 Avgeris M, Adamopoulos PG, Galani A, Xagorari M, Gourgiotis D, Trougakos IP, Voulgaris N, Dimopoulos MA, Thomaidis NS, Scorilas A. Novel Nested-Seq Approach for SARS-CoV-2 Real-Time Epidemiology and In-Depth Mutational Profiling in Wastewater. Int J Mol Sci 2021;22:8498. [PMID: 34445204 DOI: 10.3390/ijms22168498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
278 Kim C, Mahasenan KV, Bhardwaj A, Wiest O, Chang M, Mobashery S. Production of Proteins of the SARS-CoV-2 Proteome for Drug Discovery. ACS Omega 2021;6:19983-94. [PMID: 34337272 DOI: 10.1021/acsomega.1c02984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
279 Komal A, Noreen M, Akhtar J, Imran M, Jamal M, Atif M, Khan J, Roman M, Ul Haq F, Aftab U, Ghaffar A, Waheed Y. Analyses of ABO blood groups with susceptibility and symptomatic variations of COVID-19 infection, a questionnaire-based survey. APMIS 2021;129:579-86. [PMID: 34342074 DOI: 10.1111/apm.13169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
280 Shabani Z. Demyelination as a result of an immune response in patients with COVID-19. Acta Neurol Belg 2021;121:859-66. [PMID: 33934300 DOI: 10.1007/s13760-021-01691-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
281 Aslam M, Farman M, Akgül A, Ahmad A, Sun M. Generalized form of fractional order COVID-19 model with Mittag-Leffler kernel. Math Methods Appl Sci 2021;44:8598-614. [PMID: 34226779 DOI: 10.1002/mma.7286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Vale FF, Vítor JMB, Marques AT, Azevedo-Pereira JM, Anes E, Goncalves J. Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide. Virus Res 2021;304:198526. [PMID: 34339772 DOI: 10.1016/j.virusres.2021.198526] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
283 Lara-Ureña N, García-Domínguez M. Relevance of BET Family Proteins in SARS-CoV-2 Infection. Biomolecules 2021;11:1126. [PMID: 34439792 DOI: 10.3390/biom11081126] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
284 Hamady A, Lee J, Loboda ZA. Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses? Infection 2021. [PMID: 34324165 DOI: 10.1007/s15010-021-01664-z] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
285 Du Y, Wang H, Chen L, Fang Q, Zhang B, Jiang L, Wu Z, Yang Y, Zhou Y, Chen B, Lyu J, Wang Z. Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic Simulation. Front Mol Biosci 2021;8:614443. [PMID: 34386518 DOI: 10.3389/fmolb.2021.614443] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
286 Schoeman D, Fielding BC. Human Coronaviruses: Counteracting the Damage by Storm. Viruses 2021;13:1457. [PMID: 34452323 DOI: 10.3390/v13081457] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
287 Mahmoud AS, Dayhum AS, Rayes AA, Annajar BB, Eldaghayes IM. Exploiting epidemiological data to understand the epidemiology and factors that influence COVID-19 pandemic in Libya. World J Virol 2021; 10(4): 156-167 [PMID: 34367931 DOI: 10.5501/wjv.v10.i4.156] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
288 Moubarak M, Kasozi KI, Hetta HF, Shaheen HM, Rauf A, Al-Kuraishy HM, Qusti S, Alshammari EM, Ayikobua ET, Ssempijja F, Afodun AM, Kenganzi R, Usman IM, Ochieng JJ, Osuwat LO, Matama K, Al-Gareeb AI, Kairania E, Musenero M, Welburn SC, Batiha GE. The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections. Life (Basel) 2021;11:734. [PMID: 34440478 DOI: 10.3390/life11080734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
289 Huang C. Pathogenesis of Coronaviruses Through Human Monocytes and Tissue Macrophages. Viral Immunol 2021. [PMID: 34297627 DOI: 10.1089/vim.2021.0038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
290 Olaniyan OT, Dare A, Okoli B, Adetunji CO, Ibitoye BO, Okotie GE, Eweoya O. Increase in SARS-CoV-2 infected biomedical waste among low middle-income countries: environmental sustainability and impact with health implications. J Basic Clin Physiol Pharmacol 2021. [PMID: 34293833 DOI: 10.1515/jbcpp-2020-0533] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
291 Jalkanen P, Pasternack A, Maljanen S, Melén K, Kolehmainen P, Huttunen M, Lundberg R, Tripathi L, Khan H, Ritvos MA, Naves R, Haveri A, Österlund P, Kuivanen S, Jääskeläinen AJ, Kurkela S, Lappalainen M, Rantasärkkä K, Vuorinen T, Hytönen J, Waris M, Tauriainen S, Ritvos O, Kakkola L, Julkunen I. A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics. J Infect Dis 2021;224:218-28. [PMID: 33905505 DOI: 10.1093/infdis/jiab222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
292 Wong YC, Lau SY, Wang To KK, Mok BWY, Li X, Wang P, Deng S, Woo KF, Du Z, Li C, Zhou J, Chan JFW, Yuen KY, Chen H, Chen Z. Natural Transmission of Bat-like Severe Acute Respiratory Syndrome Coronavirus 2 Without Proline-Arginine-Arginine-Alanine Variants in Coronavirus Disease 2019 Patients. Clin Infect Dis 2021;73:e437-44. [PMID: 32649739 DOI: 10.1093/cid/ciaa953] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 22.0] [Reference Citation Analysis]
293 Mohammadkhanizadeh A, Nikbakht F. Investigating the potential mechanisms of depression induced-by COVID-19 infection in patients. J Clin Neurosci 2021;91:283-7. [PMID: 34373041 DOI: 10.1016/j.jocn.2021.07.023] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
294 Bhattacharya S, Agarwal S, Shrimali NM, Guchhait P. Interplay between hypoxia and inflammation contributes to the progression and severity of respiratory viral diseases. Mol Aspects Med 2021;:101000. [PMID: 34294412 DOI: 10.1016/j.mam.2021.101000] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
295 Shrestha A, Thapa TB, Giri M, Kumar S, Dhobi S, Thapa H, Dhami PP, Shahi A, Ghimire A, Rathaur ES. Knowledge and attitude on prevention of COVID-19 among community health workers in Nepal-a cross-sectional study. BMC Public Health 2021;21:1424. [PMID: 34281512 DOI: 10.1186/s12889-021-11400-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
296 Mangukia N, Rao P, Patel K, Pandya H, Rawal RM. Identifying potential human and medicinal plant microRNAs against SARS-CoV-2 3'UTR region: A computational genomics assessment. Comput Biol Med 2021;136:104662. [PMID: 34311261 DOI: 10.1016/j.compbiomed.2021.104662] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
297 Hu J, Stojanović J, Yasamineh S, Yasamineh P, Karuppannan SK, Hussain Dowlath MJ, Serati-Nouri H. The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection. Arch Virol 2021;166:2649-72. [PMID: 34278528 DOI: 10.1007/s00705-021-05152-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
298 Omais S, Kharroubi S, Zaraket H. No association between the SARS-CoV-2 variants and mortality rates in the Eastern Mediterranean Region. Gene 2021;801:145843. [PMID: 34274478 DOI: 10.1016/j.gene.2021.145843] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
299 de Jesus SF, Santos LI, Rodrigues Neto JF, Vieira TM, Mendes JB, D'angelo MFSV, Guimaraes ALS. Therapeutic perceptions in antisense RNA-mediated gene regulation for COVID-19. Gene 2021;800:145839. [PMID: 34274470 DOI: 10.1016/j.gene.2021.145839] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
300 Hassanzadeganroudsari M, Ahmadi AH, Rashidi N, Hossain MK, Habib A, Apostolopoulos V. Computational Chemistry to Repurposing Drugs for the Control of COVID-19. Biologics 2021;1:111-28. [DOI: 10.3390/biologics1020007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
301 Guo W, Lakshminarayanan H, Rodriguez-Palacios A, Salata RA, Xu K, Draz MS. Glycan Nanostructures of Human Coronaviruses. Int J Nanomedicine 2021;16:4813-30. [PMID: 34290504 DOI: 10.2147/IJN.S302516] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
302 Beale S, Johnson AM, Zambon M, Hayward AC, Fragaszy EB; Flu Watch Group. Hand Hygiene Practices and the Risk of Human Coronavirus Infections in a UK Community Cohort. Wellcome Open Res 2020;5:98. [PMID: 34250260 DOI: 10.12688/wellcomeopenres.15796.2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
303 Chazal N. Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes? Front Microbiol 2021;12:682603. [PMID: 34335504 DOI: 10.3389/fmicb.2021.682603] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
304 Zahan MN, Habibi H, Pencil A, Abdul-Ghafar J, Ahmadi SA, Juyena NS, Rahman MT, Parvej MS. Diagnosis Of Covid-19 In Symptomatic Patients: An Updated Review. Vacunas 2021. [PMID: 34276268 DOI: 10.1016/j.vacun.2021.06.002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
305 Liu Q, Wang HY. Porcine enteric coronaviruses: an updated overview of the pathogenesis, prevalence, and diagnosis. Vet Res Commun 2021;45:75-86. [PMID: 34251560 DOI: 10.1007/s11259-021-09808-0] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
306 Rice BL, Douek DC, McDermott AB, Grenfell BT, Metcalf CJE. Why are there so few (or so many) circulating coronaviruses? Trends Immunol 2021;42:751-63. [PMID: 34366247 DOI: 10.1016/j.it.2021.07.001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
307 Dai Y, Zhao Z, Zhou H, Huang D, Luo J, Zhang C, Chen Q, Chen X, Yao Y, Jiang X, Cheng J. Traditional Chinese Medicine Enema Therapy in a Patient With a Confirmed Negative SARS-CoV-2 Test in the Respiratory Tract but Positive in the Intestinal Tract: A Case Report. Front Public Health 2021;9:687283. [PMID: 34307281 DOI: 10.3389/fpubh.2021.687283] [Reference Citation Analysis]
308 Ravindran R, McReynolds C, Yang J, Hammock BD, Ikram A, Ali A, Bashir A, Zohra T, Chang WLW, Hartigan-O'Connor DJ, Rashidi HH, Khan IH. Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses. PLoS One 2021;16:e0254367. [PMID: 34242356 DOI: 10.1371/journal.pone.0254367] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
309 Sanguedolce F, Zanelli M, Froio E, Bisagni A, Zizzo M, Ascani S, Stallone G, Netti S, Ranieri E, Falagario U, Carrieri G, Cormio L. Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies. Crit Rev Clin Lab Sci 2021;:1-13. [PMID: 34236278 DOI: 10.1080/10408363.2021.1944047] [Reference Citation Analysis]
310 Chen Z, Lv Y, Xu H, Deng L. Herbal Medicine, Gut Microbiota, and COVID-19. Front Pharmacol 2021;12:646560. [PMID: 34305582 DOI: 10.3389/fphar.2021.646560] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
311 Deng J, Pan J, Qiu M, Mao L, Wang Z, Zhu G, Gao L, Su J, Hu Y, Luo OJ, Chen G, Wang P. Identification of HLA-A2 restricted CD8+ T cell epitopes in SARS-CoV-2 structural proteins. J Leukoc Biol 2021. [PMID: 34231935 DOI: 10.1002/JLB.4MA0621-020R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
312 Li G, Zhang L, Du N. Relative synonymous codon usage of ORF1ab in SARS-CoV-2 and SARS-CoV. Genes Genomics 2021. [PMID: 34228320 DOI: 10.1007/s13258-021-01136-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
313 Al-Sanea MM, Abelyan N, Abdelgawad MA, Musa A, Ghoneim MM, Al-Warhi T, Aljaeed N, Alotaibi OJ, Alnusaire TS, Abdelwahab SF, Helmy A, Abdelmohsen UR, Youssif KA. Strawberry and Ginger Silver Nanoparticles as Potential Inhibitors for SARS-CoV-2 Assisted by In Silico Modeling and Metabolic Profiling. Antibiotics (Basel) 2021;10:824. [PMID: 34356745 DOI: 10.3390/antibiotics10070824] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
314 Abu-Zaied MA, Elgemeie GH, Mahmoud NM. Anti-Covid-19 Drug Analogues: Synthesis of Novel Pyrimidine Thioglycosides as Antiviral Agents Against SARS-COV-2 and Avian Influenza H5N1 Viruses. ACS Omega 2021;6:16890-904. [PMID: 34250348 DOI: 10.1021/acsomega.1c01501] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
315 Hashemi SA, Bahrani S, Mousavi SM, Omidifar N, Arjmand M, Behbahan NGG, Ramakrishna S, Lankarani KB, Moghadami M, Firoozsani M. Ultrasensitive Biomolecule‐Less Nanosensor Based on β‐Cyclodextrin/Quinoline Decorated Graphene Oxide toward Prompt and Differentiable Detection of Corona and Influenza Viruses. Adv Materials Technologies 2021;6:2100341. [DOI: 10.1002/admt.202100341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
316 Kant R, Yadav P, Kishore S, Bairwa M, Singh M. Is it time to consider shreds of epidemiological and environmental evidence associated with high transmission of COVID-19? J Family Med Prim Care 2021;10:2120-5. [PMID: 34322402 DOI: 10.4103/jfmpc.jfmpc_2371_20] [Reference Citation Analysis]
317 Xu J, Wu Z, Zhang M, Liu S, Zhou L, Yang C, Liu C. The Role of the Gastrointestinal System in Neuroinvasion by SARS-CoV-2. Front Neurosci 2021;15:694446. [PMID: 34276298 DOI: 10.3389/fnins.2021.694446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
318 Liu C, Mu C, Zhang Q, Yang X, Yan H, Jiao H. Effects of Infection with SARS-CoV-2 on the Male and Female Reproductive Systems: A Review. Med Sci Monit 2021;27:e930168. [PMID: 34193809 DOI: 10.12659/MSM.930168] [Reference Citation Analysis]
319 Singh S, Pandey R, Tomar S, Varshney R, Sharma D, Gangenahalli G. A brief molecular insight of COVID-19: epidemiology, clinical manifestation, molecular mechanism, cellular tropism and immuno-pathogenesis. Mol Cell Biochem 2021. [PMID: 34195882 DOI: 10.1007/s11010-021-04217-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
320 Anand U, Jakhmola S, Indari O, Jha HC, Chen ZS, Tripathi V, Pérez de la Lastra JM. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update. Front Immunol 2021;12:658519. [PMID: 34276652 DOI: 10.3389/fimmu.2021.658519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 28] [Article Influence: 1.0] [Reference Citation Analysis]
321 Vakulenko Y, Deviatkin A, Drexler JF, Lukashev A. Modular Evolution of Coronavirus Genomes. Viruses 2021;13:1270. [PMID: 34209881 DOI: 10.3390/v13071270] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
322 Ayatollahi SA, Sharifi-Rad J, Tsouh Fokou PV, Mahady GB, Ansar Rasul Suleria H, Krishna Kapuganti S, Gadhave K, Giri R, Garg N, Sharma R, Ribeiro D, Rodrigues CF, Reiner Ž, Taheri Y, Cruz-Martins N. Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection. Front Pharmacol 2021;12:575877. [PMID: 34267652 DOI: 10.3389/fphar.2021.575877] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
323 Wang YQ, Li QS, Zheng XQ, Lu JL, Liang YR. Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19. Molecules 2021;26:3962. [PMID: 34209485 DOI: 10.3390/molecules26133962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
324 Srivastava S, Garg I. Post COVID-19 infection: Long-term effects on liver and kidneys. World J Meta-Anal 2021; 9(3): 220-233 [DOI: 10.13105/wjma.v9.i3.220] [Reference Citation Analysis]
325 Krüger A, de Jesus Santos AP, de Sá V, Ulrich H, Wrenger C. Aptamer Applications in Emerging Viral Diseases. Pharmaceuticals (Basel) 2021;14:622. [PMID: 34203242 DOI: 10.3390/ph14070622] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
326 Sobhia ME, Kumar GS, Sivangula S, Ghosh K, Singh H, Haokip T, Gibson J. Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors. Future Med Chem 2021;13:1435-50. [PMID: 34169728 DOI: 10.4155/fmc-2020-0264] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
327 Yang P, Yang Y, Wu Y, Huang C, Ding Y, Wang X, Wang S. An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research. J Virol Methods 2021;295:114221. [PMID: 34182038 DOI: 10.1016/j.jviromet.2021.114221] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
328 Zhu X, Zhu X, Wang M, Yang F, Sun Z, Yang X, Yan Y. Clinical characteristics and outcomes of COVID-19 long-term nucleic acid positive patients. Technol Health Care 2021. [PMID: 34250914 DOI: 10.3233/THC-212921] [Reference Citation Analysis]
329 Haghani M, Varamini P. Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature. Scientometrics 2021;:1-46. [PMID: 34188334 DOI: 10.1007/s11192-021-04036-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
330 Beale S, Johnson AM, Zambon M, Hayward AC, Fragaszy EB; Flu Watch Group. Hand Hygiene Practices and the Risk of Human Coronavirus Infections in a UK Community Cohort. Wellcome Open Res 2020;5:98. [PMID: 34250260 DOI: 10.12688/wellcomeopenres.15796.2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
331 Waqar M, Wahid B, Idrees M, Ali M, Rehman Z. Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends. Z Naturforsch C J Biosci 2021;76:425-9. [PMID: 34161693 DOI: 10.1515/znc-2020-0291] [Reference Citation Analysis]
332 Kim JS, Kim JM, Choi SK, Cho YJ, Kim SJ, Kim JA. Prevalence of Respiratory Viral Infection Using Multiplex Reverse Transcriptase-Polymerase Chain Reaction. KJFP 2021;11:210-6. [DOI: 10.21215/kjfp.2021.11.3.210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
333 Taghizadeh P, Salehi S, Heshmati A, Houshmand SM, InanlooRahatloo K, Mahjoubi F, Sanati MH, Yari H, Alavi A, Jamehdar SA, Dabiri S, Galehdari H, Haghshenas MR, Hashemian AM, Heidarzadeh A, Jahanzad I, Kheyrani E, Piroozmand A, Mojtahedi A, Nikoo HR, Rahimi Bidgoli MM, Rezvani N, Sepehrnejad M, Shakibzadeh A, Shariati G, Seyyedi N, MohammadSaleh Zahraei S, Safari I, Elahi E. Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains. Virology 2021;562:63-73. [PMID: 34265628 DOI: 10.1016/j.virol.2021.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
334 Das A, Khurshid S, Ferdausi A, Nipu ES, Das A, Ahmed FF. Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak. Comput Biol Chem 2021;93:107533. [PMID: 34166886 DOI: 10.1016/j.compbiolchem.2021.107533] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
335 Zhai X, Wang N, Jiao H, Zhang J, Li C, Ren W, Reiter RJ, Su S. Melatonin and other indoles show antiviral activities against swine coronaviruses in vitro at pharmacological concentrations. J Pineal Res 2021;:e12754. [PMID: 34139040 DOI: 10.1111/jpi.12754] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
336 Beyrampour-Basmenj H, Milani M, Ebrahimi-Kalan A, Ben Taleb Z, Ward KD, Dargahi Abbasabad G, Aliyari-Serej Z, Ebrahimi Kalan M. An Overview of the Epidemiologic, Diagnostic and Treatment Approaches of COVID-19: What do We Know? Public Health Rev 2021;42:1604061. [PMID: 34381626 DOI: 10.3389/phrs.2021.1604061] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
337 Li X, Zhang L, Chen S, Ji W, Li C, Ren L. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic. Infect Genet Evol 2021;93:104971. [PMID: 34146731 DOI: 10.1016/j.meegid.2021.104971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
338 Campione E, Lanna C, Cosio T, Rosa L, Conte MP, Iacovelli F, Romeo A, Falconi M, Del Vecchio C, Franchin E, Lia MS, Minieri M, Chiaramonte C, Ciotti M, Nuccetelli M, Terrinoni A, Iannuzzi I, Coppeda L, Magrini A, Bernardini S, Sabatini S, Rosapepe F, Bartoletti PL, Moricca N, Di Lorenzo A, Andreoni M, Sarmati L, Miani A, Piscitelli P, Valenti P, Bianchi L. Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences. Front Pharmacol 2021;12:666600. [PMID: 34220505 DOI: 10.3389/fphar.2021.666600] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
339 Ning S, Yu B, Wang Y, Wang F. SARS-CoV-2: Origin, Evolution, and Targeting Inhibition. Front Cell Infect Microbiol 2021;11:676451. [PMID: 34222046 DOI: 10.3389/fcimb.2021.676451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
340 Perret C, Le Corre N, Castro-Rodriguez JA. Emergent Pneumonia in Children. Front Pediatr 2021;9:676296. [PMID: 34222146 DOI: 10.3389/fped.2021.676296] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
341 Chen SC, Olsthoorn RCL, Yu CH. Structural phylogenetic analysis reveals lineage-specific RNA repetitive structural motifs in all coronaviruses and associated variations in SARS-CoV-2. Virus Evol 2021;7:veab021. [PMID: 34141447 DOI: 10.1093/ve/veab021] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
342 Livermore DM. Antibiotic resistance during and beyond COVID-19. JAC Antimicrob Resist 2021;3:i5-i16. [PMID: 34223149 DOI: 10.1093/jacamr/dlab052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
343 Pourhatami A, Kaviyani-Charati M, Kargar B, Baziyad H, Kargar M, Olmeda-Gómez C. Mapping the intellectual structure of the coronavirus field (2000-2020): a co-word analysis. Scientometrics 2021;:1-33. [PMID: 34149117 DOI: 10.1007/s11192-021-04038-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
344 Awogbindin IO, Ben-Azu B, Olusola BA, Akinluyi ET, Adeniyi PA, Di Paolo T, Tremblay MÈ. Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson's Disease. Front Cell Neurosci 2021;15:670298. [PMID: 34211370 DOI: 10.3389/fncel.2021.670298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
345 Dao TL, Hoang VT, Colson P, Lagier JC, Million M, Raoult D, Levasseur A, Gautret P. SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence. J Clin Med 2021;10:2635. [PMID: 34203844 DOI: 10.3390/jcm10122635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
346 Nath H, Mallick A, Roy S, Sukla S, Basu K, De A, Biswas S. Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests. J Med Microbiol 2021;70. [PMID: 34110279 DOI: 10.1099/jmm.0.001369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
347 Aghbash PS, Eslami N, Shirvaliloo M, Baghi HB. Viral coinfections in COVID-19. J Med Virol 2021;93:5310-22. [PMID: 34032294 DOI: 10.1002/jmv.27102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
348 Shah NN, Nabi SU, Rather MA, Kalwar Q, Ali SI, Sheikh WM, Ganai A, Bashir SM. An update on emerging therapeutics to combat COVID-19. Basic Clin Pharmacol Toxicol 2021;129:104-29. [PMID: 33977663 DOI: 10.1111/bcpt.13600] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
349 Rana S, Kumar P, Sharma A, Sharma S, Giri R, S. Ghosh K. Identification of Naturally Occurring Antiviral Molecules for SARS-CoV-2 Mitigation. TOCOVIDJ 2021;1:38-46. [DOI: 10.2174/2666958702101010038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
350 Kulus J, Kulus M, Stefańska K, Sobolewski J, Piotrowska-Kempisty H, Mozdziak P, Kempisty B. SARS-CoV-2 Genetic Variability and Non-Specific Immunity Associated with the Use of Different BCG Strains-A Molecular and Clinical Approach. Vaccines (Basel) 2021;9:639. [PMID: 34200951 DOI: 10.3390/vaccines9060639] [Reference Citation Analysis]
351 Xia B, Shen X, He Y, Pan X, Liu FL, Wang Y, Yang F, Fang S, Wu Y, Duan Z, Zuo X, Xie Z, Jiang X, Xu L, Chi H, Li S, Meng Q, Zhou H, Zhou Y, Cheng X, Xin X, Jin L, Zhang HL, Yu DD, Li MH, Feng XL, Chen J, Jiang H, Xiao G, Zheng YT, Zhang LK, Shen J, Li J, Gao Z. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target. Cell Res 2021;31:847-60. [PMID: 34112954 DOI: 10.1038/s41422-021-00519-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
352 Raja RK, Nguyen-Tri P, Balasubramani G, Alagarsamy A, Hazir S, Ladhari S, Saidi A, Pugazhendhi A, Samy AA. SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches. Appl Nanosci 2021;:1-29. [PMID: 34131555 DOI: 10.1007/s13204-021-01900-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
353 Ao Z, Chan M, Ouyang MJ, Olukitibi TA, Mahmoudi M, Kobasa D, Yao X. Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry. PLoS One 2021;16:e0251649. [PMID: 34106944 DOI: 10.1371/journal.pone.0251649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
354 Jackson-Thompson BM, Goguet E, Laing ED, Olsen CH, Pollett S, Hollis-Perry KM, Maiolatesi SE, Illinik L, Ramsey KF, Reyes AE, Alcorta Y, Wong MA, Davies J, Ortega O, Parmelee E, Lindrose AR, Moser M, Graydon E, Letizia AG, Duplessis CA, Ganesan A, Pratt KP, Malloy AM, Scott DW, Anderson SK, Snow AL, Dalgard CL, Powers JH 3rd, Tribble D, Burgess TH, Broder CC, Mitre E. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers. BMC Infect Dis 2021;21:544. [PMID: 34107889 DOI: 10.1186/s12879-021-06233-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
355 Milanetti E, Miotto M, Di Rienzo L, Nagaraj M, Monti M, Golbek TW, Gosti G, Roeters SJ, Weidner T, Otzen DE, Ruocco G. In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2. Front Mol Biosci 2021;8:690655. [PMID: 34179095 DOI: 10.3389/fmolb.2021.690655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
356 Goraichuk IV, Arefiev V, Stegniy BT, Gerilovych AP. Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2. Virus Res 2021;302:198473. [PMID: 34118360 DOI: 10.1016/j.virusres.2021.198473] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
357 Zhou H, Ji J, Chen X, Bi Y, Li J, Wang Q, Hu T, Song H, Zhao R, Chen Y, Cui M, Zhang Y, Hughes AC, Holmes EC, Shi W. Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses. Cell 2021:S0092-8674(21)00709-1. [PMID: 34147139 DOI: 10.1016/j.cell.2021.06.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 81] [Article Influence: 14.0] [Reference Citation Analysis]
358 Yang Y, Yang P, Huang C, Wu Y, Zhou Z, Wang X, Wang S. Inhibitory effect on SARS-CoV-2 infection of neferine by blocking Ca2+ -dependent membrane fusion. J Med Virol 2021;93:5825-32. [PMID: 34061377 DOI: 10.1002/jmv.27117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
359 Dhanjal JK, Kumar V, Garg S, Subramani C, Agarwal S, Wang J, Zhang H, Kaul A, Kalra RS, Kaul SC, Vrati S, Sundar D, Wadhwa R. Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides. Int J Biol Macromol 2021;184:297-312. [PMID: 34118289 DOI: 10.1016/j.ijbiomac.2021.06.015] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
360 Gediz Erturk A, Sahin A, Bati Ay E, Pelit E, Bagdatli E, Kulu I, Gul M, Mesci S, Eryilmaz S, Oba Ilter S, Yildirim T. A Multidisciplinary Approach to Coronavirus Disease (COVID-19). Molecules 2021;26:3526. [PMID: 34207756 DOI: 10.3390/molecules26123526] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
361 Niu S, Wang J, Bai B, Wu L, Zheng A, Chen Q, Du P, Han P, Zhang Y, Jia Y, Qiao C, Qi J, Tian WX, Wang HW, Wang Q, Gao GF. Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin. EMBO J 2021;40:e107786. [PMID: 34018203 DOI: 10.15252/embj.2021107786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
362 Van Damme E, De Meyer S, Bojkova D, Ciesek S, Cinatl J, De Jonghe S, Jochmans D, Leyssen P, Buyck C, Neyts J, Van Loock M. In vitro activity of itraconazole against SARS-CoV-2. J Med Virol 2021;93:4454-60. [PMID: 33666253 DOI: 10.1002/jmv.26917] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
363 Elsharkawy M, Sharafeldeen A, Taher F, Shalaby A, Soliman A, Mahmoud A, Ghazal M, Khalil A, Alghamdi NS, Razek AAKA, Alnaghy E, El-Melegy MT, Sandhu HS, Giridharan GA, El-Baz A. Early assessment of lung function in coronavirus patients using invariant markers from chest X-rays images. Sci Rep 2021;11:12095. [PMID: 34103587 DOI: 10.1038/s41598-021-91305-0] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
364 Chaudhury SS, Sinha K, Majumder R, Biswas A, Mukhopadhyay CD. COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation. J Biosci 2021;46:47. [PMID: 34047290 [PMID: 34047290 DOI: 10.1007/s12038-021-00165-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
365 Fischer W, Giorgi EE, Chakraborty S, Nguyen K, Bhattacharya T, Theiler J, Goloboff PA, Yoon H, Abfalterer W, Foley BT, Tegally H, San JE, de Oliveira T, Gnanakaran S, Korber B; Network for Genomic Surveillance in South Africa (NGS-SA). HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens. Cell Host Microbe 2021;29:1093-110. [PMID: 34242582 DOI: 10.1016/j.chom.2021.05.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
366 Norouzi M, Norouzi S, Ruggiero A, Khan MS, Myers S, Kavanagh K, Vemuri R. Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection. Microorganisms 2021;9:1211. [PMID: 34205044 DOI: 10.3390/microorganisms9061211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
367 Sajjad H, Majeed M, Imtiaz S, Siddiqah M, Sajjad A, Din M, Ali M. Origin, Pathogenesis, Diagnosis and Treatment Options for SARS-CoV-2: A Review. Biologia (Bratisl) 2021;:1-19. [PMID: 34092799 DOI: 10.1007/s11756-021-00792-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
368 Low ZY, Yip AJW, Sharma A, Lal SK. SARS coronavirus outbreaks past and present-a comparative analysis of SARS-CoV-2 and its predecessors. Virus Genes 2021;57:307-17. [PMID: 34061288 DOI: 10.1007/s11262-021-01846-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
369 Sang L, Guo X, Shi J, Hou S, Fan H, Lv Q. Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update. Stem Cells Int 2021;2021:5593584. [PMID: 34211556 DOI: 10.1155/2021/5593584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
370 Zhou Y, Teng Z, Chen H, Cui X, Fang F, Mou J, Jiang H, Zhang X. Virology features of a family cluster of SARS-CoV-2 infections in Shanghai, China. Biosaf Health 2021;3:187-9. [PMID: 34095806 DOI: 10.1016/j.bsheal.2021.05.003] [Reference Citation Analysis]
371 Ehsan P, Haseeb M, Khan Z, Rehan A, Singh R. Coronavirus Disease 2019 Pneumonia and Acute Pancreatitis in a Young Girl. Cureus 2021;13:e15374. [PMID: 34249527 DOI: 10.7759/cureus.15374] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
372 Tripathy A, Swain N, Gupta B. The COVID-19 pandemic: an increased risk of rheumatoid arthritis. Future Virol 2021. [PMID: 34181704 DOI: 10.2217/fvl-2020-0393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
373 Cao W, Zhang C, Wang H, Wu Q, Yuan Y, Chen J, Geng S, Zhang X. Ischemic Stroke: An Underestimated Complication of COVID-19. Aging Dis 2021;12:691-704. [PMID: 34094634 DOI: 10.14336/AD.2021.0209] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
374 Low ZY, Yip AJW, Sharma A, Lal SK. SARS coronavirus outbreaks past and present-a comparative analysis of SARS-CoV-2 and its predecessors. Virus Genes 2021;57:307-17. [PMID: 34061288 DOI: 10.1007/s11262-021-01846-9] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
375 Desimmie BA, Raru YY, Awadh HM, He P, Teka S, Willenburg KS. Insights into SARS-CoV-2 Persistence and Its Relevance. Viruses 2021;13:1025. [PMID: 34072390 DOI: 10.3390/v13061025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
376 Pechlivanis N, Togkousidis A, Tsagiopoulou M, Sgardelis S, Kappas I, Psomopoulos F. A Computational Framework for Pattern Detection on Unaligned Sequences: An Application on SARS-CoV-2 Data. Front Genet 2021;12:618170. [PMID: 34122498 DOI: 10.3389/fgene.2021.618170] [Reference Citation Analysis]
377 Wang C, Konecki DM, Marciano DC, Govindarajan H, Williams AM, Wastuwidyaningtyas B, Bourquard T, Katsonis P, Lichtarge O. Identification of evolutionarily stable functional and immunogenic sites across the SARS-CoV-2 proteome and greater coronavirus family. Bioinformatics 2021:btab406. [PMID: 34043002 DOI: 10.1093/bioinformatics/btab406] [Reference Citation Analysis]
378 Srivastava V, Ahmad A. New perspective towards therapeutic regimen against SARS-CoV-2 infection. J Infect Public Health 2021;14:852-62. [PMID: 34118735 DOI: 10.1016/j.jiph.2021.05.009] [Reference Citation Analysis]
379 Dutta M, Nezam M, Chowdhury S, Rakib A, Paul A, Sami SA, Uddin MZ, Rana MS, Hossain S, Effendi Y, Idroes R, Tallei T, Alqahtani AM, Emran TB. Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach. Front Mol Biosci 2021;8:625391. [PMID: 34124140 DOI: 10.3389/fmolb.2021.625391] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
380 Kumar V, Singh D, Kaur M, Damaševičius R. Overview of current state of research on the application of artificial intelligence techniques for COVID-19. PeerJ Comput Sci 2021;7:e564. [PMID: 34141890 DOI: 10.7717/peerj-cs.564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
381 Passariello M, Gentile C, Ferrucci V, Sasso E, Vetrei C, Fusco G, Viscardi M, Brandi S, Cerino P, Zambrano N, Zollo M, De Lorenzo C. Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2. Sci Rep 2021;11:11046. [PMID: 34040046 DOI: 10.1038/s41598-021-90348-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
382 Dowarah J, Marak BN, Yadav UCS, Singh VP. Potential drug development and therapeutic approaches for clinical intervention in COVID-19. Bioorg Chem 2021;114:105016. [PMID: 34144277 DOI: 10.1016/j.bioorg.2021.105016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
383 Seifi T, Reza Kamali A. Antiviral performance of graphene-based materials with emphasis on COVID-19: A review. Med Drug Discov 2021;:100099. [PMID: 34056572 DOI: 10.1016/j.medidd.2021.100099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
384 Escalera-Zamudio M, Pond SLK, de la Viña NM, Gutiérrez B, Thézé J, Bowden TA, Pybus OG, Hulswit RJG. Identification of site-specific evolutionary trajectories shared across human betacoronaviruses. bioRxiv 2021:2021. [PMID: 34075377 DOI: 10.1101/2021.05.24.445313] [Reference Citation Analysis]
385 Liu K, Pan X, Li L, Yu F, Zheng A, Du P, Han P, Meng Y, Zhang Y, Wu L, Chen Q, Song C, Jia Y, Niu S, Lu D, Qiao C, Chen Z, Ma D, Ma X, Tan S, Zhao X, Qi J, Gao GF, Wang Q. Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species. Cell 2021;184:3438-3451.e10. [PMID: 34139177 DOI: 10.1016/j.cell.2021.05.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
386 Zhang Y, Wen J, Li X, Li G. Exploration of hosts and transmission traits for SARS-CoV-2 based on the k-mer natural vector. Infect Genet Evol 2021;93:104933. [PMID: 34023511 DOI: 10.1016/j.meegid.2021.104933] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
387 Speckhart K, Williams JM, Tsai B. How DNA and RNA Viruses Exploit Host Chaperones to Promote Infection. Viruses 2021;13:958. [PMID: 34064125 DOI: 10.3390/v13060958] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
388 Janik E, Niemcewicz M, Podogrocki M, Majsterek I, Bijak M. The Emerging Concern and Interest SARS-CoV-2 Variants. Pathogens 2021;10:633. [PMID: 34064143 DOI: 10.3390/pathogens10060633] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 50.0] [Reference Citation Analysis]
389 Thoradeniya T, Jayasinghe S. COVID-19 and future pandemics: a global systems approach and relevance to SDGs. Global Health 2021;17:59. [PMID: 34020654 DOI: 10.1186/s12992-021-00711-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
390 Matsuo T. Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility. Biology (Basel) 2021;10:454. [PMID: 34064163 DOI: 10.3390/biology10060454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
391 Nesar S, Rafiq K, Rizwan M, Hasan SM. Approaches and perspectives for online learning during the COVID-19 pandemic and future chaos. J Educ Health Promot 2021;10:138. [PMID: 34222513 DOI: 10.4103/jehp.jehp_951_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
392 Meirson T, Bomze D, Markel G. Structural basis of SARS-CoV-2 spike protein induced by ACE2. Bioinformatics 2021;37:929-36. [PMID: 32818261 DOI: 10.1093/bioinformatics/btaa744] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
393 Gogate N, Lyman D, Bell A, Cauley E, Crandall KA, Joseph A, Kahsay R, Natale DA, Schriml LM, Sen S, Mazumder R. COVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data model. Brief Bioinform 2021:bbab191. [PMID: 34015823 DOI: 10.1093/bib/bbab191] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
394 Kamel NA, El Wakeel LM, Aboshanab KM. Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets. Viral Immunol 2021. [PMID: 34018828 DOI: 10.1089/vim.2021.0023] [Reference Citation Analysis]
395 Jelinek HF, Mousa M, Alefishat E, Osman W, Spence I, Bu D, Feng SF, Byrd J, Magni PA, Sahibzada S, Tay GK, Alsafar HS. Evolution, Ecology, and Zoonotic Transmission of Betacoronaviruses: A Review. Front Vet Sci 2021;8:644414. [PMID: 34095271 DOI: 10.3389/fvets.2021.644414] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
396 Kenu E, Odikro MA, Malm KL, Asiedu-Bekoe F, Noora CL, Frimpong JA, Calys-Tagoe B, Koram KA. Epidemiology of COVID-19 outbreak in Ghana, 2020. Ghana Med J 2020;54:5-15. [PMID: 33976436 DOI: 10.4314/gmj.v54i4s.3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
397 Zhao C, Fang X, Feng Y, Fang X, He J, Pan H. Emerging role of air pollution and meteorological parameters in COVID-19. J Evid Based Med 2021;14:123-38. [PMID: 34003571 DOI: 10.1111/jebm.12430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
398 Jing W, Procko E. ACE2-based decoy receptors for SARS coronavirus 2. Proteins 2021;89:1065-78. [PMID: 33973262 DOI: 10.1002/prot.26140] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
399 Keikha M, Karbalaei M. Convalescent plasma therapy as a conventional trick for treating COVID-19: a systematic review and meta-analysis study. New Microbes New Infect 2021;42:100901. [PMID: 34026229 DOI: 10.1016/j.nmni.2021.100901] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
400 Li P, Wang L, Yang J, Di LJ, Li J. Applications of the CRISPR-Cas system for infectious disease diagnostics. Expert Rev Mol Diagn 2021;21:723-32. [PMID: 33899643 DOI: 10.1080/14737159.2021.1922080] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
401 Auriti C, De Rose DU, Mondì V, Stolfi I, Tzialla C, On Behalf Of The Study Group Of Neonatal Infectious Diseases. Neonatal SARS-CoV-2 Infection: Practical Tips. Pathogens 2021;10:611. [PMID: 34067588 DOI: 10.3390/pathogens10050611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
402 Taheri S, Asadi S, Nilashi M, Ali Abumalloh R, Ghabban NMA, Mohd Yusuf SY, Supriyanto E, Samad S. A literature review on beneficial role of vitamins and trace elements: Evidence from published clinical studies. J Trace Elem Med Biol 2021;67:126789. [PMID: 34044222 DOI: 10.1016/j.jtemb.2021.126789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
403 Rahimi Pordanjani S, Hasanpour A, Askarpour H, Bastam D, Rafiee M, Khazaei Z, Mazaheri E, Vaziri MH, Sabour S. Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review. Int J Prev Med 2021;12:38. [PMID: 34249287 DOI: 10.4103/ijpvm.IJPVM_469_20] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
404 Maity S, Saha A. Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection. Front Microbiol 2021;12:675419. [PMID: 34054782 DOI: 10.3389/fmicb.2021.675419] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
405 Varabyou A, Pockrandt C, Salzberg SL, Pertea M. Rapid detection of inter-clade recombination in SARS-CoV-2 with Bolotie. Genetics 2021:iyab074. [PMID: 33983397 DOI: 10.1093/genetics/iyab074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
406 Mirbeyk M, Saghazadeh A, Rezaei N. Geriatrics and COVID-19. Adv Exp Med Biol 2021;1318:209-22. [PMID: 33973181 DOI: 10.1007/978-3-030-63761-3_13] [Reference Citation Analysis]
407 Van Oosterhout C. Mitigating the threat of emerging infectious diseases; a coevolutionary perspective. Virulence 2021;12:1288-95. [PMID: 33957064 DOI: 10.1080/21505594.2021.1920741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
408 Rezaei N, Ashkevarian S, Fathi MK, Hanaei S, Kolahchi Z, Ladi Seyedian SS, Rayzan E, Sarzaeim M, Vahed A, Mohamed K, Momtazmanesh S, Moradian N, Pirkoohi ZR, Sameeifar N, Yousefpour M, Sargoli S, Adiban S, Vahed A, Yazdanpanah N, Ziaei H, Saghazadeh A. Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge. Adv Exp Med Biol 2021;1318:1-22. [PMID: 33973169 DOI: 10.1007/978-3-030-63761-3_1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
409 Maab H, Mustafa F, Shabbir SJ. Cardiovascular impact of COVID-19: an array of presentations. Acta Biomed 2021;92:e2021021. [PMID: 33988162 DOI: 10.23750/abm.v92i2.10299] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
410 Salahshoori I, Mobaraki-asl N, Seyfaee A, Mirzaei Nasirabad N, Dehghan Z, Faraji M, Ganjkhani M, Babapoor A, Shadmehr SZ, Hamrang A. Overview of COVID-19 Disease: Virology, Epidemiology, Prevention Diagnosis, Treatment, and Vaccines. Biologics 2021;1:2-40. [DOI: 10.3390/biologics1010002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
411 Hassett CE, Frontera JA. Neurologic aspects of coronavirus disease of 2019 infection. Curr Opin Infect Dis 2021;34:217-27. [PMID: 33769966 DOI: 10.1097/QCO.0000000000000731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
412 Evers JM, Pehlke SJ, Jones LL, Urquhart MG. Oxygenation Strategies in Critically Ill Patients With COVID-19. Dimens Crit Care Nurs 2021;40:75-82. [PMID: 33961375 DOI: 10.1097/DCC.0000000000000463] [Reference Citation Analysis]
413 Alesawy MS, Abdallah AE, Taghour MS, Elkaeed EB, H Eissa I, Metwaly AM. In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro). Molecules 2021;26:2806. [PMID: 34068579 DOI: 10.3390/molecules26092806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
414 Harbour JC, Lyski ZL, Schell JB, Thomas A, Messer WB, Slifka MK, Nolz JC. Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein. J Immunol 2021;206:2596-604. [PMID: 33972374 DOI: 10.4049/jimmunol.2100054] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
415 Alireza Hashemi S, Bahrani S, Mojtaba Mousavi S, Omidifar N, Ghaleh Golab Behbahan N, Arjmand M, Ramakrishna S, Bagheri Lankarani K, Moghadami M, Shokripour M, Firoozsani M, Chiang WH. Ultra-precise label-free nanosensor based on integrated graphene with Au nanostars toward direct detection of IgG antibodies of SARS-CoV-2 in blood. J Electroanal Chem (Lausanne) 2021;894:115341. [PMID: 33994897 DOI: 10.1016/j.jelechem.2021.115341] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
416 Anastassopoulou C, Manoussopoulos Y, Lampropoulou V, Tsakris A. Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes. Future Microbiol 2021;16:455-9. [PMID: 33960807 DOI: 10.2217/fmb-2020-0300] [Reference Citation Analysis]
417 Anand U, Bianco F, Suresh S, Tripathi V, Núñez-Delgado A, Race M. SARS-CoV-2 and other viruses in soil: An environmental outlook. Environ Res 2021;198:111297. [PMID: 33971130 DOI: 10.1016/j.envres.2021.111297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
418 Hua S, Yang Y, Zou D, Li J, Yan K, Xu Y, Jiang X, Rong X, Ye D. COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies. Biomed Pharmacother 2021;140:111685. [PMID: 34015585 DOI: 10.1016/j.biopha.2021.111685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
419 Ryder SP, Morgan BR, Coskun P, Antkowiak K, Massi F. Analysis of Emerging Variants in Structured Regions of the SARS-CoV-2 Genome. Evol Bioinform Online 2021;17:11769343211014167. [PMID: 34017166 DOI: 10.1177/11769343211014167] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
420 Naveed M, Tehreem S, Arshad S, Bukhari SA, Shabbir MA, Essa R, Ali N, Zaib S, Khan A, Al-Harrasi A, Khan I. Design of a novel multiple epitope-based vaccine: An immunoinformatics approach to combat SARS-CoV-2 strains. J Infect Public Health 2021;14:938-46. [PMID: 34119848 DOI: 10.1016/j.jiph.2021.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
421 Xia X, Yuan P, Liu Y, Wang Y, Cao W, Zheng JC. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword? Immunology 2021;163:416-30. [PMID: 33742451 DOI: 10.1111/imm.13329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
422 Khan FM, Ahmad T, Gulistan M, Chammam W, Khan M, Hui J. Epidemiology of coronaviruses, genetics, vaccines, and scenario of current pandemic of coronavirus diseases 2019 (COVID-19): a fuzzy set approach. Hum Vaccin Immunother 2021;17:1296-303. [PMID: 33720797 DOI: 10.1080/21645515.2020.1798697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
423 Chittora D, Meena BR, Mittholiya S, Sharma K. Updates of COVID-19. Res Biomed Eng 2021;37:835-48. [DOI: 10.1007/s42600-021-00140-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
424 Muhamad SA, Ugusman A, Kumar J, Skiba D, Hamid AA, Aminuddin A. COVID-19 and Hypertension: The What, the Why, and the How. Front Physiol 2021;12:665064. [PMID: 34012410 DOI: 10.3389/fphys.2021.665064] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
425 Caillet-Saguy C, Durbesson F, Rezelj VV, Gogl G, Tran QD, Twizere JC, Vignuzzi M, Vincentelli R, Wolff N. Host PDZ-containing proteins targeted by SARS-CoV-2. FEBS J 2021. [PMID: 33864728 DOI: 10.1111/febs.15881] [Cited by in Crossref: 7] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
426 Viana-Llamas MC, Arroyo-Espliguero R, Silva-Obregón JA, Uribe-Heredia G, Núñez-Gil I, García-Magallón B, Torán-Martínez CG, Castillo-Sandoval A, Díaz-Caraballo E, Rodríguez-Guinea I, Domínguez-López J. Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study. Med Clin (Engl Ed) 2021;156:428-36. [PMID: 33969222 DOI: 10.1016/j.medcle.2020.12.015] [Reference Citation Analysis]
427 Abdoulaye AH, Hai D, Tang Q, Jiang D, Fu Y, Cheng J, Lin Y, Li B, Kotta-Loizou I, Xie J. Two distant helicases in one mycovirus: evidence of horizontal gene transfer between mycoviruses, coronaviruses and other nidoviruses. Virus Evol 2021;7:veab043. [PMID: 34055389 DOI: 10.1093/ve/veab043] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
428 Zhang Y, Su L, Chen Y, Yu S, Zhang D, Mao H, Fang L. Etiology and clinical characteristics of SARS-CoV-2 and other human coronaviruses among children in Zhejiang Province, China 2017-2019. Virol J 2021;18:89. [PMID: 33931105 DOI: 10.1186/s12985-021-01562-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
429 Majumdar P, Niyogi S. SARS-CoV-2 mutations: the biological trackway towards viral fitness. Epidemiol Infect 2021;149:e110. [PMID: 33928885 DOI: 10.1017/S0950268821001060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
430 Bağ Soytaş R, Ünal D, Arman P, Suzan V, Emiroğlu Gedik T, Can G, Korkmazer B, Karaali R, Börekçi Ş, Kuşkucu MA, Yavuzer H, Suna Erdinçler D, Döventaş A. Factors affecting mortality in geriatric patients hospitalized with COVID-19. Turk J Med Sci 2021;51:454-63. [PMID: 33315348 DOI: 10.3906/sag-2008-91] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
431 Yeh TY, Contreras GP. Viral transmission and evolution dynamics of SARS-CoV-2 in shipboard quarantine. Bull World Health Organ 2021;99:486-95. [PMID: 34248221 DOI: 10.2471/BLT.20.255752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
432 Ahsan T, Rani B, Siddiqui R, D'Souza G, Memon R, Lutfi I, I Hasan O, Javed R, Khan F, Hassan M. Clinical Variants, Characteristics, and Outcomes Among COVID-19 Patients: A Case Series Analysis at a Tertiary Care Hospital in Karachi, Pakistan. Cureus 2021;13:e14761. [PMID: 34084685 DOI: 10.7759/cureus.14761] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
433 Bertho N, Meurens F. The pig as a medical model for acquired respiratory diseases and dysfunctions: An immunological perspective. Mol Immunol 2021;135:254-67. [PMID: 33933817 DOI: 10.1016/j.molimm.2021.03.014] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
434 Pirzada RH, Haseeb M, Batool M, Kim M, Choi S. Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication. Cells 2021;10:1052. [PMID: 33946869 DOI: 10.3390/cells10051052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
435 Nicastro E, Verdoni L, Bettini LR, Zuin G, Balduzzi A, Montini G, Biondi A, D'Antiga L. COVID-19 in Immunosuppressed Children. Front Pediatr 2021;9:629240. [PMID: 33996683 DOI: 10.3389/fped.2021.629240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
436 Tarifi A, Al Shdaifat AA, Al-Shudifat AM, Azab M, Ismail J, Bashir R, Amro A, Altarifi A, Khader Y. Clinical, sinonasal, and long-term smell and taste outcomes in mildly symptomatic COVID-19 patients. Int J Clin Pract 2021;75:e14260. [PMID: 33884722 DOI: 10.1111/ijcp.14260] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
437 Müller NF, Kistler KE, Bedford T. Recombination patterns in coronaviruses. bioRxiv 2021:2021. [PMID: 33948594 DOI: 10.1101/2021.04.28.441806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
438 Owen L, Shivkumar M, Laird K. The Stability of Model Human Coronaviruses on Textiles in the Environment and during Health Care Laundering. mSphere 2021;6:e00316-21. [PMID: 33910996 DOI: 10.1128/mSphere.00316-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
439 Jacob Machado D, Scott R, Guirales S, Janies DA. Fundamental evolution of all Orthocoronavirinae including three deadly lineages descendent from Chiroptera-hosted coronaviruses: SARS-CoV, MERS-CoV and SARS-CoV-2. Cladistics 2021. [PMID: 34219906 DOI: 10.1111/cla.12454] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
440 Resál T, Bor R, Szántó K, Fábián A, Rutka M, Sacco M, Ribaldone DG, Molander P, Nancey S, Kopylov U, Vavricka S, Drobne D, Lukas M, Farkas K, Szepes Z, Molnár T. Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey. Therap Adv Gastroenterol 2021;14:17562848211006678. [PMID: 33995580 DOI: 10.1177/17562848211006678] [Reference Citation Analysis]
441 Majdoubi A, Michalski C, O'Connell SE, Dada S, Narpala S, Gelinas J, Mehta D, Cheung C, Winkler DF, Basappa M, Liu AC, Görges M, Barakauskas VE, Irvine M, Mehalko J, Esposito D, Sekirov I, Jassem AN, Goldfarb DM, Pelech S, Douek DC, McDermott AB, Lavoie PM. A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2. JCI Insight 2021;6:146316. [PMID: 33720905 DOI: 10.1172/jci.insight.146316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
442 Wang Y, Zeng J, Zhang C, Chen C, Qiu Z, Pang J, Xu Y, Dong Z, Song Y, Liu W, Dong P, Sun L, Chen YQ, Shu Y, Du X. New framework for recombination and adaptive evolution analysis with application to the novel coronavirus SARS-CoV-2. Brief Bioinform 2021:bbab107. [PMID: 33885735 DOI: 10.1093/bib/bbab107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
443 Stevaert A, Krasniqi B, Van Loy B, Nguyen T, Thomas J, Vandeput J, Jochmans D, Thiel V, Dijkman R, Dehaen W, Voet A, Naesens L. Betulonic Acid Derivatives Interfering with Human Coronavirus 229E Replication via the nsp15 Endoribonuclease. J Med Chem 2021;64:5632-44. [PMID: 33877845 DOI: 10.1021/acs.jmedchem.0c02124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
444 Li BS, Li ZC, Hu Y, Liang LJ, Zou LR, Guo QF, Zheng ZH, Yu JX, Song T, Wu J. Genomic Evolution and Variation of SARS-CoV-2 in the Early Phase of COVID-19 Pandemic in Guangdong Province, China. Curr Med Sci 2021;41:228-35. [PMID: 33877539 DOI: 10.1007/s11596-021-2340-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
445 Savla SR, Prabhavalkar KS, Bhatt LK. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management. Expert Rev Anti Infect Ther 2021;:1-17. [PMID: 33832398 DOI: 10.1080/14787210.2021.1915129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
446 Ghaleb AA, Sadky A, Meghaizel MA, El Etriby S. Prognostic Value of Troponin I in COVID-19 Patients. TOCMJ 2021;15:18-22. [DOI: 10.2174/1874192402115010018] [Reference Citation Analysis]
447 Bozzano F, Dentone C, Perrone C, Di Biagio A, Fenoglio D, Parodi A, Mikulska M, Bruzzone B, Giacobbe DR, Vena A, Taramasso L, Nicolini L, Patroniti N, Pelosi P, Gratarola A, De Palma R, Filaci G, Bassetti M, De Maria A; GECOVID study group. Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity. PLoS Pathog 2021;17:e1009448. [PMID: 33861802 DOI: 10.1371/journal.ppat.1009448] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 25.0] [Reference Citation Analysis]
448 Kenyeres B, Ánosi N, Bányai K, Mátyus M, Orosz L, Kiss A, Kele B, Burián K, Lengyel G. Comparison of four PCR and two point of care assays used in the laboratory detection of SARS-CoV-2. J Virol Methods 2021;293:114165. [PMID: 33872650 DOI: 10.1016/j.jviromet.2021.114165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
449 Mishra D, Maurya RR, Kumar K, Munjal NS, Bahadur V, Sharma S, Singh P, Bahadur I. Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies. J Mol Liq 2021;335:116185. [PMID: 33879934 DOI: 10.1016/j.molliq.2021.116185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
450 Cheng L, Han X, Zhu Z, Qi C, Wang P, Zhang X. Functional alterations caused by mutations reflect evolutionary trends of SARS-CoV-2. Brief Bioinform 2021;22:1442-50. [PMID: 33580783 DOI: 10.1093/bib/bbab042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
451 Pourfridoni M, Abbasnia SM, Shafaei F, Razaviyan J, Heidari-Soureshjani R. Fluid and Electrolyte Disturbances in COVID-19 and Their Complications. Biomed Res Int 2021;2021:6667047. [PMID: 33937408 DOI: 10.1155/2021/6667047] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
452 Diab AM, Carleton BC, Goralski KB. COVID-19 pathophysiology and pharmacology: what do we know and how did Canadians respond? A review of Health Canada authorized clinical vaccine and drug trials. Can J Physiol Pharmacol 2021;99:577-88. [PMID: 33852809 DOI: 10.1139/cjpp-2021-0038] [Reference Citation Analysis]
453 Hu T, Li J, Zhou H, Li C, Holmes EC, Shi W. Bioinformatics resources for SARS-CoV-2 discovery and surveillance. Brief Bioinform 2021;22:631-41. [PMID: 33416890 DOI: 10.1093/bib/bbaa386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
454 Meng Q, Chu Y, Shao C, Chen J, Wang J, Gao Z, Yu J, Kang Y. Roles of host small RNAs in the evolution and host tropism of coronaviruses. Brief Bioinform 2021;22:1096-105. [PMID: 33587745 DOI: 10.1093/bib/bbab027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
455 Mousavi Maleki MS, Rostamian M, Madanchi H. Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2. Expert Rev Anti Infect Ther 2021;:1-13. [PMID: 33844613 DOI: 10.1080/14787210.2021.1912593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
456 Rahmawati PL, Tini K, Susilawathi NM, Wijayanti IAS, Samatra DP. Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2. J Clin Neurol 2021;17:155-63. [PMID: 33835735 DOI: 10.3988/jcn.2021.17.2.155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
457 Bhimala KR, Patra GK, Mopuri R, Mutheneni SR. Prediction of COVID-19 cases using the weather integrated deep learning approach for India. Transbound Emerg Dis 2021. [PMID: 33837675 DOI: 10.1111/tbed.14102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
458 Murashko MM, Stasevich EM, Schwartz AM, Kuprash DV, Uvarova AN, Demin DE. The Role of RNA in DNA Breaks, Repair and Chromosomal Rearrangements. Biomolecules 2021;11:550. [PMID: 33918762 DOI: 10.3390/biom11040550] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
459 Sermet-Gaudelus I, Temmam S, Huon C, Behillil S, Gajdos V, Bigot T, Lurier T, Chrétien D, Backovic M, Delaunay-Moisan A, Donati F, Albert M, Foucaud E, Mesplées B, Benoist G, Faye A, Duval-Arnould M, Cretolle C, Charbit M, Aubart M, Auriau J, Lorrot M, Kariyawasam D, Fertitta L, Orliaguet G, Pigneur B, Bader-Meunier B, Briand C, Enouf V, Toubiana J, Guilleminot T, van der Werf S, Leruez-Ville M, Eloit M. Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020. Euro Surveill 2021;26. [PMID: 33797390 DOI: 10.2807/1560-7917.ES.2021.26.13.2001782] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
460 Cazzato G, Foti C, Colagrande A, Cimmino A, Scarcella S, Cicco G, Sablone S, Arezzo F, Romita P, Lettini T, Resta L, Ingravallo G. Skin Manifestation of SARS-CoV-2: The Italian Experience. J Clin Med 2021;10:1566. [PMID: 33917774 DOI: 10.3390/jcm10081566] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
461 Zhuang S, Tang L, Dai Y, Feng X, Fang Y, Tang H, Jiang P, Wu X, Fang H, Chen H. Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). PeerJ 2021;9:e11232. [PMID: 33889450 DOI: 10.7717/peerj.11232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
462 Aldhahri M, Alghamdi R. Awareness of COVID-19 Before and After Quarantine Based on Crowdsourced Data From Rabigh City, Saudi Arabia: A Cross-Sectional and Comparative Study. Front Public Health 2021;9:632024. [PMID: 33898375 DOI: 10.3389/fpubh.2021.632024] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
463 Alberca GGF, Solis-Castro RL, Solis-Castro ME, Alberca RW. Coronavirus disease–2019 and the intestinal tract: An overview. World J Gastroenterol 2021; 27(13): 1255-1266 [PMID: 33833480 DOI: 10.3748/wjg.v27.i13.1255] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
464 Srivastava S, Rai PS, Jain A, Shenoy S. Perception and practice regarding infection control measures in Radiology department during pre-COVID and COVID times-A survey among radiologists and a review of current concepts and literature. Indian J Radiol Imaging 2021;31:S139-47. [PMID: 33814774 DOI: 10.4103/ijri.IJRI_567_20] [Reference Citation Analysis]
465 Nie J, Li Q, Zhang L, Cao Y, Zhang Y, Li T, Wu J, Liu S, Zhang M, Zhao C, Liu H, Nie L, Qin H, Wang M, Lu Q, Li X, Liu J, Liang H, Jiang T, Duan K, Yang X, Shen Y, Huang W, Wang Y. Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses. Cell Discov 2021;7:21. [PMID: 33824288 DOI: 10.1038/s41421-021-00256-3] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
466 Dheyab MA, Khaniabadi PM, Aziz AA, Jameel MS, Mehrdel B, Oglat AA, Khaleel HA. Focused role of nanoparticles against COVID-19: Diagnosis and treatment. Photodiagnosis Photodyn Ther 2021;34:102287. [PMID: 33836276 DOI: 10.1016/j.pdpdt.2021.102287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
467 Taher M, Tik N, Susanti D. Drugs intervention study in COVID-19 management. Drug Metabolism and Personalized Therapy 2021;0:20200173. [DOI: 10.1515/dmdi-2020-0173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
468 Barrantes FJ. The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations. Brain Behav Immun Health 2021;14:100251. [PMID: 33842898 DOI: 10.1016/j.bbih.2021.100251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
469 Marchi R, Sugita B, Centa A, Fonseca AS, Bortoletto S, Fiorentin K, Ferreira S, Cavalli LR. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review. Infect Genet Evol 2021;91:104832. [PMID: 33812037 DOI: 10.1016/j.meegid.2021.104832] [Cited by in Crossref: 5] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
470 Jain S, Abrham E, Khan MN, Mathur R. An Account of Immune Senescence in the Clinical Pathophysiology of COVID-19 Infection in Aging. Aging Dis 2021;12:662-70. [PMID: 33815889 DOI: 10.14336/AD.2020.1019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
471 Lagacé-Wiens P, Bullard J, Cole R, Van Caeseele P. Seasonality of coronaviruses and other respiratory viruses in Canada: Implications for COVID-19. Can Commun Dis Rep 2021;47:132-8. [PMID: 34012336 DOI: 10.14745/ccdr.v47i03a02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
472 Makatsa MS, Tincho MB, Wendoh JM, Ismail SD, Nesamari R, Pera F, de Beer S, David A, Jugwanth S, Gededzha MP, Mampeule N, Sanne I, Stevens W, Scott L, Blackburn J, Mayne ES, Keeton RS, Burgers WA. SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients. Front Plant Sci 2021;12:589940. [PMID: 33868324 DOI: 10.3389/fpls.2021.589940] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
473 Vlasova AN, Saif LJ. Bovine Coronavirus and the Associated Diseases. Front Vet Sci 2021;8:643220. [PMID: 33869323 DOI: 10.3389/fvets.2021.643220] [Cited by in Crossref: 4] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
474 Jardine J, Morris E. COVID-19 in Women's health: Epidemiology. Best Pract Res Clin Obstet Gynaecol 2021;73:81-90. [PMID: 33906791 DOI: 10.1016/j.bpobgyn.2021.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
475 Farman M, Aslam M, Akgül A, Ahmad A. Modeling of fractional-order COVID-19 epidemic model with quarantine and social distancing. Math Methods Appl Sci 2021;44:9334-50. [PMID: 34230734 DOI: 10.1002/mma.7360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
476 de Mello Malta F, Amgarten D, Val FC, Cervato MC, de Azevedo BMC, de Souza Basqueira M, Dos Santos Alves CO, Nobrega MS, de Souza Reis R, Sebe P, Gretschischkin MC, de Oliveira DDC, Nakamura CNI, Chazanas PLN, Pinho JRR. Mass molecular testing for COVID19 using NGS-based technology and a highly scalable workflow. Sci Rep 2021;11:7122. [PMID: 33782491 DOI: 10.1038/s41598-021-86498-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
477 Hosseini SA, Zahedipour F, Mirzaei H, Kazemi Oskuee R. Potential SARS-CoV-2 vaccines: Concept, progress, and challenges. Int Immunopharmacol 2021;97:107622. [PMID: 33895475 DOI: 10.1016/j.intimp.2021.107622] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
478 Nazir R, Ali J, Rasul I, Widemann E, Shafiq S. Eco-Environmental Aspects of COVID-19 Pandemic and Potential Control Strategies. Int J Environ Res Public Health 2021;18:3488. [PMID: 33801704 DOI: 10.3390/ijerph18073488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
479 Lian J, Wang Z, Xu Z, Chen T, Shao G, Zhang X, Qin J, Xie Q, Lin W. Distribution and molecular characterization of avian infectious bronchitis virus in southern China. Poult Sci 2021;100:101169. [PMID: 34116347 DOI: 10.1016/j.psj.2021.101169] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
480 Zhang Y, Gargan S, Lu Y, Stevenson NJ. An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity. Viruses 2021;13:560. [PMID: 33810391 DOI: 10.3390/v13040560] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
481 Jiang C, Li X, Ge C, Ding Y, Zhang T, Cao S, Meng L, Lu S. Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection. J Pharm Anal 2021;11:257-64. [PMID: 33815862 DOI: 10.1016/j.jpha.2021.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
482 Kifle ZD, Enyew EF, Mekuria AB. A Recent Achievement in the Discovery and Development of Vaccines and Therapeutic Agents in the Race for COVID-19 Protection and Treatment. J Evid Based Integr Med 2021;26:2515690X211003727. [PMID: 33761791 DOI: 10.1177/2515690X211003727] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
483 Gazzaz ZJ. Diabetes and COVID-19. Open Life Sci 2021;16:297-302. [PMID: 33817321 DOI: 10.1515/biol-2021-0034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
484 Lednicky JA, Tagliamonte MS, White SK, Elbadry MA, Alam MM, Stephenson CJ, Bonny TS, Loeb JC, Telisma T, Chavannes S, Ostrov DA, Mavian C, De Rochars VMB, Salemi M, Morris JG. Emergence of porcine delta-coronavirus pathogenic infections among children in Haiti through independent zoonoses and convergent evolution. medRxiv 2021:2021. [PMID: 33791709 DOI: 10.1101/2021.03.19.21253391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
485 Mosselhy DA, Assad MA, Sironen T, Elbahri M. Could Nanotheranostics be the Answer to the Coronavirus Crisis? Glob Chall 2021;5:2000112. [PMID: 34141446 DOI: 10.1002/gch2.202000112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
486 Carmi G, Gorohovski A, Mukherjee S, Frenkel-Morgenstern M. Non-optimal codon usage preferences of coronaviruses determine their promiscuity for infecting multiple hosts. FEBS J 2021;288:5201-23. [PMID: 33756061 DOI: 10.1111/febs.15835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
487 Abedzadeh-Kalahroudi M, Sehat M, Vahedpour Z, Talebian P, Haghighi A. Clinical and obstetric characteristics of pregnant women with Covid-19: A case series study on 26 patients. Taiwan J Obstet Gynecol 2021;60:458-62. [PMID: 33966728 DOI: 10.1016/j.tjog.2021.03.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
488 Najafi-Ghalehlou N, Roudkenar MH, Langerodi HZ, Roushandeh AM. Taming of Covid-19: potential and emerging application of mesenchymal stem cells. Cytotechnology 2021;:1-46. [PMID: 33776206 DOI: 10.1007/s10616-021-00461-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
489 Maneira C, Bermejo PM, Pereira GAG, de Mello FDSB. Exploring G protein-coupled receptors and yeast surface display strategies for viral detection in baker's yeast: SARS-CoV-2 as a case study. FEMS Yeast Res 2021;21:foab004. [PMID: 33469649 DOI: 10.1093/femsyr/foab004] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
490 Hönemann M, Lück C, Maier M, Pietsch C, Dietze N, Berthold T, Encalada MVN, Grünewald T, Neumeister V, Dalpke A, Liebert UG. Comprehensive evaluation of eight commercial SARS-CoV-2 IgG assays. Diagn Microbiol Infect Dis 2021;100:115382. [PMID: 33930691 DOI: 10.1016/j.diagmicrobio.2021.115382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
491 Li Z, Lang Y, Liu L, Bunyatov MI, Sarmiento AI, de Groot RJ, Boons GJ. Synthetic O-acetylated sialosides facilitate functional receptor identification for human respiratory viruses. Nat Chem 2021;13:496-503. [PMID: 33753916 DOI: 10.1038/s41557-021-00655-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
492 Jo WK, Drosten C, Drexler JF. The evolutionary dynamics of endemic human coronaviruses. Virus Evol 2021;7:veab020. [PMID: 33768964 DOI: 10.1093/ve/veab020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
493 El-Demerdash A, Metwaly AM, Hassan A, Abd El-Aziz TM, Elkaeed EB, Eissa IH, Arafa RK, Stockand JD. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19). Biomolecules 2021;11:460. [PMID: 33808721 DOI: 10.3390/biom11030460] [Cited by in Crossref: 11] [Cited by in F6Publishing: 37] [Article Influence: 11.0] [Reference Citation Analysis]
494 Chathappady House NN, Palissery S, Sebastian H. Corona Viruses: A Review on SARS, MERS and COVID-19. Microbiol Insights 2021;14:11786361211002481. [PMID: 33795938 DOI: 10.1177/11786361211002481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
495 Mishra P, Sohrab S, Mishra SK. A review on the phytochemical and pharmacological properties of Hyptis suaveolens (L.) Poit. Futur J Pharm Sci 2021;7:65. [PMID: 33728353 DOI: 10.1186/s43094-021-00219-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
496 Zhang W, Liu K, Zhang P, Cheng W, Li L, Zhang F, Yu Z, Li L, Zhang X. CRISPR-Based Approaches for Efficient and Accurate Detection of SARS-CoV-2. Lab Med 2021;52:116-21. [PMID: 33316059 DOI: 10.1093/labmed/lmaa101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
497 Cruz-González A, Muñoz-Velasco I, Cottom-Salas W, Becerra A, Campillo-Balderas JA, Hernández-Morales R, Vázquez-Salazar A, Jácome R, Lazcano A. Structural analysis of viral ExoN domains reveals polyphyletic hijacking events. PLoS One 2021;16:e0246981. [PMID: 33730017 DOI: 10.1371/journal.pone.0246981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
498 Wang C, van Haperen R, Gutiérrez-Álvarez J, Li W, Okba NMA, Albulescu I, Widjaja I, van Dieren B, Fernandez-Delgado R, Sola I, Hurdiss DL, Daramola O, Grosveld F, van Kuppeveld FJM, Haagmans BL, Enjuanes L, Drabek D, Bosch BJ. A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies. Nat Commun 2021;12:1715. [PMID: 33731724 DOI: 10.1038/s41467-021-21968-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 58] [Article Influence: 16.0] [Reference Citation Analysis]
499 Ravindra NG, Alfajaro MM, Gasque V, Huston NC, Wan H, Szigeti-Buck K, Yasumoto Y, Greaney AM, Habet V, Chow RD, Chen JS, Wei J, Filler RB, Wang B, Wang G, Niklason LE, Montgomery RR, Eisenbarth SC, Chen S, Williams A, Iwasaki A, Horvath TL, Foxman EF, Pierce RW, Pyle AM, van Dijk D, Wilen CB. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes. PLoS Biol 2021;19:e3001143. [PMID: 33730024 DOI: 10.1371/journal.pbio.3001143] [Cited by in Crossref: 16] [Cited by in F6Publishing: 65] [Article Influence: 16.0] [Reference Citation Analysis]
500 Song LG, Xie QX, Lao HL, Lv ZY. Human coronaviruses and therapeutic drug discovery. Infect Dis Poverty 2021;10:28. [PMID: 33726861 DOI: 10.1186/s40249-021-00812-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
501 Laskar R, Ali S. Phylo-geo-network and haplogroup analysis of 611 novel coronavirus (SARS-CoV-2) genomes from India. Life Sci Alliance 2021;4:e202000925. [PMID: 33727249 DOI: 10.26508/lsa.202000925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
502 Rezaei-Tavirani M, Rostami Nejad M, Arjmand B, Rezaei Tavirani S, Razzaghi M, Mansouri V. Fibrinogen Dysregulation is a Prominent Process in Fatal Conditions of COVID-19 Infection; a Proteomic Analysis. Arch Acad Emerg Med 2021;9:e26. [PMID: 34027421 DOI: 10.22037/aaem.v9i1.1128] [Reference Citation Analysis]
503 VanInsberghe D, Neish AS, Lowen AC, Koelle K. Recombinant SARS-CoV-2 genomes are currently circulating at low levels. bioRxiv 2021:2020. [PMID: 33758853 DOI: 10.1101/2020.08.05.238386] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 14.0] [Reference Citation Analysis]
504 Friston KJ, Parr T, Zeidman P, Razi A, Flandin G, Daunizeau J, Hulme OJ, Billig AJ, Litvak V, Price CJ, Moran RJ, Lambert C. Second waves, social distancing, and the spread of COVID-19 across the USA. Wellcome Open Res 2020;5:103. [PMID: 33954262 DOI: 10.12688/wellcomeopenres.15986.3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
505 Bakhshandeh B, Jahanafrooz Z, Abbasi A, Goli MB, Sadeghi M, Mottaqi MS, Zamani M. Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus. Microb Pathog 2021;154:104831. [PMID: 33727169 DOI: 10.1016/j.micpath.2021.104831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
506 Nardacci R, Colavita F, Castilletti C, Lapa D, Matusali G, Meschi S, Del Nonno F, Colombo D, Capobianchi MR, Zumla A, Ippolito G, Piacentini M, Falasca L. Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis. Cell Death Dis 2021;12:263. [PMID: 33712574 DOI: 10.1038/s41419-021-03527-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
507 Römer C. Viruses and Endogenous Retroviruses as Roots for Neuroinflammation and Neurodegenerative Diseases. Front Neurosci 2021;15:648629. [PMID: 33776642 DOI: 10.3389/fnins.2021.648629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
508 Hu Y, Ma C, Szeto T, Hurst B, Tarbet B, Wang J. Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses. ACS Infect Dis 2021;7:586-97. [PMID: 33645977 DOI: 10.1021/acsinfecdis.0c00761] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 24.0] [Reference Citation Analysis]
509 Kaliyaperumal D, Rk K, Alagesan M, Ramalingam S. Characterization of cardiac autonomic function in COVID-19 using heart rate variability: a hospital based preliminary observational study. J Basic Clin Physiol Pharmacol 2021;32:247-53. [PMID: 33705614 DOI: 10.1515/jbcpp-2020-0378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
510 Mancuso G, Perulli GD, Lavrnić S, Morandi B, Toscano A. SARS-CoV-2 from Urban to Rural Water Environment: Occurrence, Persistence, Fate, and Influence on Agriculture Irrigation. A Review. Water 2021;13:764. [DOI: 10.3390/w13060764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
511 Vianna FSL, Fraga LR, Abeche AM, Silva AAD, Sanseverino MTV, Schuler-Faccini L. COVID-19 during pregnancy and adverse outcomes: Concerns and recommendations from The Brazilian Teratology Information Service. Genet Mol Biol 2021;44:e20200224. [PMID: 33710249 DOI: 10.1590/1678-4685-GMB-2020-0224] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
512 Milani M, Donalisio M, Bonotto RM, Schneider E, Arduino I, Boni F, Lembo D, Marcello A, Mastrangelo E. Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors. Antiviral Res 2021;189:105055. [PMID: 33713730 DOI: 10.1016/j.antiviral.2021.105055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
513 Alotaibi A, Shiblee M, Alshahrani A. Prediction of Severity of COVID-19-Infected Patients Using Machine Learning Techniques. Computers 2021;10:31. [DOI: 10.3390/computers10030031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
514 Colina SE, Serena MS, Echeverría MG, Metz GE. Clinical and molecular aspects of veterinary coronaviruses. Virus Res 2021;297:198382. [PMID: 33705799 DOI: 10.1016/j.virusres.2021.198382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
515 Leontitsis A, Senok A, Alsheikh-Ali A, Al Nasser Y, Loney T, Alshamsi A. SEAHIR: A Specialized Compartmental Model for COVID-19. Int J Environ Res Public Health 2021;18:2667. [PMID: 33800896 DOI: 10.3390/ijerph18052667] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
516 Li X, Xia WY, Jiang F, Liu DY, Lei SQ, Xia ZY, Wu QP. Review of the risk factors for SARS-CoV-2 transmission. World J Clin Cases 2021; 9(7): 1499-1512 [PMID: 33728294 DOI: 10.12998/wjcc.v9.i7.1499] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
517 Gebretsadik D, Gebremichael S, Belete MA. Knowledge, Attitude and Practice Toward COVID-19 Pandemic Among Population Visiting Dessie Health Center for COVID-19 Screening, Northeast Ethiopia. Infect Drug Resist 2021;14:905-15. [PMID: 33716509 DOI: 10.2147/IDR.S297047] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
518 Yokoyama R, Kurano M, Morita Y, Shimura T, Nakano Y, Qian C, Xia F, He F, Kishi Y, Okada J, Yoshikawa N, Nagura Y, Okazaki H, Moriya K, Seto Y, Kodama T, Yatomi Y. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan. PLoS One 2021;16:e0247711. [PMID: 33661990 DOI: 10.1371/journal.pone.0247711] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
519 Zhang W, He H, Zhu L, Liu G, Wu L. Food Safety in Post-COVID-19 Pandemic: Challenges and Countermeasures. Biosensors (Basel) 2021;11:71. [PMID: 33806704 DOI: 10.3390/bios11030071] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
520 Hassanzadeh P. The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing. Life Sci 2021;274:119289. [PMID: 33676931 DOI: 10.1016/j.lfs.2021.119289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
521 Silva RN, Goulart CDL, Oliveira MR, Tacao GY, Back GD, Severin R, Faghy MA, Arena R, Borghi-Silva A. Cardiorespiratory and skeletal muscle damage due to COVID-19: making the urgent case for rehabilitation. Expert Rev Respir Med 2021;15:1107-20. [PMID: 33606567 DOI: 10.1080/17476348.2021.1893169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
522 Parikh SR, Parikh RS. Chemical disinfectants in ophthalmic practice. Indian J Ophthalmol 2021;69:510-6. [PMID: 33595464 DOI: 10.4103/ijo.IJO_1549_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
523 Abdellatiif MH, Ali A, Ali A, Hussien MA. Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19. Open Chemistry 2021;19:245-64. [DOI: 10.1515/chem-2021-0024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
524 Barrantes FJ. Structural biology of coronavirus ion channels. Acta Crystallogr D Struct Biol 2021;77:391-402. [PMID: 33825700 DOI: 10.1107/S2059798321001431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
525 Luo J, Zhu X, Jian J, Chen X, Yin K. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment. Acta Biochim Biophys Sin (Shanghai) 2021;53:273-82. [PMID: 33428706 DOI: 10.1093/abbs/gmaa176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
526 Gutiérrez-Álvarez J, Honrubia JM, Fernández-Delgado R, Wang L, Castaño-Rodríguez C, Zúñiga S, Sola I, Enjuanes L. Genetically Engineered Live-Attenuated Middle East Respiratory Syndrome Coronavirus Viruses Confer Full Protection against Lethal Infection. mBio 2021;12:e00103-21. [PMID: 33653888 DOI: 10.1128/mBio.00103-21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
527 El-Sayed A, Kamel M. Coronaviruses in humans and animals: the role of bats in viral evolution. Environ Sci Pollut Res Int 2021;28:19589-600. [PMID: 33655480 DOI: 10.1007/s11356-021-12553-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
528 Huang Y, Zhang Y, Ma L. Meta-analysis of laboratory results in patients with severe coronavirus disease 2019. Exp Ther Med 2021;21:449. [PMID: 33747184 DOI: 10.3892/etm.2021.9877] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
529 Coerdt KM, Khachemoune A. Corona viruses: reaching far beyond the common cold. Afr Health Sci 2021;21:207-13. [PMID: 34394299 DOI: 10.4314/ahs.v21i1.27] [Reference Citation Analysis]
530 Saviñon-Flores F, Méndez E, López-Castaños M, Carabarin-Lima A, López-Castaños KA, González-Fuentes MA, Méndez-Albores A. A Review on SERS-Based Detection of Human Virus Infections: Influenza and Coronavirus. Biosensors (Basel) 2021;11:66. [PMID: 33670852 DOI: 10.3390/bios11030066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
531 Sakr MM, Elsayed NS, El-Housseiny GS. Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review. Microb Pathog 2021;154:104809. [PMID: 33647446 DOI: 10.1016/j.micpath.2021.104809] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
532 Xu N, Lv A, Li T, Li X, Huang M, Su Y. Experiences of healthcare providers during the coronavirus pandemic and its impact on them: protocol for a mixed-methods systematic review. BMJ Open 2021;11:e043686. [PMID: 33637546 DOI: 10.1136/bmjopen-2020-043686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
533 Case JB, Winkler ES, Errico JM, Diamond MS. On the road to ending the COVID-19 pandemic: Are we there yet? Virology 2021;557:70-85. [PMID: 33676349 DOI: 10.1016/j.virol.2021.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
534 Smail SW, Saeed M, Twana Alkasalias, Khudhur ZO, Younus DA, Rajab MF, Abdulahad WH, Hussain HI, Niaz K, Safdar M. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review. Food Chem Toxicol 2021;150:112087. [PMID: 33640537 DOI: 10.1016/j.fct.2021.112087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
535 Anand U, Adelodun B, Pivato A, Suresh S, Indari O, Jakhmola S, Jha HC, Jha PK, Tripathi V, Di Maria F. A review of the presence of SARS-CoV-2 RNA in wastewater and airborne particulates and its use for virus spreading surveillance. Environ Res 2021;196:110929. [PMID: 33640498 DOI: 10.1016/j.envres.2021.110929] [Cited by in Crossref: 12] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
536 Choi WI, Kim IB, Park SJ, Ha EH, Lee CW. Comparison of the clinical characteristics and mortality of adults infected with human coronaviruses 229E and OC43. Sci Rep 2021;11:4499. [PMID: 33627764 DOI: 10.1038/s41598-021-83987-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
537 Sun J, Liu M, Yang N. Insight into the origin of SARS-CoV-2 through structural analysis of receptor recognition: a molecular simulation study. RSC Adv 2021;11:8718-29. [PMID: 35423354 DOI: 10.1039/d1ra00127b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
538 Nazario-Toole AE, Xia H, Gibbons TF. Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution. Mil Med 2021:usab031. [PMID: 33609027 DOI: 10.1093/milmed/usab031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
539 Ji YL, Wu Y, Qiu Z, Ming H, Zhang Y, Zhang AN, Leng Y, Xia ZY. The Pathogenesis and Treatment of COVID-19: A System Review. Biomed Environ Sci 2021;34:50-60. [PMID: 33531107 DOI: 10.3967/bes2021.007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
540 Abdellatif AAH, Tawfeek HM, Abdelfattah A, El-Saber Batiha G, Hetta HF. Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems. J Drug Deliv Sci Technol 2021;63:102435. [PMID: 33643448 DOI: 10.1016/j.jddst.2021.102435] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
541 Zhang H, Ma S, Han T, Qu G, Cheng C, Uy JP, Shaikh MB, Zhou Q, Song EJ, Sun C. Association of smoking history with severe and critical outcomes in COVID-19 patients: A systemic review and meta-analysis.Eur J Integr Med. 2021;43:101313. [PMID: 33619437 DOI: 10.1016/j.eujim.2021.101313] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
542 Maldonado LL, Bertelli AM, Kamenetzky L. Molecular features similarities between SARS-CoV-2, SARS, MERS and key human genes could favour the viral infections and trigger collateral effects. Sci Rep 2021;11:4108. [PMID: 33602998 DOI: 10.1038/s41598-021-83595-1] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
543 Kalungi A, Kinyanda E, Akena DH, Kaleebu P, Bisangwa IM. Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Plasmodium falciparum Infection Be Protective? Front Immunol 2021;12:565625. [PMID: 33679730 DOI: 10.3389/fimmu.2021.565625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
544 Husev M, Rovenchak A. On the Verge of Life: Distribution of Nucleotide Sequences in Viral RNAs. Biosemiotics 2021;:1-17. [PMID: 33613787 DOI: 10.1007/s12304-021-09403-5] [Reference Citation Analysis]
545 Chan KK, Tan TJC, Narayanan KK, Procko E. An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants. Sci Adv 2021;7:eabf1738. [PMID: 33597251 DOI: 10.1126/sciadv.abf1738] [Cited by in Crossref: 19] [Cited by in F6Publishing: 52] [Article Influence: 19.0] [Reference Citation Analysis]
546 Horndler L, Delgado P, Abia D, Balabanov I, Martínez-Fleta P, Cornish G, Llamas MA, Serrano-Villar S, Sánchez-Madrid F, Fresno M, van Santen HM, Alarcón B. Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein. EMBO Mol Med 2021;13:e13549. [PMID: 33471406 DOI: 10.15252/emmm.202013549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
547 Okpara IC, Oghagbon EK. Mitigating the Risk of COVID-19 Deaths in Cardiovascular Disease Patients in Africa Resource Poor Communities. Front Cardiovasc Med 2021;8:626115. [PMID: 33665211 DOI: 10.3389/fcvm.2021.626115] [Reference Citation Analysis]
548 Shahhosseini N, Wong G, Kobinger GP, Chinikar S. SARS-CoV-2 spillover transmission due to recombination event. Gene Rep 2021;23:101045. [PMID: 33615041 DOI: 10.1016/j.genrep.2021.101045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
549 Kunnumakkara AB, Rana V, Parama D, Banik K, Girisa S, Henamayee S, Thakur KK, Dutta U, Garodia P, Gupta SC, Aggarwal BB. COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci 2021;:119201. [PMID: 33607159 DOI: 10.1016/j.lfs.2021.119201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
550 Pestka SB. Old drug, new Trick? The rationale for the treatment of COVID-19 with activated protein C. Med Hypotheses 2021;149:110537. [PMID: 33647606 DOI: 10.1016/j.mehy.2021.110537] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
551 Miotto M, Di Rienzo L, Bò L, Boffi A, Ruocco G, Milanetti E. Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin. Front Mol Biosci 2021;8:607443. [PMID: 33659275 DOI: 10.3389/fmolb.2021.607443] [Cited by in Crossref: 5] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
552 Ravi RC, Ponugubati CC, Bonu SK, Athkuri S, Uppalapati LV, Majeti C. Knowledge and awareness on novel coronavirus spread among dental fraternities in Visakhapatnam, India: A questionnaire-based survey. J Educ Health Promot 2020;9:353. [PMID: 33575389 DOI: 10.4103/jehp.jehp_458_20] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
553 Dobaño C, Santano R, Jiménez A, Vidal M, Chi J, Rodrigo Melero N, Popovic M, López-Aladid R, Fernández-Barat L, Tortajada M, Carmona-Torre F, Reina G, Torres A, Mayor A, Carolis C, García-Basteiro AL, Aguilar R, Moncunill G, Izquierdo L. Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies. Transl Res 2021;232:60-74. [PMID: 33582244 DOI: 10.1016/j.trsl.2021.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
554 Shang J, Du L, Han N, Lv D, Wang J, Yang H, Bai L, Tang H. Severe acute respiratory syndrome coronavirus 2 for physicians: Molecular characteristics and host immunity (Review). Mol Med Rep 2021;23:262. [PMID: 33576464 DOI: 10.3892/mmr.2021.11901] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
555 Laing ED, Sterling SL, Richard SA, Epsi NJ, Coggins S, Samuels EC, Phogat S, Yan L, Moreno N, Coles CL, Drew M, Mehalko J, Merritt S, Mende K, Munster V, de Wit E, Chung KK, Millar EV, Tribble DR, Simons MP, Pollett SD, Esposito D, Lanteri C, Clifton GT, Mitre E, Burgess TH, Broder CC. Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses. medRxiv 2021:2021. [PMID: 33594376 DOI: 10.1101/2021.02.10.21251518] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
556 Alipoor SD, Mortaz E, Jamaati H, Tabarsi P, Bayram H, Varahram M, Adcock IM. COVID-19: Molecular and Cellular Response. Front Cell Infect Microbiol 2021;11:563085. [PMID: 33643932 DOI: 10.3389/fcimb.2021.563085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
557 Saha I, Ghosh N, Maity D, Seal A, Plewczynski D. COVID-DeepPredictor: Recurrent Neural Network to Predict SARS-CoV-2 and Other Pathogenic Viruses. Front Genet 2021;12:569120. [PMID: 33643375 DOI: 10.3389/fgene.2021.569120] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
558 Wißmann JE, Kirchhoff L, Brüggemann Y, Todt D, Steinmann J, Steinmann E. Persistence of Pathogens on Inanimate Surfaces: A Narrative Review. Microorganisms 2021;9:343. [PMID: 33572303 DOI: 10.3390/microorganisms9020343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
559 Schuster O, Zvi A, Rosen O, Achdout H, Ben-Shmuel A, Shifman O, Yitzhaki S, Laskar O, Feldberg L. Specific and Rapid SARS-CoV-2 Identification Based on LC-MS/MS Analysis. ACS Omega 2021;6:3525-34. [PMID: 33585737 DOI: 10.1021/acsomega.0c04691] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
560 Shamsi A, Mohammad T, Anwar S, Amani S, Khan MS, Husain FM, Rehman MT, Islam A, Hassan MI. Potential drug targets of SARS-CoV-2: From genomics to therapeutics. Int J Biol Macromol 2021;177:1-9. [PMID: 33577820 DOI: 10.1016/j.ijbiomac.2021.02.071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
561 Ephrem BG, Appaadurai SG, Dhanasekaran BR. Analysis of COVID-19 infections in GCC countries to identify the indicators correlating the number of cases and deaths. PRR 2021;5:54-67. [DOI: 10.1108/prr-08-2020-0027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
562 Beale S, Lewer D, Aldridge RW, Johnson AM, Zambon M, Hayward A, Fragaszy E. Household transmission of seasonal coronavirus infections: Results from the Flu Watch cohort study. Wellcome Open Res 2020;5:145. [PMID: 33553677 DOI: 10.12688/wellcomeopenres.16055.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
563 Wang Q, Zhou ZJ, You Z, Wu DY, Liu SJ, Zhang WL, Fan KR, Luo R, Qiu Y, Ge XY. Epidemiology and evolution of novel deltacoronaviruses in birds in central China. Transbound Emerg Dis 2021. [PMID: 33559368 DOI: 10.1111/tbed.14029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
564 Raghuvamsi PV, Tulsian NK, Samsudin F, Qian X, Purushotorman K, Yue G, Kozma MM, Hwa WY, Lescar J, Bond PJ, MacAry PA, Anand GS. SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets. Elife 2021;10:e63646. [PMID: 33554856 DOI: 10.7554/eLife.63646] [Cited by in Crossref: 17] [Cited by in F6Publishing: 32] [Article Influence: 17.0] [Reference Citation Analysis]
565 Ding Q, Shults NV, Gychka SG, Harris BT, Suzuki YJ. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease. Int J Mol Sci 2021;22:1687. [PMID: 33567524 DOI: 10.3390/ijms22041687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
566 Dyrdak R, Hodcroft EB, Wahlund M, Neher RA, Albert J. Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020. J Clin Virol 2021;136:104754. [PMID: 33601153 DOI: 10.1016/j.jcv.2021.104754] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
567 Mehmood I, Ijaz M, Ahmad S, Ahmed T, Bari A, Abro A, Allemailem KS, Almatroudi A, Tahir Ul Qamar M. SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development. Int J Environ Res Public Health 2021;18:1626. [PMID: 33567746 DOI: 10.3390/ijerph18041626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
568 Chakravarty D, Das Sarma J. Murine-β-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2. J Neurovirol 2021;27:197-216. [PMID: 33547593 DOI: 10.1007/s13365-021-00945-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
569 Bhatta M, Nandi S, Dutta S, Saha MK. Coronavirus (SARS-CoV-2): a systematic review for potential vaccines.Hum Vaccin Immunother. 2021;1-18. [PMID: 33545014 DOI: 10.1080/21645515.2020.1865774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
570 Fleming N, Sacks LJ, Pham CT, Neoh SL, Ekinci EI. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting. Diabet Med 2021;38:e14509. [PMID: 33377213 DOI: 10.1111/dme.14509] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
571 Wells HL, Letko M, Lasso G, Ssebide B, Nziza J, Byarugaba DK, Navarrete-Macias I, Liang E, Cranfield M, Han BA, Tingley MW, Diuk-Wasser M, Goldstein T, Johnson CK, Mazet JAK, Chandran K, Munster VJ, Gilardi K, Anthony SJ. The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus. Virus Evol 2021;7:veab007. [PMID: 33754082 DOI: 10.1093/ve/veab007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
572 Deep A, Verma K, Swaroop S, Kumar A, Rungta S. Novel coronavirus (COVID-19) and its potential G.I. manifestation: A review. J Family Med Prim Care 2020;9:5474-9. [PMID: 33532381 DOI: 10.4103/jfmpc.jfmpc_1082_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
573 Shetti NP, Mishra A, Bukkitgar SD, Basu S, Narang J, Raghava Reddy K, Aminabhavi TM. Conventional and Nanotechnology-Based Sensing Methods for SARS Coronavirus (2019-nCoV). ACS Appl Bio Mater 2021;4:1178-90. [PMID: 34192244 DOI: 10.1021/acsabm.0c01545] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
574 Zarandi PK, Zinatizadeh MR, Zinatizadeh M, Yousefi MH, Rezaei N. SARS-CoV-2: From the pathogenesis to potential anti-viral treatments. Biomed Pharmacother 2021;137:111352. [PMID: 33550050 DOI: 10.1016/j.biopha.2021.111352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
575 Nalugo M, Schulte LJ, Masood MF, Zayed MA. Microvascular Angiopathic Consequences of COVID-19. Front Cardiovasc Med 2021;8:636843. [PMID: 33604359 DOI: 10.3389/fcvm.2021.636843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
576 Nakagawa K, Makino S. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression. Cells 2021;10:300. [PMID: 33540583 DOI: 10.3390/cells10020300] [Cited by in Crossref: 6] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
577 Naik AQ, Zafar T, Shrivastava VK. The Perspective of Coronavirus Disease Outbreak: Epidemiology, Transmission, and Possible Treatment. Vector-Borne and Zoonotic Diseases 2021;21:78-85. [DOI: 10.1089/vbz.2020.2678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
578 Choudhary J, Dheeman S, Sharma V, Katiyar P, Karn SK, Sarangi MK, Chauhan AK, Verma G, Baliyan N. Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review. Biol Proced Online 2021;23:5. [PMID: 33526007 DOI: 10.1186/s12575-020-00141-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
579 Ram K, Thakur RC, Singh DK, Kawamura K, Shimouchi A, Sekine Y, Nishimura H, Singh SK, Pavuluri CM, Singh RS, Tripathi SN. Why airborne transmission hasn't been conclusive in case of COVID-19? An atmospheric science perspective. Sci Total Environ 2021;773:145525. [PMID: 33940729 DOI: 10.1016/j.scitotenv.2021.145525] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
580 Rehman Z, Fahim A, Bhatti MF. Scouting the receptor-binding domain of SARS coronavirus 2: a comprehensive immunoinformatics inquisition. Future Virology 2021;16:117-32. [DOI: 10.2217/fvl-2020-0269] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
581 Mishra SK, Tripathi T. One year update on the COVID-19 pandemic: Where are we now? Acta Trop 2021;214:105778. [PMID: 33253656 DOI: 10.1016/j.actatropica.2020.105778] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 82.0] [Reference Citation Analysis]
582 Khan AA, Baildya N, Dutta T, Ghosh NN. Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study. Microb Pathog 2021;152:104762. [PMID: 33524563 DOI: 10.1016/j.micpath.2021.104762] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
583 Adivitiya, Kaushik MS, Chakraborty S, Veleri S, Kateriya S. Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections. Biology (Basel) 2021;10:95. [PMID: 33572760 DOI: 10.3390/biology10020095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
584 Viana-Llamas MC, Arroyo-Espliguero R, Silva-Obregón JA, Uribe-Heredia G, Núñez-Gil I, García-Magallón B, Torán-Martínez CG, Castillo-Sandoval A, Díaz-Caraballo E, Rodríguez-Guinea I, Domínguez-López J. Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study. Med Clin (Barc) 2021;156:428-36. [PMID: 33627230 DOI: 10.1016/j.medcli.2020.12.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
585 Pepin KM, Miller RS, Wilber MQ. A framework for surveillance of emerging pathogens at the human-animal interface: Pigs and coronaviruses as a case study. Prev Vet Med 2021;188:105281. [PMID: 33530012 DOI: 10.1016/j.prevetmed.2021.105281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
586 Jin H, Zhao Z, Lan Q, Zhou H, Mai Z, Wang Y, Ding X, Zhang W, Pi J, Evans CE, Liu X. Nasal Delivery of Hesperidin/Chitosan Nanoparticles Suppresses Cytokine Storm Syndrome in a Mouse Model of Acute Lung Injury. Front Pharmacol 2020;11:592238. [PMID: 33584267 DOI: 10.3389/fphar.2020.592238] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
587 Fischer N, Dauby N, Bossuyt N, Reynders M, Gérard M, Lacor P, Daelemans S, Lissoir B, Holemans X, Magerman K, Jouck D, Bourgeois M, Delaere B, Quoilin S, Van Gucht S, Thomas I, Barbezange C, Subissi L. Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study. Lancet Microbe 2021;2:e105-14. [PMID: 33937883 DOI: 10.1016/S2666-5247(20)30221-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
588 Han MW, Wang M, Xu MY, Qi WP, Wang P, Xi D. Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury. World J Clin Cases 2021; 9(3): 528-539 [PMID: 33553391 DOI: 10.12998/wjcc.v9.i3.528] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
589 Yin C. Latent periodicity-2 in coronavirus SARS-CoV-2 genome: Evolutionary implications. J Theor Biol 2021;515:110604. [PMID: 33508323 DOI: 10.1016/j.jtbi.2021.110604] [Reference Citation Analysis]
590 Yang D. Application of Nanotechnology in the COVID-19 Pandemic. Int J Nanomedicine 2021;16:623-49. [PMID: 33531805 DOI: 10.2147/IJN.S296383] [Cited by in Crossref: 9] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
591 Lockbaum GJ, Reyes AC, Lee JM, Tilvawala R, Nalivaika EA, Ali A, Kurt Yilmaz N, Thompson PR, Schiffer CA. Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188. Viruses 2021;13:174. [PMID: 33503819 DOI: 10.3390/v13020174] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 38.0] [Reference Citation Analysis]
592 Yu M, Zhang T, Zhang W, Sun Q, Li H, Li JP. Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins-An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic. Front Mol Biosci 2020;7:628551. [PMID: 33569392 DOI: 10.3389/fmolb.2020.628551] [Cited by in Crossref: 4] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
593 Al-Salihi KA, Khalaf JM. The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects. Vet World 2021;14:190-9. [PMID: 33642804 DOI: 10.14202/vetworld.2021.190-199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
594 Janik E, Bartos M, Niemcewicz M, Gorniak L, Bijak M. SARS-CoV-2: Outline, Prevention, and Decontamination. Pathogens 2021;10:114. [PMID: 33498679 DOI: 10.3390/pathogens10020114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
595 Wells HL, Letko M, Lasso G, Ssebide B, Nziza J, Byarugaba DK, Navarrete-Macias I, Liang E, Cranfield M, Han BA, Tingley MW, Diuk-Wasser M, Goldstein T, Johnson CK, Mazet J, Chandran K, Munster VJ, Gilardi K, Anthony SJ. The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus. bioRxiv 2021:2020. [PMID: 32676605 DOI: 10.1101/2020.07.07.190546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
596 Masoomikarimi M, Garmabi B, Alizadeh J, Kazemi E, Azari Jafari A, Mirmoeeni S, Dargahi M, Taheri N, Jafari R. Advances in immunotherapy for COVID-19: A comprehensive review. Int Immunopharmacol 2021;93:107409. [PMID: 33581501 DOI: 10.1016/j.intimp.2021.107409] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
597 Verma J, Subbarao N. A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics. Arch Virol 2021;166:697-714. [PMID: 33483791 DOI: 10.1007/s00705-021-04961-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
598 Mamkulathil Devasia R, Altaf M, Fahad Alrefaei A, Manoharadas S. Enhanced production of camptothecin by immobilized callus of Ophiorrhiza mungos and a bioinformatic insight into its potential antiviral effect against SARS-CoV-2. J King Saud Univ Sci 2021;33:101344. [PMID: 33531790 DOI: 10.1016/j.jksus.2021.101344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
599 Doharey PK, Singh V, Gedda MR, Sahoo AK, Varadwaj PK, Sharma B. In silico study indicates antimalarials as direct inhibitors of SARS-CoV-2-RNA dependent RNA polymerase. J Biomol Struct Dyn 2021;:1-18. [PMID: 33475021 DOI: 10.1080/07391102.2021.1871956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
600 Sallam M, Ababneh NA, Dababseh D, Bakri FG, Mahafzah A. Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa. Heliyon 2021;7:e06035. [PMID: 33495741 DOI: 10.1016/j.heliyon.2021.e06035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
601 Panda SK, Sen Gupta PS, Biswal S, Ray AK, Rana MK. ACE-2-Derived Biomimetic Peptides for the Inhibition of Spike Protein of SARS-CoV-2. J Proteome Res 2021;20:1296-303. [PMID: 33472369 DOI: 10.1021/acs.jproteome.0c00686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
602 Aziz A, Asif M, Ashraf G, Farooq U, Yang Q, Wang S. Trends in biosensing platforms for SARS-CoV-2 detection: A critical appraisal against standard detection tools. Curr Opin Colloid Interface Sci 2021;52:101418. [PMID: 33495685 DOI: 10.1016/j.cocis.2021.101418] [Cited by in Crossref: 12] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
603 Ganiny S, Nisar O. Mathematical modeling and a month ahead forecast of the coronavirus disease 2019 (COVID-19) pandemic: an Indian scenario. Model Earth Syst Environ 2021;:1-12. [PMID: 33490366 DOI: 10.1007/s40808-020-01080-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
604 Haas P, Muralidharan M, Krogan NJ, Kaake RM, Hüttenhain R. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology. J Proteome Res 2021;20:1133-52. [PMID: 33464917 DOI: 10.1021/acs.jproteome.0c00764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
605 Finkelstein MT, Mermelstein AG, Parker Miller E, Seth PC, Stancofski ED, Fera D. Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies. Viruses 2021;13:134. [PMID: 33477902 DOI: 10.3390/v13010134] [Cited by in Crossref: 19] [Cited by in F6Publishing: 33] [Article Influence: 19.0] [Reference Citation Analysis]
606 Khanduri A, Anand U, Doss M, Lovett L. Severe acute mitral valve regurgitation in a COVID-19-infected patient. BMJ Case Rep 2021;14:e239782. [PMID: 33462059 DOI: 10.1136/bcr-2020-239782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
607 Smith LTAC, Hodges CDRJ, Pratt M, Porter IM. Case Report: COVID-19 Patient With Chief Complaint of Anosmia and Ageusia; a Unique Perspective on Atypical Symptomatology and Management in the Military. Mil Med 2020;185:e2176-9. [PMID: 32776115 DOI: 10.1093/milmed/usaa196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
608 Aslam M, Farman M, Akgül A, Su M. Modeling and simulation of fractional order COVID-19 model with quarantined-isolated people. Math Methods Appl Sci 2021. [PMID: 33821071 DOI: 10.1002/mma.7191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
609 van Teijlingen E, Sathian B, Simkhada P, Banerjee I. COVID-19 in Qatar: Ways forward in public health and treatment. Qatar Med J 2020;2020:38. [PMID: 33447537 DOI: 10.5339/qmj.2020.38] [Reference Citation Analysis]
610 Zhang Z, Zhang L, Zhu A, Wang Y, Guan W, Zeng Z, Sun J, Li F, Zhao J, Yang Z, Zhao J, Zhong N. Narrative review of the novel coronavirus SARS-CoV-2: update on genomic characteristics, transmissions and animal model. J Thorac Dis 2020;12:7454-66. [PMID: 33447433 DOI: 10.21037/jtd-20-2084] [Reference Citation Analysis]
611 Acquah C, Jeevanandam J, Tan KX, Danquah MK. Engineered Aptamers for Enhanced COVID-19 Theranostics. Cell Mol Bioeng 2021;:1-13. [PMID: 33488836 DOI: 10.1007/s12195-020-00664-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
612 Ajayi A, Akhigbe R, K. Ram S, Kuku A, Bamidele J. Management of COVID-19 among Health Care Givers: An Afro-Asian Perspective. Asian J of Epidemiology 2021;14:11-21. [DOI: 10.3923/aje.2021.11.21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
613 Servidio C, Stellacci F. Therapeutic approaches against coronaviruses acute respiratory syndrome. Pharmacol Res Perspect 2021;9:e00691. [PMID: 33378565 DOI: 10.1002/prp2.691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
614 Almomani EY, Qablan AM, Atrooz FY, Almomany AM, Hajjo RM, Almomani HY. The Influence of Coronavirus Diseases 2019 (COVID-19) Pandemic and the Quarantine Practices on University Students' Beliefs About the Online Learning Experience in Jordan. Front Public Health 2020;8:595874. [PMID: 33520916 DOI: 10.3389/fpubh.2020.595874] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
615 Habib HM, Ibrahim S, Zaim A, Ibrahim WH. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed Pharmacother 2021;136:111228. [PMID: 33454595 DOI: 10.1016/j.biopha.2021.111228] [Cited by in Crossref: 19] [Cited by in F6Publishing: 71] [Article Influence: 19.0] [Reference Citation Analysis]
616 Wang R, Stephen P, Tao Y, Zhang W, Lin SX. Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic. Biomed Pharmacother 2021;137:111232. [PMID: 33486202 DOI: 10.1016/j.biopha.2021.111232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
617 Chen B, Liu M, Huang C. Current diagnostic and therapeutic strategies for COVID-19. J Pharm Anal 2021;11:129-37. [PMID: 33520327 DOI: 10.1016/j.jpha.2020.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
618 Siddique F, Abbas RZ, Mansoor MK, Alghamdi ES, Saeed M, Ayaz MM, Rahman M, Mahmood MS, Iqbal A, Manzoor M, Abbas A, Javaid A, Hussain I. An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants. Front Vet Sci 2020;7:586637. [PMID: 33521076 DOI: 10.3389/fvets.2020.586637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
619 Pontes C, Ruiz-Serra V, Lepore R, Valencia A. Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic β-CoVs. Comput Struct Biotechnol J 2021;19:759-66. [PMID: 33456724 DOI: 10.1016/j.csbj.2021.01.006] [Reference Citation Analysis]
620 Lavine JS, Bjornstad ON, Antia R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science 2021;371:741-5. [PMID: 33436525 DOI: 10.1126/science.abe6522] [Cited by in Crossref: 86] [Cited by in F6Publishing: 129] [Article Influence: 86.0] [Reference Citation Analysis]
621 Mészáros B, Sámano-Sánchez H, Alvarado-Valverde J, Čalyševa J, Martínez-Pérez E, Alves R, Shields DC, Kumar M, Rippmann F, Chemes LB, Gibson TJ. Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications. Sci Signal 2021;14:eabd0334. [PMID: 33436497 DOI: 10.1126/scisignal.abd0334] [Cited by in Crossref: 14] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
622 Herrera NG, Morano NC, Celikgil A, Georgiev GI, Malonis RJ, Lee JH, Tong K, Vergnolle O, Massimi AB, Yen LY, Noble AJ, Kopylov M, Bonanno JB, Garrett-Thomson SC, Hayes DB, Bortz RH 3rd, Wirchnianski AS, Florez C, Laudermilch E, Haslwanter D, Fels JM, Dieterle ME, Jangra RK, Barnhill J, Mengotto A, Kimmel D, Daily JP, Pirofski LA, Chandran K, Brenowitz M, Garforth SJ, Eng ET, Lai JR, Almo SC. Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis. ACS Omega 2021;6:85-102. [PMID: 33458462 DOI: 10.1021/acsomega.0c03512] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 21.0] [Reference Citation Analysis]
623 Chiem K, Morales Vasquez D, Park JG, Platt RN, Anderson T, Walter MR, Kobie JJ, Ye C, Martinez-Sobrido L. Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes. J Virol 2021:JVI. [PMID: 33431557 DOI: 10.1128/JVI.02209-20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
624 Liu D, Wu F, Cen Y, Ye L, Shi X, Huang Y, Fang S, Ma L. Comparative research on nucleocapsid and spike glycoprotein as the rapid immunodetection targets of COVID-19 and establishment of immunoassay strips. Mol Immunol 2021;131:6-12. [PMID: 33450670 DOI: 10.1016/j.molimm.2021.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
625 Song X, Shi Y, Ding W, Niu T, Sun L, Tan Y, Chen Y, Shi J, Xiong Q, Huang X, Xiao S, Zhu Y, Cheng C, Fu ZF, Liu ZJ, Peng G. Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes. Nat Commun 2021;12:141. [PMID: 33420048 DOI: 10.1038/s41467-020-20401-y] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
626 Diniz LRL, Perez-Castillo Y, Elshabrawy HA, Filho CDSMB, de Sousa DP. Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies. Biomolecules 2021;11:74. [PMID: 33430299 DOI: 10.3390/biom11010074] [Cited by in Crossref: 9] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
627 Duan S, Zhou M, Zhang W, Shen J, Qi R, Qin X, Yu H, Zhou C, Hu Q, Yu XJ. Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China. PLoS Negl Trop Dis 2021;15:e0008975. [PMID: 33411805 DOI: 10.1371/journal.pntd.0008975] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
628 Desalegn Z, Deyessa N, Teka B, Shiferaw W, Hailemariam D, Addissie A, Abagero A, Kaba M, Abebe W, Nega B, Ayele W, Haile T, Gebrehiwot Y, Amogne W, Kantelhardt EJ, Abebe T. COVID-19 and the public response: Knowledge, attitude and practice of the public in mitigating the pandemic in Addis Ababa, Ethiopia. PLoS One 2021;16:e0244780. [PMID: 33411766 DOI: 10.1371/journal.pone.0244780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
629 Maison DP, Ching LL, Shikuma CM, Nerurkar VR. Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation. bioRxiv 2021:2021. [PMID: 33442699 DOI: 10.1101/2021.01.06.425497] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 14.0] [Reference Citation Analysis]
630 Shi Y, Shi J, Sun L, Tan Y, Wang G, Guo F, Hu G, Fu Y, Fu ZF, Xiao S, Peng G. Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins. J Virol 2021:JVI. [PMID: 33414160 DOI: 10.1128/JVI.02284-20] [Reference Citation Analysis]
631 Krishnan A, Hamilton JP, Alqahtani SA, Woreta TA. COVID-19: An overview and a clinical update. World J Clin Cases 2021; 9(1): 8-23 [PMID: 33511168 DOI: 10.12998/wjcc.v9.i1.8] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
632 Hryhorowicz S, Ustaszewski A, Kaczmarek-Ryś M, Lis E, Witt M, Pławski A, Ziętkiewicz E. European context of the diversity and phylogenetic position of SARS-CoV-2 sequences from Polish COVID-19 patients. J Appl Genet 2021;62:327-37. [PMID: 33400131 DOI: 10.1007/s13353-020-00603-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
633 Tripathi N, Tripathi N, Goshisht MK. COVID-19: inflammatory responses, structure-based drug design and potential therapeutics. Mol Divers 2021. [PMID: 33400086 DOI: 10.1007/s11030-020-10176-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
634 Majumder J, Minko T. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19. AAPS J 2021;23:14. [PMID: 33400058 DOI: 10.1208/s12248-020-00532-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 91] [Article Influence: 7.0] [Reference Citation Analysis]
635 Gorgulla C, Padmanabha Das KM, Leigh KE, Cespugli M, Fischer PD, Wang ZF, Tesseyre G, Pandita S, Shnapir A, Calderaio A, Gechev M, Rose A, Lewis N, Hutcheson C, Yaffe E, Luxenburg R, Herce HD, Durmaz V, Halazonetis TD, Fackeldey K, Patten JJ, Chuprina A, Dziuba I, Plekhova A, Moroz Y, Radchenko D, Tarkhanova O, Yavnyuk I, Gruber C, Yust R, Payne D, Näär AM, Namchuk MN, Davey RA, Wagner G, Kinney J, Arthanari H. A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening. iScience 2021;24:102021. [PMID: 33426509 DOI: 10.1016/j.isci.2020.102021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
636 Rai P, Kumar BK, Deekshit VK, Karunasagar I, Karunasagar I. Detection technologies and recent developments in the diagnosis of COVID-19 infection. Appl Microbiol Biotechnol 2021;105:441-55. [PMID: 33394144 DOI: 10.1007/s00253-020-11061-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 50] [Article Influence: 16.0] [Reference Citation Analysis]
637 Szabolcs M, Sauter JL, Frosina D, Geronimo JA, Hernandez E, Selbs E, Rapkiewicz AV, Rekhtman N, Baine MK, Jäger E, Travis WD, Jungbluth AA. Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues. Appl Immunohistochem Mol Morphol 2021;29:5-12. [PMID: 33086222 DOI: 10.1097/PAI.0000000000000878] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
638 Yu CY, Chan KG, Yean CY, Ang GY. Nucleic Acid-Based Diagnostic Tests for the Detection SARS-CoV-2: An Update. Diagnostics (Basel) 2021;11:53. [PMID: 33401392 DOI: 10.3390/diagnostics11010053] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 36.0] [Reference Citation Analysis]
639 Awadasseid A, Wu Y, Tanaka Y, Zhang W. SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations. Int J Biol Sci 2021;17:97-106. [PMID: 33390836 DOI: 10.7150/ijbs.47827] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
640 Aygün D, Önal P, Apaydın G, Çokuğraş H. Coronavirus infections in childhood and vaccine studies. Turk Arch Pediatr 2021;56:10-4. [PMID: 34013223 DOI: 10.5152/TurkArchPediatr.2020.20255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
641 Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, Li T, Margolick JB, Pawelec G, Leng SX. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev 2021;65:101205. [PMID: 33137510 DOI: 10.1016/j.arr.2020.101205] [Cited by in Crossref: 196] [Cited by in F6Publishing: 188] [Article Influence: 196.0] [Reference Citation Analysis]
642 Peng F, Yuan H, Wu S, Zhou Y. Recent Advances on Drugs and Vaccines for COVID-19. Inquiry 2021;58:469580211055630. [PMID: 34818922 DOI: 10.1177/00469580211055630] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
643 Gohil K, Samson R, Dastager S, Dharne M. Probiotics in the prophylaxis of COVID-19: something is better than nothing. 3 Biotech 2021;11:1. [PMID: 33262924 DOI: 10.1007/s13205-020-02554-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 26.0] [Reference Citation Analysis]
644 Obaidullah AJ, Alanazi MM, Alsaif NA, Albassam H, Almehizia AA, Alqahtani AM, Mahmud S, Sami SA, Emran TB. Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2. RSC Adv 2021;11:18103-21. [DOI: 10.1039/d1ra02885e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
645 Bian J, Li Z. Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. Acta Pharm Sin B 2021;11:1-12. [PMID: 33072500 DOI: 10.1016/j.apsb.2020.10.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 41.0] [Reference Citation Analysis]
646 Vedova-costa JMD, Ramos ELP, Boschero RA, Ferreira GN, Soccol VT, Santiani MH, Pacce VD, Lustosa BPR, Vicente VA, Soccol CR. A Review on COVID-19 Diagnosis Tests Approved for Use in Brazil and the Impact on Pandemic Control. Braz arch biol technol 2021;64:e21200147. [DOI: 10.1590/1678-4324-75years-2021200147] [Reference Citation Analysis]
647 Akbulut E. Mutations in Main Protease of SARS CoV-2 Decreased Boceprevir Affinity. Braz arch biol technol 2021;64:e21200803. [DOI: 10.1590/1678-4324-2021200803] [Reference Citation Analysis]
648 Li J, He X, Yuan Yuan, Zhang W, Li X, Zhang Y, Li S, Guan C, Gao Z, Dong G. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Am J Infect Control 2021;49:82-9. [PMID: 32540370 DOI: 10.1016/j.ajic.2020.06.008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 60.0] [Reference Citation Analysis]
649 Trivedi V, Biswas K, Fattepur S, Sreeharsha N. Study on Genome Sequence of Novel Corona virus (Sars-Cov-2) Strains in Different Countries. Biomed Pharmacol J 2020;13:2015-24. [DOI: 10.13005/bpj/2080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
650 He W, Chen Q. [Progress in source tracking of SARS-CoV-2]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1838-42. [PMID: 33380405 DOI: 10.12122/j.issn.1673-4254.2020.12.22] [Reference Citation Analysis]
651 Dimonaco NJ, Salavati M, Shih BB. Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin Populations. Viruses 2020;13:E49. [PMID: 33396801 DOI: 10.3390/v13010049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
652 Kim E, Lee D. Coronaviruses: SARS, MERS and COVID-19. Korean J Clin Lab Sci 2020;52:297-309. [DOI: 10.15324/kjcls.2020.52.4.297] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
653 Kumar A, Loharch S, Kumar S, Ringe RP, Parkesh R. Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2. Comput Struct Biotechnol J 2021;19:424-38. [PMID: 33391634 DOI: 10.1016/j.csbj.2020.12.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
654 Chang O, Gonzales-Zubiate FA, Zhinin-Vera L, Valencia-Ramos R, Pineda I, Diaz-Barrios A. A protein folding robot driven by a self-taught agent. Biosystems 2021;201:104315. [PMID: 33358827 DOI: 10.1016/j.biosystems.2020.104315] [Reference Citation Analysis]
655 Berhane Y, Suderman M, Babiuk S, Pickering B. Susceptibility of turkeys, chickens and chicken embryos to SARS-CoV-2. Transbound Emerg Dis 2020. [PMID: 33372384 DOI: 10.1111/tbed.13970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
656 Celardo I, Pace L, Cifaldi L, Gaudio C, Barnaba V. The immune system view of the coronavirus SARS-CoV-2. Biol Direct 2020;15:30. [PMID: 33371901 DOI: 10.1186/s13062-020-00283-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
657 Zhu H, Du W, Song M, Liu Q, Herrmann A, Huang Q. Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2. Comput Struct Biotechnol J 2021;19:467-76. [PMID: 33505639 DOI: 10.1016/j.csbj.2020.12.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
658 Paraskevis D, Kostaki EG, Alygizakis N, Thomaidis NS, Cartalis C, Tsiodras S, Dimopoulos MA. A review of the impact of weather and climate variables to COVID-19: In the absence of public health measures high temperatures cannot probably mitigate outbreaks. Sci Total Environ 2021;768:144578. [PMID: 33450689 DOI: 10.1016/j.scitotenv.2020.144578] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
659 Jarai BM, Stillman Z, Bomb K, Kloxin AM, Fromen CA. Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19. ACS Biomater Sci Eng 2021;7:1742-64. [PMID: 33356134 DOI: 10.1021/acsbiomaterials.0c01287] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
660 Mukherjee TK, Malik P, Maitra R, Hoidal JR. Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses. Curr Med Res Opin 2021;37:207-17. [PMID: 33306409 DOI: 10.1080/03007995.2020.1862532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
661 Ravelomanantsoa NAF, Guth S, Andrianiaina A, Andry S, Gentles A, Ranaivoson HC, Brook CE. The zoonotic potential of bat-borne coronaviruses. Emerg Top Life Sci 2020;4:353-69. [PMID: 33258903 DOI: 10.1042/ETLS20200097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
662 Young KT, Lahmers KK, Sellers HS, Stallknecht DE, Poulson RL, Saliki JT, Tompkins SM, Padykula I, Siepker C, Howerth EW, Todd M, Stanton JB. Randomly primed, strand-switching, MinION-based sequencing for the detection and characterization of cultured RNA viruses. J Vet Diagn Invest 2021;33:202-15. [PMID: 33357075 DOI: 10.1177/1040638720981019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
663 Refaey RH, El-Ashrey MK, Nissan YM. Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study. Virology 2021;554:48-54. [PMID: 33370597 DOI: 10.1016/j.virol.2020.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
664 Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, Khan ST. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules 2020;26:E39. [PMID: 33374759 DOI: 10.3390/molecules26010039] [Cited by in Crossref: 23] [Cited by in F6Publishing: 82] [Article Influence: 11.5] [Reference Citation Analysis]
665 Laali A, Tabibzadeh A, Esghaei M, Yousefi P, Soltani S, Ajdarkosh H, Mosavi-Jarrahi A, Karbalaie Niya MH. Liver Function Tests Profile in COVID-19 Patients at the Admission Time: A Systematic Review of Literature and Conducted Researches. Adv Biomed Res 2020;9:74. [PMID: 33912490 DOI: 10.4103/abr.abr_73_20] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
666 Tagliamonte MS, Abid N, Borocci S, Sangiovanni E, Ostrov DA, Kosakovsky Pond SL, Salemi M, Chillemi G, Mavian C. Multiple Recombination Events and Strong Purifying Selection at the Origin of SARS-CoV-2 Spike Glycoprotein Increased Correlated Dynamic Movements. Int J Mol Sci 2020;22:E80. [PMID: 33374797 DOI: 10.3390/ijms22010080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
667 Ortega MA, Fraile-Martínez O, García-Montero C, García-Gallego S, Sánchez-Trujillo L, Torres-Carranza D, Álvarez-Mon MÁ, Pekarek L, García-Honduvilla N, Bujan J, Álvarez-Mon M, Asúnsolo Á, De la Torre B. An integrative look at SARS‑CoV‑2 (Review). Int J Mol Med 2021;47:415-34. [PMID: 33416095 DOI: 10.3892/ijmm.2020.4828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
668 Won JH, Lee H. The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic. Int J Mol Sci 2020;21:E9775. [PMID: 33371468 DOI: 10.3390/ijms21249775] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 8.5] [Reference Citation Analysis]
669 Chan KK, Tan TJC, Narayanan KK, Procko E. An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants. bioRxiv 2020:2020. [PMID: 33398275 DOI: 10.1101/2020.10.18.344622] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 6.5] [Reference Citation Analysis]
670 Shatizadeh Malekshahi S, Yavarian J, Shafiei-Jandaghi NZ. Usage of peptidases by SARS-CoV-2 and several human coronaviruses as receptors: A mysterious story. Biotechnol Appl Biochem 2020. [PMID: 33347649 DOI: 10.1002/bab.2087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
671 Fernandes IG, de Brito CA, Dos Reis VMS, Sato MN, Pereira NZ. SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It? Oxid Med Cell Longev 2020;2020:8844280. [PMID: 33381273 DOI: 10.1155/2020/8844280] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
672 De Sabato L, Di Bartolo I, De Marco MA, Moreno A, Lelli D, Cotti C, Delogu M, Vaccari G. Can Coronaviruses Steal Genes from the Host as Evidenced in Western European Hedgehogs by EriCoV Genetic Characterization? Viruses 2020;12:E1471. [PMID: 33419245 DOI: 10.3390/v12121471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
673 Li J, Geng J, Su L, Yang B, Gai Z. A case series report of hospitalized children with severe acute respiratory syndrome coronavirus-2 infection in Jinan, China. SAGE Open Med Case Rep 2020;8:2050313X20978018. [PMID: 33329895 DOI: 10.1177/2050313X20978018] [Reference Citation Analysis]
674 Elaswad A, Fawzy M, Basiouni S, Shehata AA. Mutational spectra of SARS-CoV-2 isolated from animals. PeerJ 2020;8:e10609. [PMID: 33384909 DOI: 10.7717/peerj.10609] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
675 Galipeau Y, Greig M, Liu G, Driedger M, Langlois MA. Humoral Responses and Serological Assays in SARS-CoV-2 Infections. Front Immunol 2020;11:610688. [PMID: 33391281 DOI: 10.3389/fimmu.2020.610688] [Cited by in Crossref: 43] [Cited by in F6Publishing: 101] [Article Influence: 21.5] [Reference Citation Analysis]
676 Bobay LM, O'Donnell AC, Ochman H. Recombination events are concentrated in the spike protein region of Betacoronaviruses. PLoS Genet 2020;16:e1009272. [PMID: 33332358 DOI: 10.1371/journal.pgen.1009272] [Cited by in Crossref: 15] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
677 Hadisi Z, Walsh T, Dabiri SMH, Seyfoori A, Hamdi D, Mirani B, Pagan E, Jardim A, Akbari M. Management of Coronavirus Disease 2019 (COVID-19) Pandemic: From Diagnosis to Treatment Strategies. Adv Ther (Weinh) 2020;:2000173. [PMID: 33614905 DOI: 10.1002/adtp.202000173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
678 Shen L, Cui S, Zhang D, Lin C, Chen L, Wang Q. Comparison of four commercial RT-PCR diagnostic kits for COVID-19 in China. J Clin Lab Anal 2021;35:e23605. [PMID: 33320386 DOI: 10.1002/jcla.23605] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
679 Barek MA, Aziz MA, Islam MS. Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases. Heliyon 2020;6:e05684. [PMID: 33344791 DOI: 10.1016/j.heliyon.2020.e05684] [Cited by in Crossref: 19] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
680 Zhu X, Yang L, Huang K. COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment. Diabetes Metab Syndr Obes 2020;13:4953-9. [PMID: 33363393 DOI: 10.2147/DMSO.S285197] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
681 Vivarelli S, Falzone L, Torino F, Scandurra G, Russo G, Bordonaro R, Pappalardo F, Spandidos DA, Raciti G, Libra M. Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review). Int J Oncol 2021;58:145-57. [PMID: 33491759 DOI: 10.3892/ijo.2020.5159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
682 Hartanto H, Wu M, Lam ML, Chen TH. Microfluidic immunoassay for detection of serological antibodies: A potential tool for rapid evaluation of immunity against SARS-CoV-2. Biomicrofluidics 2020;14:061507. [PMID: 33343783 DOI: 10.1063/5.0031521] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
683 Bratosiewicz-Wąsik J, Wąsik TJ. Does Virus-Receptor Interplay Influence Human Coronaviruses Infection Outcome? Med Sci Monit 2020;26:e928572. [PMID: 33311429 DOI: 10.12659/MSM.928572] [Reference Citation Analysis]
684 Zappulli V, Ferro S, Bonsembiante F, Brocca G, Calore A, Cavicchioli L, Centelleghe C, Corazzola G, De Vreese S, Gelain ME, Mazzariol S, Moccia V, Rensi N, Sammarco A, Torrigiani F, Verin R, Castagnaro M. Pathology of Coronavirus Infections: A Review of Lesions in Animals in the One-Health Perspective. Animals (Basel) 2020;10:E2377. [PMID: 33322366 DOI: 10.3390/ani10122377] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
685 Lee SC, Son KJ, Han CH, Jung JY, Park SC. Impact of comorbid asthma on severity of coronavirus disease (COVID-19). Sci Rep 2020;10:21805. [PMID: 33311519 DOI: 10.1038/s41598-020-77791-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
686 Du Y, Zhou N, Zha W, Lv Y. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutr Metab Cardiovasc Dis 2021;31:745-55. [PMID: 33549450 DOI: 10.1016/j.numecd.2020.12.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
687 Jakhmola S, Indari O, Kashyap D, Varshney N, Rani A, Sonkar C, Baral B, Chatterjee S, Das A, Kumar R, Jha HC. Recent updates on COVID-19: A holistic review. Heliyon 2020;6:e05706. [PMID: 33324769 DOI: 10.1016/j.heliyon.2020.e05706] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
688 Gorain B, Choudhury H, Molugulu N, Athawale RB, Kesharwani P. Fighting Strategies Against the Novel Coronavirus Pandemic: Impact on Global Economy. Front Public Health 2020;8:606129. [PMID: 33363098 DOI: 10.3389/fpubh.2020.606129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
689 Sharma R, Palanisamy A, Dhama K, Mal G, Singh B, Singh KP. Exploring the possible use of saponin adjuvants in COVID-19 vaccine. Hum Vaccin Immunother 2020;16:2944-53. [PMID: 33295829 DOI: 10.1080/21645515.2020.1833579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
690 Gomes CP, Fernandes DE, Casimiro F, da Mata GF, Passos MT, Varela P, Mastroianni-Kirsztajn G, Pesquero JB. Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics. Front Cell Infect Microbiol 2020;10:589505. [PMID: 33364201 DOI: 10.3389/fcimb.2020.589505] [Cited by in Crossref: 15] [Cited by in F6Publishing: 35] [Article Influence: 7.5] [Reference Citation Analysis]
691 Arman A, Tajik M, Nazemipour M, Ahmadinejad Z, Shahrestanaki SK, Hazrati E, Mansournia N, Mansournia MA. Risk factors of developing critical conditions in Iranian patients with COVID-19. Glob Epidemiol 2021;3:100046. [PMID: 33521624 DOI: 10.1016/j.gloepi.2020.100046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
692 Al-Mohammad A, Partridge DG, Fent G, Watson O, Lewis NT, Storey RF, Makris M, Chico TJ. The cardiac complications of COVID-19: many publications, multiple uncertainties. Vasc Biol 2020;2:R105-14. [PMID: 33283157 DOI: 10.1530/VB-20-0009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
693 Alexandrova R, Beykov P, Vassilev D, Jukić M, Podlipnik Č. The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19. Biotechnology & Biotechnological Equipment 2021;35:74-102. [DOI: 10.1080/13102818.2020.1847683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
694 Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claër L, Quentric P, Fadlallah J, Devilliers H, Ghillani P, Gunn C, Hockett R, Mudumba S, Guihot A, Luyt CE, Mayaux J, Beurton A, Fourati S, Bruel T, Schwartz O, Lacorte JM, Yssel H, Parizot C, Dorgham K, Charneau P, Amoura Z, Gorochov G. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med 2021;13:eabd2223. [PMID: 33288662 DOI: 10.1126/scitranslmed.abd2223] [Cited by in Crossref: 166] [Cited by in F6Publishing: 378] [Article Influence: 83.0] [Reference Citation Analysis]
695 Ali S, Alam BF, Farooqi F, Almas K, Noreen S. Dental and Medical Students' Knowledge and Attitude toward COVID-19: A Cross-Sectional Study from Pakistan. Eur J Dent 2020;14:S97-S104. [PMID: 33285569 DOI: 10.1055/s-0040-1719219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
696 Yuan Y, He J, Gong L, Li W, Jiang L, Liu J, Chen Q, Yu J, Hou S, Shi Y, Lu S, Zhang Z, Ge Y, Sa N, He L, Wu J, Sun Y, Liu Z. Molecular epidemiology of SARS-CoV-2 clusters caused by asymptomatic cases in Anhui Province, China. BMC Infect Dis 2020;20:930. [PMID: 33287717 DOI: 10.1186/s12879-020-05612-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
697 Younger DS. Coronavirus 2019: clinical and neuropathological aspects. Curr Opin Rheumatol 2021;33:49-57. [PMID: 33229976 DOI: 10.1097/BOR.0000000000000769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
698 Wang RY, Zheng KQ, Xu BZ, Zhang W, Si JG, Xu CY, Chen H, Xu ZY, Wu XM. Healthy neonate born to a SARS-CoV-2 infected woman: A case report and review of literature. World J Clin Cases 2020; 8(23): 6016-6025 [PMID: 33344600 DOI: 10.12998/wjcc.v8.i23.6016] [Reference Citation Analysis]
699 Wang R, Zheng K, Xu B, Zhang W, Si J, Xu C, Chen H, Xu Z, Wu X. Healthy neonate born to a SARS-CoV-2 infected woman: A case report and review of literature. WJCC 2020;8:6012-20. [DOI: 10.12998/wjcc.v8.i23.6012] [Reference Citation Analysis]
700 Poston D, Weisblum Y, Wise H, Templeton K, Jenks S, Hatziioannou T, Bieniasz P. Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection. Clin Infect Dis 2021;73:e1208-11. [PMID: 33270134 DOI: 10.1093/cid/ciaa1803] [Cited by in Crossref: 14] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
701 Ang JP, Dong F, Patalinghug J. COVID-19: effectiveness of socioeconomic factors in containing the spread and mortality. International Review of Applied Economics 2021;35:164-87. [DOI: 10.1080/02692171.2020.1853078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
702 Albtoush OM, Al-Shdefat RB, Al-Akaileh A. Chest CT scan features from 302 patients with COVID-19 in Jordan. Eur J Radiol Open 2020;7:100295. [PMID: 33288999 DOI: 10.1016/j.ejro.2020.100295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
703 Hokello J, Sharma AL, Shukla GC, Tyagi M. A narrative review on the basic and clinical aspects of the novel SARS-CoV-2, the etiologic agent of COVID-19. Ann Transl Med 2020;8:1686. [PMID: 33490198 DOI: 10.21037/atm-20-5272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
704 Siddiqui O, Manchanda V, Yadav A, Sagar T, Tuteja S, Nagi N, Saxena S. Comparison of two real-time polymerase chain reaction assays for the detection of severe acute respiratory syndrome-CoV-2 from combined nasopharyngeal-throat swabs. Indian J Med Microbiol 2020;38:385-9. [PMID: 33154251 DOI: 10.4103/ijmm.IJMM_20_279] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
705 Kumar P, Ahmad MI, Singh S. COVID-19: A Devastating Pandemic. Pharm Sci 2020;26:S3-S11. [DOI: 10.34172/ps.2020.34] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
706 Yoshizawa N, Ishihara R, Omiya D, Ishitsuka M, Hirano S, Suzuki T. Application of a Photocatalyst as an Inactivator of Bovine Coronavirus. Viruses 2020;12:E1372. [PMID: 33266175 DOI: 10.3390/v12121372] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
707 Santopolo S, Riccio A, Santoro MG. The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy. Biochem Biophys Res Commun 2021;538:80-7. [PMID: 33303190 DOI: 10.1016/j.bbrc.2020.10.080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
708 Le TK, Paris C, Khan KS, Robson F, Ng WL, Rocchi P. Nucleic Acid-Based Technologies Targeting Coronaviruses. Trends Biochem Sci 2021;46:351-65. [PMID: 33309323 DOI: 10.1016/j.tibs.2020.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
709 Thakur S, Mayank, Sarkar B, Ansari AJ, Khandelwal A, Arya A, Poduri R, Joshi G. Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update. Food Chem Toxicol 2021;147:111887. [PMID: 33253764 DOI: 10.1016/j.fct.2020.111887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
710 Hefeda MM. CT chest findings in patients infected with COVID-19: review of literature. Egypt J Radiol Nucl Med 2020;51. [DOI: 10.1186/s43055-020-00355-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
711 Cheng Y, Yue L, Wang Z, Zhang J, Xiang G. Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus. J Diabetes Complications 2021;35:107809. [PMID: 33288414 DOI: 10.1016/j.jdiacomp.2020.107809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
712 Tang L, Wang Y, Zhang Y, Zhang XY, Zeng XC, Song B. COVID-19: A review of what radiologists need to know. World J Clin Cases 2020; 8(22): 5501-5512 [PMID: 33344540 DOI: 10.12998/wjcc.v8.i22.5501] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
713 Chan AP, Choi Y, Schork NJ. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets. mSphere 2020;5:e00754-20. [PMID: 33239366 DOI: 10.1128/mSphere.00754-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
714 Laing E, Sterling S, Richard S, Epsi N, Phogat S, Samuels E, Yan L, Moreno N, Coles C, Drew M, Mehalko J, English C, Merritt S, Mende K, Chung K, Clifton G, Munster V, de Wit E, Tribble D, Agan B, Esposito D, Lanteri C, Mitre E, Burgess T, Broder C. A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactions. Res Sq 2020:rs. [PMID: 33269345 DOI: 10.21203/rs.3.rs-105768/v1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
715 Ghosh S, Malik YS. Drawing Comparisons between SARS-CoV-2 and the Animal Coronaviruses. Microorganisms 2020;8:E1840. [PMID: 33238451 DOI: 10.3390/microorganisms8111840] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
716 Sahoo S, Mahapatra SR, Parida BK, Rath S, Dehury B, Raina V, Mohakud NK, Misra N, Suar M. DBCOVP: A database of coronavirus virulent glycoproteins. Comput Biol Med 2021;129:104131. [PMID: 33276297 DOI: 10.1016/j.compbiomed.2020.104131] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
717 Suzuki YJ, Nikolaienko SI, Dibrova VA, Dibrova YV, Vasylyk VM, Novikov MY, Shults NV, Gychka SG. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells. Vascul Pharmacol 2021;137:106823. [PMID: 33232769 DOI: 10.1016/j.vph.2020.106823] [Cited by in Crossref: 11] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
718 Wang W, Lin XD, Zhang HL, Wang MR, Guan XQ, Holmes EC, Zhang YZ. Extensive genetic diversity and host range of rodent-borne coronaviruses. Virus Evol 2020;6:veaa078. [PMID: 33318860 DOI: 10.1093/ve/veaa078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
719 Benzigar MR, Bhattacharjee R, Baharfar M, Liu G. Current methods for diagnosis of human coronaviruses: pros and cons. Anal Bioanal Chem 2021;413:2311-30. [PMID: 33219449 DOI: 10.1007/s00216-020-03046-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
720 Monni G, Corda V, Iuculano A. Prenatal screening diagnosis and management in the era of coronavirus: the Sardinian experience. J Perinat Med 2020;48:943-9. [PMID: 32628637 DOI: 10.1515/jpm-2020-0208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
721 Magadum A, Kishore R. Cardiovascular Manifestations of COVID-19 Infection. Cells 2020;9:E2508. [PMID: 33228225 DOI: 10.3390/cells9112508] [Cited by in Crossref: 25] [Cited by in F6Publishing: 47] [Article Influence: 12.5] [Reference Citation Analysis]
722 Younis NK, Zareef RO, Al Hassan SN, Bitar F, Eid AH, Arabi M. Hydroxychloroquine in COVID-19 Patients: Pros and Cons. Front Pharmacol 2020;11:597985. [PMID: 33364965 DOI: 10.3389/fphar.2020.597985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
723 Chen YJ, Bagchi P, Tsai B. ER functions are exploited by viruses to support distinct stages of their life cycle. Biochem Soc Trans 2020;48:2173-84. [PMID: 33119046 DOI: 10.1042/BST20200395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
724 Rajendran M, Roy S, Ravichandran K, Mishra B, Gupta DK, Nagarajan S, Arul Selvaraj RC, Provaznik I. In silico screening and molecular dynamics of phytochemicals from Indian cuisine against SARS-CoV-2 MPro. J Biomol Struct Dyn 2020;:1-15. [PMID: 33200680 DOI: 10.1080/07391102.2020.1845980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
725 Yang H, Chi Y, Chen Z, Fan Y, Wu H, Hu X, Wu T, Xiao B, Zhang M. Differential Diagnosis and Hospital Emergency Management for Fastlane Treatment of Central Nervous System Infection Under the COVID-19 Epidemic in Changsha, China. Front Neurol 2020;11:555202. [PMID: 33192989 DOI: 10.3389/fneur.2020.555202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
726 Bozkurt F, Yousef A, Abdeljawad T. Analysis of the outbreak of the novel coronavirus COVID-19 dynamic model with control mechanisms. Results Phys 2020;19:103586. [PMID: 33527069 DOI: 10.1016/j.rinp.2020.103586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
727 Hu Z, Yang Z, Li Q, Zhang A. The COVID-19 Infodemic: Infodemiology Study Analyzing Stigmatizing Search Terms. J Med Internet Res 2020;22:e22639. [PMID: 33156807 DOI: 10.2196/22639] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
728 Gentles AD, Guth S, Rozins C, Brook CE. A review of mechanistic models of viral dynamics in bat reservoirs for zoonotic disease. Pathog Glob Health 2020;114:407-25. [PMID: 33185145 DOI: 10.1080/20477724.2020.1833161] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
729 Al-Zaqri N, Pooventhiran T, Alharthi FA, Bhattacharyya U, Thomas R. Structural investigations, quantum mechanical studies on proton and metal affinity and biological activity predictions of selpercatinib. J Mol Liq 2021;325:114765. [PMID: 33746318 DOI: 10.1016/j.molliq.2020.114765] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
730 Noor FM, Islam MM. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. J Community Health 2020;45:1270-82. [PMID: 32918645 DOI: 10.1007/s10900-020-00920-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 82] [Article Influence: 27.0] [Reference Citation Analysis]
731 Wang L, Xiang Y. Spike Glycoprotein-Mediated Entry of SARS Coronaviruses. Viruses 2020;12:E1289. [PMID: 33187074 DOI: 10.3390/v12111289] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
732 Sharma P, Reddy PK, Kumar B. Trace Element Zinc, a Nature's Gift to Fight Unprecedented Global Pandemic COVID-19. Biol Trace Elem Res 2021;199:3213-21. [PMID: 33170448 DOI: 10.1007/s12011-020-02462-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
733 Khalili H, Nourian A, Ahmadinejad Z, Emadi Kouchak H, Jafari S, Dehghan Manshadi SA, Rasolinejad M, Kebriaeezadeh A. Efficacy and safety of sofosbuvir/ ledipasvir in treatment of patients with COVID-19; A randomized clinical trial. Acta Biomed 2020;91:e2020102. [PMID: 33525212 DOI: 10.23750/abm.v91i4.10877] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
734 Benski C, Di Filippo D, Taraschi G, Reich MR. Guidelines for Pregnancy Management During the COVID-19 Pandemic: A Public Health Conundrum. Int J Environ Res Public Health 2020;17:E8277. [PMID: 33182412 DOI: 10.3390/ijerph17218277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
735 Sofi MS, Hamid A, Bhat SU. SARS-CoV-2: A critical review of its history, pathogenesis, transmission, diagnosis and treatment. Biosaf Health 2020;2:217-25. [PMID: 33196035 DOI: 10.1016/j.bsheal.2020.11.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
736 Yang Y, Chen XFD, Chen Y, Xie H, Xie C, Ying L. The influence of hypoglycemia and hyperglycemia on the adverse outcome of COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22587. [PMID: 33126305 DOI: 10.1097/MD.0000000000022587] [Reference Citation Analysis]
737 Chu G, Jiao W, Xie F, Zhang M, Niu H. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Associated Urogenital Disease: A Current Update. World J Mens Health 2021;39:444-53. [PMID: 33151049 DOI: 10.5534/wjmh.200168] [Reference Citation Analysis]
738 Al-Subaie AM. Coagulopathies in novel coronavirus (SARS-CoV-2) pandemic: Emerging evidence for hematologists. Saudi J Biol Sci 2021;28:956-61. [PMID: 33169062 DOI: 10.1016/j.sjbs.2020.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
739 Shi L, Li Q, Li K, Zheng J, He Y, Zhang X, Gong X, Wang W, Zhang Q, Dai C, Zhao W, Meng X, Du F, Fan P, Li C, Gao C, Yang Y, Liu X, Chen Y, Liu J, Li J, Yang N, Niu Y, Chen H, Zhang G, Yan T, Zhu L, Han Q, Fan W, Ye F, Liu Z, Lin S, Zhao Y, Chen T. Quarantine at home may not enough!-from the epidemiological data in Shaanxi Province of China. BMC Res Notes 2020;13:506. [PMID: 33187555 DOI: 10.1186/s13104-020-05342-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
740 Rana EA, Chowdhury NS, Islam MS, Ara J, Nasrin SS, Dutta P, Bristi SZT, Nizami TA, Chakraborty P, Siddiki AZ. Molecular detection and prevalence of SARS-CoV-2 during the early outbreak in Southern Bangladesh. Int J One Health 2020;6:153-9. [DOI: 10.14202/ijoh.2020.153-159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
741 Khorramdelazad H, Kazemi MH, Najafi A, Keykhaee M, Zolfaghari Emameh R, Falak R. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection. Microb Pathog 2021;152:104554. [PMID: 33157216 DOI: 10.1016/j.micpath.2020.104554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
742 Abdul-Kadir MA, Lim LT. Human coronaviruses: ophthalmic manifestations. BMJ Open Ophthalmol 2020;5:e000630. [PMID: 33195813 DOI: 10.1136/bmjophth-2020-000630] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
743 Ryoo N, Pyun JM, Baek MJ, Suh J, Kang MJ, Wang MJ, Youn YC, Yang DW, Kim SY, Park YH, Kim S. Coping with Dementia in the Middle of the COVID-19 Pandemic. J Korean Med Sci 2020;35:e383. [PMID: 33140593 DOI: 10.3346/jkms.2020.35.e383] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
744 Pišlar A, Mitrović A, Sabotič J, Pečar Fonović U, Perišić Nanut M, Jakoš T, Senjor E, Kos J. The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors. PLoS Pathog 2020;16:e1009013. [PMID: 33137165 DOI: 10.1371/journal.ppat.1009013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
745 Wu S, Tian C, Liu P, Guo D, Zheng W, Huang X, Zhang Y, Liu L. Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions. J Med Virol 2021;93:2132-40. [PMID: 33090512 DOI: 10.1002/jmv.26597] [Cited by in Crossref: 20] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
746 Hu Y, Ma C, Szeto T, Hurst B, Tarbet B, Wang J. Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture. bioRxiv 2020:2020. [PMID: 33140049 DOI: 10.1101/2020.10.30.362335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
747 Ahmed MH, Hassan A. Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review. SN Compr Clin Med. 2020;1-10. [PMID: 33163859 DOI: 10.1007/s42399-020-00610-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 60] [Article Influence: 10.5] [Reference Citation Analysis]
748 Guruprasad L. Human coronavirus spike protein-host receptor recognition. Prog Biophys Mol Biol 2021;161:39-53. [PMID: 33137344 DOI: 10.1016/j.pbiomolbio.2020.10.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
749 El Hassab MA, Shoun AA, Al-Rashood ST, Al-Warhi T, Eldehna WM. Identification of a New Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular Dynamics, and MM-PBSA Calculations. Front Chem 2020;8:584894. [PMID: 33195080 DOI: 10.3389/fchem.2020.584894] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
750 Barbosa A, Varsani A, Morandini V, Grimaldi W, Vanstreels RET, Diaz JI, Boulinier T, Dewar M, González-Acuña D, Gray R, McMahon CR, Miller G, Power M, Gamble A, Wille M. Risk assessment of SARS-CoV-2 in Antarctic wildlife. Sci Total Environ 2021;755:143352. [PMID: 33162142 DOI: 10.1016/j.scitotenv.2020.143352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
751 Chen YH, Wang H. Exploring Diversity of COVID‑19 Based on Substitution Distance. Infect Drug Resist 2020;13:3887-94. [PMID: 33149633 DOI: 10.2147/IDR.S277620] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
752 Fathi F, Sami R, Mozafarpoor S, Hafezi H, Motedayyen H, Arefnezhad R, Eskandari N. Immune system changes during COVID-19 recovery play key role in determining disease severity. Int J Immunopathol Pharmacol 2020;34:2058738420966497. [PMID: 33076729 DOI: 10.1177/2058738420966497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
753 Ma NL, Peng W, Soon CF, Noor Hassim MF, Misbah S, Rahmat Z, Yong WTL, Sonne C. Covid-19 pandemic in the lens of food safety and security. Environ Res 2021;193:110405. [PMID: 33130165 DOI: 10.1016/j.envres.2020.110405] [Cited by in Crossref: 14] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
754 Cheng ZJ, Qu HQ, Tian L, Duan Z, Hakonarson H. COVID-19: Look to the Future, Learn from the Past. Viruses 2020;12:E1226. [PMID: 33138262 DOI: 10.3390/v12111226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
755 Abdelghany TM, Ganash M, Bakri MM, Qanash H, Al-Rajhi AMH, Elhussieny NI. SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions. Biomed J 2021;44:86-93. [PMID: 33602634 DOI: 10.1016/j.bj.2020.10.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
756 Sanghvi AR. COVID-19: An overview for dermatologists. Int J Dermatol 2020;59:1437-49. [PMID: 33107038 DOI: 10.1111/ijd.15257] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
757 de Morais HA, Dos Santos AP, do Nascimento NC, Kmetiuk LB, Barbosa DS, Brandão PE, Guimarães AMS, Pettan-Brewer C, Biondo AW. Natural Infection by SARS-CoV-2 in Companion Animals: A Review of Case Reports and Current Evidence of Their Role in the Epidemiology of COVID-19.